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11. INTRODUCTION AND BACKGROUND 
1.1 General introduction 
Each year in Norway, about 130 children and adolescents under the age of 15 are diagnosed 
with cancer (incidence 15,3/100.000), and 40 children die annually of cancer [1]. Each year, 
approximately 40 children and adolescents in this age group are diagnosed with Acute 
Lymphatic Leukaemia (ALL) (incidence 3,9/100.000) [2]. ALL constitutes nearly 1/3 of all 
the cases of childhood cancer, and brain tumours about 1/4. Different solid tumours form the 
rest, as shown in figure 1.
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These are types of cancer that strike children and adolescents at an age when they are very 
vulnerable, both physically and psychologically. ALL is most typically diagnosed in 
preschool-age children, with a striking incidence peak at age 2-7 years [3], which is a period 
of life with rapid brain maturation and development.
New treatments involving a combination of chemotherapy and radiotherapy have resulted in 
significant improvements in the rate of survival, from about 20 % in 1960 to approximately 
80 % in terms of the average 5-years survival in recent years [2, 4]. Thus, about 1 of every 
1.000 adults who reaches the age of 20 in developed Western countries will be a long-time 
survivor of childhood cancer [5]. In developed countries, advances in medical treatment are a 
result of coordinated and targeted research by specialized groups, e.g., the Children’s 
Oncology Group (in the U.S.), the Cancer Study Group (in the U.K.), and the Société 
Distribution (%) of the most 
common forms of childhood 
cancer under the age of 15 in the 
Nordic countries, 1985 – 1994.
2Internationale d’Oncologie Pédiatrique (SIOP), as well as of centralized treatment in hospitals 
specializing in paediatric oncology [5]. These efforts have resulted in considerable similarities 
between treatment protocols and survival rates in different countries. In the Nordic countries, 
a Nordic Paediatric Haematology and Oncology group (NOPHO) has been established, which 
ensures that children from the Nordic countries are all treated according to the same protocol 
[2].
1.1.1 Clinical background 
For a ten-year period from 1993-2002 I was employed as a clinical psychologist consultant in 
the Norwegian Cancer Organization and connected to the Department of Paediatrics at St. 
Olavs University Hospital in Trondheim. Through this work I became acquainted with many 
children who had cancer, and with their families, and got to follow them during the different 
phases of their treatment. I also had the opportunity to observe their efforts to readapt to a 
normal life with friends, at kindergarten or school, and was able to follow the progress of 
parents as they returned to work and struggled to establish a normal life again (not least for 
the siblings), after long periods when their energy was drained by the cancer. ALL is certainly 
a long-lasting process that poses tremendous challenge to both child and family. It was 
amazing to see how they were able to cope and find strength to continue their life.
During my clinical work I felt an increasing need to understand more about the impact of 
cancer such as ALL and its treatment on individuals who live for years after their initial 
diagnosis. The children often underwent regular and extremely painful procedures during the 
active treatment phase. The treatment can be aggressive, lengthy and very painful, and they 
often experienced multiple hospitalizations, physical side-effects and many restrictions in 
their everyday activities as a result of this. I often wondered what impact such periods of 
extreme stress might have on a child and on her/his parents and siblings. I also had the 
opportunity to follow some children after they finished their treatment. It was my experience 
that some of the children and their families had a hard time finding their way back to a 
“normal” life, and that they often suffered in silence. Their needs did not seem to be met after 
their treatment ended. It was these experiences that gave me the motivation to plan a follow-
up study about children with ALL, which matured and became a reality the day I got a four 
year scholarship from the Department of Psychology at the Norwegian University of Science 
and Technology (NTNU).
31.1.2 Acute Lymphoblastic Leukaemia (ALL) 
ALL is the most common form of childhood cancer, and comprises about 85% of leukaemia 
cases, 10-15% are Acute Myelogen Leukaemia (AML). ALL is a malignant disorder of the 
lymphoid cells found in the bone marrow: it is a fast-growing cancer of the white blood cells, 
where malignant white blood cells migrate via the circulatory system to virtually the entire 
organ system, including the CNS. In cases involving ALL, the bone marrow produces many 
unformed cells called “blasts” which would normally develop into lymphocytes. However, 
these blasts are abnormal, do not develop further, and cannot fight infections. The number of 
abnormal or leukaemia cells grows quickly. They crowd out the healthy red blood cells, white 
blood cells and platelets that the body needs [6].
The typical symptoms of ALL are: 1) Anaemia, 2) a reduced amount of white blood cells, 3) 
fever, 4) loss of energy/fatigue, 5) frequent infections, 6) easy bleeding or bruising, and 7) 
diffuse pain, especially in the bones. Furthermore, during ALL the abnormal cells may collect 
in the brain or spinal cord (CNS). This may result headaches, sometimes accompanied by 
vomiting, although most children with the disease do not have these symptoms. Leukaemia 
cells can also collect in the testicles and cause swelling. The diagnosis is given after an 
assessment of blood tests and bone marrow aspiration [6, 7].  
1.1.3 ALL treatment, physical and psychological side effects  
Intensifying the treatment for ALL has improved the overall prognosis [8]. ALL treatment 
protocols normally involve different combinations of chemotherapy (CT) and, in some very 
rare cases, cranial irradiation therapy (CRT). The intensity depends on the severity of the 
ALL. Prophylactic treatment which focused on treating the CNS in order to prevent CNS 
relapse was central in raising the survival rate. However, its agents are known to have a 
transiting neurotoxic effect, which is thought to play a central part in the occurrence of 
persistent brain sequelae [9-14] and neuropsychological function deficits [15, 16]. As 
documentation on the connection between CRT and cognitive and neuropsychological late 
effects grew, doses of CRT were reduced from 2400Cgy to 1800Cgy and their usage was 
restricted to high intensive protocols only. Today, direct CNS treatment is prescribed for older 
children only, and with a clear CNS-affection. With limits placed on the use of CRT, there 
was an increased use of CT directed toward CNS. How effective therapy might be depends on 
4several factors, including what combination of therapeutic agents is used to treat the disease, 
the intensity of the treatment protocol, and the risk of relapse [17]. 
The treatment groups for the NOPHO-ALL-1992 protocol are: 1) Standard risk (SR), 2) 
Intermediate risk (IR), 3) High risk (HR), 4) High risk-1 (HR-1), 5) High risk-2 (HR-2), and 
6) Very high risk-1 (VHR). In general, risk group assignment is assessed mainly on the 
child’s age and leukocyte count. The contemporary protocols are more individualized, 
involving the careful assignment of children to leukemic risk groups. For instance, children 
who undergo more intensive therapies are classified as HR. For SR patients, most protocols 
treat the CNS without CRT, achieving comparable efficacy with intrathecal and systemic drug 
combinations. HR patients, however, may require CRT to provide the CNS with adequate 
protection against relapse or even to protect against the risk of haematological relapse [6].  
The length of treatment for ALL can vary from 2 to 2,5 years [17], and is mostly 
divided into three or four phases: 1) remission induction (with the induction phase taking up 
the first 7 weeks of treatment); 2) CNS preventative-/prophylactic therapy; 3) consolidation, 
and 4) maintenance. The first remission induction phase entails an initial, highly intensive 
period of treatment, where the disease is brought into remission during a period of intensive 
drug therapy that typically lasts about 7 weeks. The purpose of the remission induction phase 
is to rapidly eradicate leukaemia cells from the bone marrow and circulatory system. This 
phase is then followed by an intensification of the treatment. This prophylactic or preventative 
phase of therapy can last from weeks to months and is necessary to prevent CNS relapse, 
because the CNS is known to serve as a sanctuary for occult leukaemia.  This treatment may 
involve CRT in combination with a drug delivered directly into the spinal canal (so-called 
intrathecal therapy), or, in many institutions, drug therapy on its own. Consolidation may be 
used to intensify therapy following remission induction. This phase of the treatment continues 
for several months and is then followed by maintenance therapy which usually lasts for about 
2 years. This involves drug therapies only, often with periods of intrathecal therapy. 
Maintenance therapy is required for prolonged periods (often many months) afterwards 
because of the possible presence of undetectable and potentially fatal amounts of leukaemia 
cells [6, 17]. 
Treatment for ALL involves high levels of acute distress, generally caused by anxiety and 
pain associated with some of the medical procedures – such as bone marrow aspirations, 
5lumbar and venous punctions, and injections with chemotherapeutic agents, as well as bouts 
of nausea and vomiting resulting from chemotherapy and from continued anxiety associated 
with the treatment [6, 18, 19]. 
Children undergoing treatment for ALL experience a number of bodily changes. Some side 
effects, such as weight loss or gain, loss of hair, and mouth ulcers, may be reversible, while 
others, such as sterility, and organic brain damage, may be permanent. Visible changes to the 
physical appearance of a child are a constant reminder that she or he is different from other 
children. The side effects which accompany the treatment continually affect the child’s self-
image, and concerns about a potential loss of self-esteem brought about by these alterations in 
body image have been the focus of previous research [18, 20, 21]. 
Changes to a child’s physical appearance can bring about a loss of self-confidence which in 
turn can lead to regressive behaviour, a withdrawal from her or his peers, and a fear of 
attending school, all of which can affect the phase of emotional and social adjustment and the 
level of academic performance. The life-threatening nature of the disease is the most striking 
aspect of cancer. Studies have shown that the child is fully aware of how serious the disease 
is, and this awareness is associated with increased anxiety [22-24]. It has been shown that a 
child’s age is a less important factor in how aware he or she is of the potential for a shortened 
life-span than is her or his experience with the disease and its treatment. Levels of anxiety in a 
child with cancer seem to increase the longer the disease progresses and the more visits there 
are to the clinic [22, 25]. For parents, the child’s treatment involves emotional as well as 
practical burdens in addition to the threat of loss. Previous studies have shown an increase in 
anxiety and depression, feelings of guilt, sleep disturbance, isolation and anxiety about the 
future, as well as increases in stress and in conflicts between the couples [26-28], in addition 
to rises in the levels of PTSD symptoms [29-33]. 
1.2 Late effects 
The challenges associated with survivorship have attracted more and more attention as the 
number of cancer survivors goes up annually. Since these numbers should continue to rise, it 
becomes even more important to understand the unique needs of this population and to 
identify those who are most at risk of complications in their treatment, and who might benefit 
from interventions designed to alleviate or reduce that risk. Considering that they are exposed, 
6among other things, to treatment such as radiotherapy and chemotherapy, survivors will be 
vulnerable to a range of late effects [34, 35]. Medical and psychological late effects are 
defined as occurring after the successful completion of medical therapy, usually two or more 
years from the time of diagnosis [36]. 
1.2.1 Somatic complications 
Late effects from the new treatment forms may give rise to somatic complications such as 
reduced fertility (particularly in boys), cardiomyopathy (especially in girls), reduced lung 
functioning, and osteoporosis. Further complications include reduced linear growth and 
endocrine disturbances brought about when cranial irradiation is included in therapy, in 
addition to second cancer (in 2-3 percent of all patients) [3]. A recent meta-analysis showed 
that children who were survivors of ALL appeared to experience clinically significant 
declines in neurocognitive functioning [37]. 
1.2.2 Health-related quality of life (HRQOL), mental health, psychosocial and 
cognitive outcomes 
As the treatment for such cancer can be aggressive and associated with both acute and long-
term morbidity [38], the focus in much of the research has changed, with the emphasis now 
being on the health-related quality of life [39], as well as psychosocial [40], cognitive and 
neuropsychological outcomes [41]. The study of the health-related quality of life (HRQOL) in 
children is a relatively new field of research [42]. Such studies can have considerable 
significance for understanding children’s psychosocial functioning and development [43, 44]. 
The child’s risk of mental and psychosocial problems is doubled or tripled in the presence of a 
chronic condition [45, 46]. Psychosocial outcomes in childhood cancer have been the subject 
of previous research, but do not generally provide consistent results with regards to 
psychosocial adjustment. Studies have shown that many survivors function reasonably well, 
with little difference found between results for survivors and those for their peers or siblings 
[31, 47, 48].  It is also reported that a considerable proportion of survivors had long-term 
coping [49, 50], while poorer coping in cancer patients was associated with longer treatment 
time [49].  Coping styles are more closely described in Paper 5. In addition, other studies have 
indicated increased risks of maladaptive psychosocial sequels, such as depression, anxiety, 
problems of self-esteem and fluctuations in mood [20, 51], moderate emotional difficulties 
(including depression), problems with interpersonal relationships, withdrawal and isolation, 
7the use of denial as a defence mechanism, strong dependency on parents [50, 52, 53], and 
symptoms of posttraumatic stress [29, 33]. Controversial findings with regards to childhood 
cancer and psychosocial adjustment [50, 51, 53] can be explained by methodological 
restrictions – such as heterogeneity in samples of patients with respect to time since diagnosis, 
differences in diagnosis, and differences in age at the time of diagnosis with concomitant 
differences in levels of development [40]. Other explanations can include differences in 
treatment protocols and intensitivity [54], as well as a lack of sensitivity in the tools of 
investigation - e.g. self-report instruments for children are still quite limited. In addition, a 
further problem has been the different criteria used when selecting control groups (norm 
data/matched control groups of children from a healthy population/ siblings/peers) [37, 55]. 
Earlier studies have also tended to focus on different domains when it comes to looking at 
psychological variables, which make it difficult to compare them. All of these aspects place 
limitations on how useful the findings are with regards to actual adjustment problems for 
children with cancer [56].  
Studies on the cognitive outcomes of CNS prophylaxis yield contradictory results [54], 
though recent reports suggest that survivors treated with chemotherapy only, also suffered 
minor cognitive impairment [14, 57-60]. Furthermore, a recent meta-analysis showed that 
children who survived ALL appeared to experience clinically significant declines in 
neurocognitive functioning [37], both in global and specific areas of neurocognitive 
functioning. These effects were thought to have been caused by the treatments used to cure 
their disease. Interestingly, these declines are less clear when compared to normative data 
[37].  Hence, continued evaluation of levels of cognitive and learning functioning in children 
who have been treated for moderate-risk acute lymphocytic leukaemia is recommended [54, 
61-62]. Last et al [5] focus on the fact that it is not yet known what happens to aging brains long 
after they have been exposed to cranial radiation therapy and/or chemotherapy during 
childhood.
Some previous studies suggest that the risk of CNS toxicity in SR patients can be 
considerably reduced by treating the CNS without radiation [63]. But the intensive drug 
therapy required and the neurotoxic potential of these agents raise questions about the extent 
to which cognition can be spared. For instance, the dexamethasone used in the induction 
treatment phase has been shown to lessen the risk for CNS relapse and to improve the overall 
event-free survival, but it has also been suspected of increasing the risk of neurocognitive 
8damage [3]. In some studies, comparable neuropsychological sequelae have been documented 
among children treated with and without CRT [64-66].  
1.3 Developmental aspects 
The implications of cancer vary with each child’s cognitive, emotional and social course of 
development. How children understand the cancer they suffer from is greatly influenced by 
such developmental aspects as their ability to acquire knowledge, to understand and reflect 
upon their situation. Both the coping strategies of their families, and the attitudes 
professionals have to informing the child, will have a further impact on the children’s 
adaptation [25]. In modern developmental psychology, the interactive process between 
children and their caregivers is considered critical for a child’s development and adjustment 
[67, 68]. This important alliance between the child and caregiver can be disturbed when a 
child falls ill with cancer, because the parents can have anxieties and worries of their own, 
and this therefore become a crucial aspect of the child’s further development and adjustment 
[69]. It should therefore be emphasized that caregivers have a separate need of follow-up care, 
in order to be able to provide good support to their children. How a child copes with her or his 
illness depends a great deal on the backup they receive from the whole family [70]. 
A paediatric health-related quality of life (HRQOL) instrument which includes a 
developmental perspective must therefore be sensitive both to cognitive and emotional 
changes throughout the age span. Daily functioning in contexts that are relevant for children, 
such as school and the local community should also be assessed [71]. The following questions 
are all affected by the child’s development: what can I ask; how should I ask; can I ask the 
child her/himself? What are the important areas children of different ages need to function in? 
Developmental tasks will vary from age to age, starting with their getting together with peers 
at the age of 4 to5: the performance of school-related tasks then becomes central, followed by 
gaining a position among peers and developing romantic relationships during adolescence, 
with a transition towards autonomy taking place in late adolescence. These are all examples of 
universal developmental tasks. Having a chronic condition may have a considerable effect on 
the process and outcome of dealing with these tasks [72].
Developmental issues in HRQOL have not received sufficient attention despite the 
obvious fact that children and adolescents undergo continuous and quite rapid development 
[43, 72]. Measuring HRQOL is therefore a task that may need to be assessed in slightly 
9different ways for children at different ages or for the same child over a certain period of time. 
And this raises certain questions: can the same definition of HRQOL be used across child 
development, or should HRQOL address different contents according to the child’s point of 
development? [74] The WHO has stressed that tools of measurement should be child centred, 
self-reported, age-dependent and cross-culturally comparable [75].  
1.4 Assessment of HRQOL in children 
The evaluation of HRQOL in adults is well established, and HRQOL measures are 
routinely included in many clinical trials. From a historical perspective, the measurement of 
children’s HRQOL has received less attention. The question of children’s HRQOL did not 
start to gain momentum until the 1980s [76]. Despite the growing interest in HRQOL 
outcomes, there are still only a few measures which attempt to assess HRQOL outcomes for 
children and adolescents [77]. Among the approximately 20.000 publications on HRQOL, 
around 15 % were related to children (N= 3050). HRQOL is meant to show how the patient 
functions in everyday life, using physical health as well as emotional, social and educational 
functioning as the yardsticks. Information about HRQOL in children with cancer might thus 
provide us with a more comprehensive means of evaluating the outcome of treatment than 
survival rates and relapse-free intervals alone.   
In everyday language, the phrase Quality of life (QOL) can mean several things, and these 
meanings have the potential to complicate the scientific study of QOL. The term QOL can be 
synonymous with happiness, or material wealth. Definitions and ideals will be dependent on 
the specific social, cultural, spiritual and historical circumstances in which we find ourselves.  
The term HRQOL is frequently used interchangeably with quality of life (QOL) [78]. 
However, QOL is considered as a broader and more general conceptual term related to non 
health-related aspects of life (e.g., the evaluation of the impact of architectural surroundings 
on general well-being) [79]: and as we have just seen, QOL is often synonymous with 
happiness or material wealth. The concept of HRQOL refers specifically to the impact that 
health and illnesses may have on the well-being of an individual, and on her or his ability to 
function in daily life, with respect to physical health, as well as emotional, social and school 
functioning, as these are delineated by the World Health Organization [80]. It is often 
distinguished from the more general and popular meanings of the term. This thesis is centred 
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on questions of HRQOL, but for the sake of simplicity the abbreviation QOL is also adopted 
sometimes.  
Any instrument used to measure HRQOL must be multidimensional and consist of the 
physical, psychological (including emotional and cognitive), and social-health dimensions 
delineated by the World Health Organization (WHO) [80]. The literature shows that there is 
substantial support for the systematic assessment of HRQOL as an important means of 
measuring outcome in paediatric populations. Medical efforts to extend the length of 
children’s lives should be augmented by efforts to improve the qualitative aspects of their 
lives as well. A recent review shows that although HRQOL research has become a major area 
of interest in paediatric outcome research, studies using HRQOL as an instrument of 
measurement remain limited [5]. To date, most studies have focused on broad adjustment 
issues such as depression and anxiety, educational attainment, and social functioning. Only 
recently have there been studies which focus on QOL [5]. There is a need for including QOL 
measures in paediatric settings and research trials, particularly given the fact that normal 
childhood development can be profoundly affected by the toxicities and untoward effects of 
aggressive medical treatments [81]. 
However, the lack of valid and reliable measures for children and adolescents does place 
certain limitations on current HRQOL research [82]. The presence of low concordance 
between proxy-and self-reports suggests a critical need in paediatric HRQOL measurement 
for reliable and valid child self-report instruments for the broadest possible age range [83]. 
Pediatric patient self-report should be considered the standard for measuring HRQOL, but 
there are times – when a child is too young, too cognitively impaired or fatigued to complete a 
HRQOL instrument, for example – that parent proxy-report instruments are also needed [84]. 
A previous review [77] showed that over 50% of studies used parents to report on their child’s 
QOL, and 40% used clinical staff. Only 19% of the studies addressed age differences in QOL, 
and QOL was assessed more often for older children (13-18 years) than for those between 6 
and 12 years.
HRQOL measures are categorized as either generic or disease-specific. Choosing 
between a generic or specific disease (or perhaps in some cases a combination of both), 
depends largely on the research question, the patient group in the study, the quality of the 
measure, or having the possibility to compare with a control group. Generic measures allow 
us to make comparisons between survivors and either control groups or the general 
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population. In a study of cancer patients who had been cured, a generic measure might 
sometimes be preferable to a cancer-specific one, because it provides the possibility of using 
the same instrument for a control group drawn from the general population. So choosing 
which tool of measurement is most appropriate has to be related to the overall purpose of the 
study.
1.4.1 HRQOL measures – methodological aspects
The lack of consensus regarding how to define QOL has previously been highlighted [85].
Koot and Wallander [73] note that QOL is a concept which is difficult to categorize and 
challenging to operate with. However, some researchers adopt stricter criteria, focusing on 
more comprehensive measures of QOL for which psychometric data are available. An 
important factor in selecting a HRQOL measure will be its psychometric adequacy as well as 
its ability to tap outcomes of primary interest to a particular investigation [81]. The 
importance of validating new translations should be emphasized, in order to investigate if the 
psychometric properties can be used further in both clinical practice and research. The two 
concepts required for a satisfactory measure are validity and reliability [43]. Validity is 
judged according to whether or not the questionnaire measures what it is supposed to 
measure, and is related to systematic measurement errors [86], while reliability is evaluated 
according to random errors and is related to the precision or consistency of the questionnaire 
(61).
Validity
Various ways of determining validity are discussed in detail elsewhere [86]. In this study we 
have used content, construct and discriminant validity. Content validity, which is related to 
face validity, is connected to the developmental process of a questionnaire and assesses the 
degree to which a test appears to measure what it claims to measure. It is meant to 
demonstrate how well procedures of comprehensive development were followed and 
documented. For the purposes of QOL assessments, validity usually asks “Does the measure 
accurately assess the theoretical construct of interest”, and this is thought to be a difficult 
question to answer, given the inconsistencies in QOL definitions and theoretical models [43, 
87].
Construct validity assesses whether or not a test measures the construct it purports to 
measure – e.g. that a QOL scale succeeds in measuring QOL. It particularly evaluates how 
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consistently an instrument of measurement relates to the concepts (i.e. constructs) that are 
being measured.  The process of establishing construct validity represents a key element in 
differentiating the science of behavioural measurement from other, non-scientific, approaches 
to the analysis of human behaviour [88]. This is a continuous process involving the theory 
behind the concepts and various psychometric testing. To demonstrate construct validity it is 
necessary to show not only that a measurement tool correlates highly with other variables 
with which it should correlate theoretically, but also that it does not correlate with variables 
from which it should differ. Discriminant validity, which involves comparisons with other 
known group, describes an instrument’s ability to discriminate accurately between known 
groups of patients: the discriminative validity of a measure is investigated by determining 
whether or not scores on a test accurately distinguish between children and adolescents known 
to differ in terms of their health status [81].  
Reliability
Reliability is a measure of random errors and is usually expressed by a number between 0 and 
1, where 1 indicates perfect reliability and 0 indicates the complete absence of any reliability. 
Reliability tells us about the precision or consistency of the test.
The internal consistency of the questionnaire is related to the number of items within a scale 
and their covariation when measuring a specific dimension. Internal consistency refers to the 
extent to which the items of a domain or scale assess the same dimension, and is normally 
measured using Cronbach’s alpha, which estimates the overall correlation between items 
included in a scale [89]. This is a statistical assessment of the correlation between items 
within a dimension, and it determines whether or not items within a scale correlate positively 
(that is to say, that they measure the same thing). The use of Cronbach’s alpha as a predictor 
of reliability proceeds from the assumption that all items reflect the same single underlying 
concept. An internal consistency of .70 or higher is recommended for measures used to detect 
between-group differences in clinical trials or outcome research [90].  
1.4.2 The PedsQLTM4.0
The Pediatric Quality of Life Inventory (PedsQL) has been translated into many European and 
other international languages, and is widely used in research. PedsQL was translated into 
Norwegian during 2002/2003, at a time when no other HRQOL measurements for children 
were available in Norway [91]. 
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The PedsQL[83] is considered one of the most promising HRQOL instruments for 
children and adolescents, integrating generic core scales and disease-specific modules into 
one system of measurement [92]. As a tool, it is particularly effective because it includes a 
broad age range with developmental sensitivity as well as categories for both parents and the 
young persons themselves. The PedsQL version 4.0 builds on programmatic instrument 
development research over the past 15 years, beginning with the measurement of pain and 
functional status [93]. The 4.0 version was designed to measure the core health dimensions 
delineated by WHO [80], including role (school) functioning [83], and was developed through 
focus groups and cognitive interviews [82]. The PedsQL 4.0 has been proposed as a valid and 
reliable generic paediatric HRQOL measurement that can be used for self-reports and proxy-
reports in age groups ranging from 2 to 18 years [83], and can also be used in clinical 
practice, clinical trials, and other research, as well as in school health settings and community 
populations [73, 83].  The PedsQL has shown satisfactory psychometric properties [83, 91].  
A Cronbach’s alpha  0.77 was obtained for the Norwegian translation of the PedsQL for the 
age group 13-15, which indicates good internal consistency [91]. 
1.4.3 The translation process 
The translation and linguistic validation of the PedsQL questionnaire followed recommended 
guidelines [94, 95]. Two independent forward translations were carried out by a psychiatrist 
and a clinical psychologist, and the translators discussed semantic and conceptual 
discrepancies before finally developing a consensus forward translation.  The back translation, 
whereby the first version of the PedsQL questionnaire was translated from the target language 
into the source language, was performed independently by a skilled English speaker with 
considerable experience of living in countries where English was the native language.
In a following pilot-project, the questionnaire was administered to a total of 10 
children, 12 adolescents and 23 parents in order to test how items were interpreted and 
understood, and response ratings: cognitive interview techniques [94] were used to obtain 
feedback about both. The questionnaires were then revised in response to feedback from 
children and parents. A written report was sent to Varni for further review. Relevant changes 
made during the translation process were checked and authorized by Varni.
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1.5 The parental perspective 
Good family functioning is one of the strongest contributors to adjustment both in 
children with chronic health problems [96] and healthy children. A cancer diagnosis poses a 
considerable threat to normal parent-child relationships [38]. Drotar 1997 [96] points out that 
in almost every reviewed study where there were non-significant findings related to 
family/parental functioning and child psychological outcomes, the amount of variance 
accounted for in children’s psychological outcomes was quite low overall – his approximate 
estimate is by 10-15%.  Research shows that high family cohesion and low family conflict 
consistently predict better adjustment in youths with chronic illness [96], as do adequate 
support from the family and wider network in combination with effective communication 
about the illness between parents and children [97, 98] Studies show that negative parental 
emotional responses, such as depression, are associated with poor adjustment both in children 
with cancer and children who are healthy [99].
The parent proxy-ratings are often qualitatively different from their children’s own 
rating and even from each other. Most research suggests that mothers are more involved than 
fathers in handling the emotional and instrumental demands and responsibilities associated 
with caretaking [97]. Eiser (2005) points out that fathers often remain more involved in 
everyday life despite the child’s illness. This aspect may influence the father’s own situation 
and needs, since by staying at home or at work more during the time the child is being treated, 
the father will not be able to get adequate help for his own emotional needs, and this may 
affect his later adjustment. Even as research participants, fathers are less involved 
longitudinally than mothers [100]. Hanson [97] argues that more data is needed because 
fathers have not been the subject of many studies. But what is clear is that a chronic condition 
in the family has different effects: each family member will experience different changes that 
have an impact on their QOL, at the same time as the family climate as a whole will be altered 
[97]. Higher levels of anxiety, distress, and/or depression have been found in some parents 
with children who have chronic conditions: parental adjustment overall has been consistently 
correlated with levels of support and stress in the family generally [98].  
2. AIMS OF THE STUDY 
The general aim of the present study was to increase our knowledge about children in 
remission from ALL, with a particular focus on their HRQOL, mental health, psychosocial 
and intellectual functioning. This was undertaken in order to contribute to improving the 
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rehabilitation and follow-up phase for children in remission from ALL, and to help prevent 
psychosocial problems for children, and their families, after they have been treated for cancer.  
Since no HRQOL measures were available at that time in Norway, an important first task was 
to translate the PedsQLTM 4.0 into Norwegian, and to start investigating the psychometric 
properties of the newly translated instruments of measurement to ensure that they could be 
used further in the main study of children in remission from ALL.  
The following specific aims evolved: 
1. To describe HRQOL in children and adolescents in remission from ALL by assessing 
both the PedsQL child self-report and parent proxy-report compared to healthy 
controls, and further to assess intellectual functioning in children in remission from 
ALL compared to healthy children (Paper I).   
2. To explore aspects of mental health and psychosocial adjustment for children in 
remission from ALL and their parents compared to healthy controls (Paper II).  
3. To evaluate the reliability and validity of the Norwegian translation of the PedsQL TM
(version 4.0 generic core scale) in a sample of healthy young adolescents (Paper III).
4. To examine the value of the PedsQL as a tool with which to assess depressive 
symptoms in a sample of young adolescents – controlling at the same time for 
recognized risk factors such as adverse and stressful life events as well as social 
anxiety. (Paper IV) 
5. To describe and discuss the theoretical and clinical aspects of the children’s 
adjustment to, and understanding of, their cancer experience. (Paper V). 
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3.  METHODOLOGY 
3.1 Study design 
The present study is based on a cross-sectional design. The information needed to register 
treatment related factors was gathered retrospectively from the medical records at the two 
participating University Hospitals – Rikshospitalet-Radiumhospitalet HF and St. Olavs. The 
data on HRQOL, mental health, psychosocial and intellectual functioning which was used to 
provide outcome variables, was gathered during the follow-up period.
 3.2 Subjects
The follow-up study of 40 children in remission from ALL between the ages of 8 and 15 
years, and their parents, was carried out from the autumn of 2003 to the autumn of 2004, and 
data from their control group was collated between the autumn of 2005 and the spring of 
2006. A validation study of 224 healthy young adolescents and parents was performed in 
2003 to corroborate the quality of the translated PedsQL questionnaire used in the follow-up 
study of children with ALL.  
3.2.1 Patient inclusion/exclusion criteria and control group 
Children and adolescents in remission from ALL were recruited from two University 
Hospitals in Norway: Rikshospitalet-Radiumhospitalet Medical Centre in Oslo and St. Olavs 
University Hospital in Trondheim. The children were born between 1989 and 1995, had a 
mean age of 11.8 (range 8.5-15.4), took part 4.2-12.5 years after their ALL diagnosis, and 
were treated according to the Nordic protocol, The Nordic Society of Paediatric 
Haematology/Oncology (NOPHO-ALL, 1992): their parents were also invited to participate 
in the study. Children who suffered relapses, or who had other kinds of severe medical 
condition (e.g. Down’s syndrome) were excluded. Of the 56 children who fulfilled the criteria 
for participation, a total of 40 (71.4%), comprising 21 girls (52.5%) and 19 boys (47.5%), 
took part. Parental information was supplied by 36 mothers, whose mean age was 40.0 (range 
30-55), and 21 fathers, whose mean age was 43.0 (range 32-58): each parent was asked to 
give their evaluation of the PedsQL proxy-report separately. Data regarding diagnoses and 
treatment protocols were collected from the medical records. The average age at the time ALL 
was diagnosed was 4.0 years (range 0-7.6). The average time since diagnosis was 7.9 years 
(range 4.2-12.5). The treatment categories were scored according to the Nordic protocol 
Children with ALL
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(NOPHO-ALL, 1992) with the following categories: 1) Standard risk (SR); 2) Intermediate 
risk (IR); 3) High risk (HR); 4) High risk-1 (HR-1); 5) High risk-2 (HR-2); and 6) Very high 
risk-1 (VHR). With regards to the small sample in the four last categories, we scored these as 
one category – high/very high risk. One child had been treated with chemotherapy combined 
with radiation therapy (1800Cgy), and the remaining children with chemotherapy only. The 
analyses were also performed without the irradiated case. One child was in the infant-risk 
group, and treated according to the NOPHO-92 protocol HR-1. Sociodemographic 
characteristics and treatment-related variables are presented in Table 1 (page 18).   
Control group  
The children treated for ALL were compared to a group of healthy children with a similar age 
and gender distribution (n=42) (79,3%) (Table 1), recruited from two elementary schools and  
two junior high schools in the middle part of Norway, and from both urban and rural areas. 
Children with a psychiatric diagnosis or with other specific and relevant medical problems 
such as cognitive dysfunction were excluded. Informed consent was obtained from all of the 
children and adolescents, as well as from their parents. The study was approved by the 
Regional Ethics Committee of Medical Research. Characteristics for the control group are 
shown in Table 1 (page 18).
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Table 1.  Sociodemographic characteristics of children with ALL and healthy controls.
Treatment variables for children with ALL.
    ALL
  (n = 40) 
Healthy
(n = 42) 
t score               P
  Gender   
       -.11    .91     Girl: n (%)               21    (52.5)     21 (50.0) 
     Boy: n (%) 19    (47.5) 21 (50.0) 
  Age at study 
         .14 .92            Mean (SD)      11.8   (1.9)       11.8 (1.9) 
             Median            11.4     11.6 
             Range              8.5-15.4 8.11-15.0  
  Family Composition   
        -.75 .46            Both parents   31     (77.5) 29 (69.0) 
             Single mothers    8     (20.0) 12 (28.6) 
             Single fathers    1       (2.5)        1   (2.4) 
  Parental Characteristics   
           Age, median (range)   
               Mother  40.0 (30-55) 40.0 (31-52)         -.25 .81 
               Father  43.0 (32-58) 43.5 (34-72)         -.09 .93 
Education, median(range)     
               Mother  14.0 (10-19) 13.0 (9-19)           .07 .95 
               Father  14.0 (10-20)    13.0 (10-19)           .84 .40 
Community             .69 .49 
           Urban  15     (37.5)     18 (42.9)     
           Rural  25     (62.5) 24 (57.1)   
Home             .72 .48 
           Own house       36     (90.0) 39 (92.9)   
           Own apartment    3       (7.5)        3   (7.1)   
           Renting apartment    1       (2.5)            -   
Economy            -.04 .96 
           Very satisfying  27     (67.5) 21 (50.0)   
           Good                      8     (20.0) 21 (50.0) 
  
           Poor                       5     (12.5)            - 
  
Diagnosis and treatment   
  
       Age at diagnosis     
           Mean (SD)   4.0 (1.9)      -   
           Median 3.1 -   
           Range 0-7.6 -   
Years since diagnosis     
           Mean (SD) 7.9 (2.0) -   
           Median 7.1 -   
           Range 4.2-12.5 -   
Treatment protocols      
           Standard risk 15 (37.5) - 
           Intermediary risk 15 (37.5) - 
          High/very high risk 10 (25.0) -
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3.2.2 Validation study 
The validation study included young adolescents (n=425) and their caregivers (n=237), 
recruited from six junior high schools in Norway –three from urban, and three from rural, 
areas. A total of 440 questionnaires were distributed of which 425 were returned, which gives 
a response rate of 96.6%. Self-report forms were completed by 425 adolescents, comprising 
235 girls (56%) and 184 boys (44%): six did not report gender. In junior high schools in 
Norway adolescents between the ages of 13 to 15 are divided into three different grades, and 
the participants were distributed as follows for the 8th, 9th and 10th grades: 33%, 33% and 
34%, respectively. Proxy-reports were completed by 237 (56%) caregivers. The proxy-reports 
were completed by mothers in 139 (59% of the) cases; by both parents in 69 (29% of the) 
cases; by fathers in 27 (11% of the) cases; or by other caregivers such as grandparents in 2 
(0.8% of the) cases. An adolescent self-report and a parent proxy-report on the PedsQL were 
available for 229 of the adolescents. Informed consent was obtained from all the children and 
adolescents, as well as from their parents.  
3.2.3 Refusers and missing data 
Children with ALL 
The final sample included 71.4% of those eligible. In the 16 families that did not participate, 
there were more girls (n=13) than boys (n=3). Most of them stated they were too busy or 
distressed, that they were not willing to participate, or that they did not want to relive previous 
experiences of sickness and hospitalization. Practical reasons such as geographical distance 
were also a factor.
Validation study 
A sample of 440 young adolescents and their parents were recruited from six junior high 
schools in Norway – three from urban, and three from rural, areas. A total of 440 
questionnaires were distributed, of which 425 were returned. Thus, the final sample included 
96.6% of these eligible. 
Because of the anonymity required during such procedures, more information about non-
respondents among the sample of adolescents as well as the sample of parents was not 
available.
20
3.2.4 Sample representativity 
Norway is a small country, with a total of five University Hospitals. Two of them took part in 
this study – Rikshospitalet-Radiumhospitalet Medical Centre in Oslo and St.Olavs University 
Hospital in Trondheim. These two university hospitals diagnosed approximately 77 of 146 
children with ALL in Norway during this time span (1989-1995). This is 52.7% of the total 
sample in Norway. 
The validation study supports the idea that the present study is representative, given that the 
response rate was 96.59%, and given too that response rates were evenly distributed among 
13, 14 and 15 year olds. The schools which took part are also representative for both urban 
and rural areas in Norway.
3.3 Procedures and methods
Procedures for the study of children treated for ALL and their control group  
Leaders of the Paediatric departments of Rikshospitalet-Radiumshospitalet (RH) and St. 
Olavs hospital were contacted and gave us their permission to contact the patients whose 
names were taken from their patient pool. Written information about the project and 
consensus formulas for the parents and for the older children were sent to the parents of 56 
survivors by ordinary mail, and they were contacted by phone for further information. After 
informed consent was received from the families, appointments were made by phone for the 
interview, which was often planned to coincide with their follow-up appointment at the 
hospital. All assessments of both the children and their parents were carried out at the 
hospital. The interview session was conducted by a clinical psychologist (the author). The 
parents of the children treated for ALL were interviewed separately. All children were 
individually assessed by different standardized instruments in a quiet room. Data regarding 
treatment protocols were collected from the patient’s medical records.
With regards to the control group, the educational sections of two municipal districts were 
contacted in order to discuss the demographics of different schools and for permission to 
contact school principals in their county. When informed consent was given in writing by the 
sections, four school headmasters were contacted and their informed consent was given in 
turn. Two headmasters in the city of Trondheim were instructed to make a sample by drawing 
lots based on age and gender matches. Another group from the rural county of Nord-
Trøndelag was matched along the lines of gender and the nearest age in month.  Lots 
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were drawn when this became necessary, as when several children matched the age-group. 
Written information and consent formula were sent to the families by the different principals, 
and they also contacted the families by phone to inform them about the project. When 
informed consent was given by the parents and adolescents, the assessments with each child 
were carried out individually in a quiet room at the schools, using the same procedure as with 
the children in remission from ALL. 
After the assessments each pupil received an envelope, which contained information and a 
questionnaire for their parents. Parents were asked to fill out the questionnaires separately 
before returning them in a pre-stamped envelope. When necessary, the participants were 
further able to contact the researcher by phone to obtain additional information. 
The design and methods used in the study were chosen on the basis of clinical experiences 
and research traditions at the Division of Child and Adolescent Psychiatry, Rikshospitalet-
Radiumhospitalet and the Department of Psychology, NTNU. The choice of methods was 
based on the following criteria: 
1) internationally acknowledged methods  
2) documented reliability and validity  
3) appropriate to the age group concerned
4) closely related to the aims of the study and 
5) assessed issues raised by the study with the aid of relevant clinical experience and 
literature on adolescents with chronic illnesses. 
The study used a multi-modal design, combining the methods of (i) interviews with the 
parents and (ii) questionnaires with both child and parent informants. It was seen as preferable 
that the HRQOL and psychiatric assessments were performed by an investigator (in this case, 
the author) who had no prior knowledge of any of the particulars of the ALL treatment. This 
method eliminated the possibility that answers might have been formulated to please or 
otherwise to avoid the discomfort of sharing information with, an authority figure responsible 
for the previous treatment.  
Procedures for children in the PedsQL validation study: 
Local junior high schools were contacted and teachers distributed written consent forms that 
the adolescents gave to their parents. Each pupil received an envelope, which contained 
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information and a questionnaire for their parents. Parents were asked to return the completed 
questionnaire in a pre-stamped envelope. The participants could further contact the 
researchers to obtain additional information. Approval forms signed by the parents and 
returned to the teacher, confirmed that the adolescent had been given permission to 
participate.  
The self-report instruments were administrated and completed in the classrooms.  
Children were given verbal and written instructions before completing questionnaires in class, 
and this was done under the supervision of a research assistant.
3.4 Methods used for children, adolescents and parents: 
A general overview of the methods used in this study is given below, and further details are 
provided in the papers. 
3.4.1 Medical treatment protocols 
Data on diagnoses and treatment protocols were collected from the medical records. The 
average age at the time of the ALL diagnosis was 3.4 years (range 0-7). The average time 
since diagnosis was 7 years (range 4-14). The treatment categories were scored according to 
the Nordic protocol (NOPHO-ALL, 1992) with the following treatment categories: 1) 
Standard risk (SR): 2) Intensive risk (IR); 3) High risk (HR); 4) High risk-1 (HR-1); 5) High 
risk-2 (HR-2); and 6) Very high risk-1 (VHR). With regards to the small sample in the four 
last categories, we scored these as one category – high/very high risk.
3.4.2 HRQOL 
The Pediatric Quality of Life Inventory (PedsQLTM4.0) [82] was used to measure HRQOL in 
children and adolescents. The 23-item PedsQL, version 4.0 Generic Core Scales, can be 
grouped into 4 domains of HRQOL: 1) Physical Functioning (8 items); 2) Emotional 
Functioning (5 items); 3) Social Functioning (5 items); and 4) School Functioning (5 items). 
The Generic Core Scales are comprised of a child self-report covering ages 5 to 7, 8 to 12 and 
13 to 18 years. The parent proxy-report covers ages 2 to 4, 5 to 7, 8 to 12 and 13 to 18, and 
assesses how the parents perceive their child’s HRQOL. The items for self-report and proxy-
report are essentially identical, differing in the language that they use, which is 
developmentally appropriate, and in using the first or third-person pronoun. 
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The questions ask how much of a problem each item has been during the past 1 
month: 0 = never a problem; 1= almost never a problem; 2 = sometimes a problem; 3 = often 
a problem; 4 = almost always a problem. Respondents are asked how many health problems 
they have experienced during the past month, and to rate these in terms of degree (e.g. I hurt 
or ache), activities (e.g. It’s hard for me to run), or feelings (e.g. I feel afraid or scared).  
Items are reverse-scored and linearly transformed to a 0 to 100 scale (0 = 100, 1 = 75, 
2 = 50, 3 = 25, 4 = 0), so that higher scores indicate a better HRQOL. Scale scores are 
computed as the sum of the items divided by the number of items answered (this accounts for 
missing data). In addition to the four subscales, a Total Summary Health score (23 items) can 
be computed. A Psychosocial Health Summary score (15 items) can be computed as the sum 
of the items divided by the number of items answered in the Emotional, Social, and School 
Functioning Subscales, and a Physical Health Summary score (8 items) is the same as the 
Physical Functioning subscale. The PedsQLTM4.0 provided a very reliable Total Scale score 
with a Cronbach’s alpha  0.89, and it has been shown to differentiate between healthy 
children and children with chronic health conditions [102]. A Norwegian version of the 
PedsQL 4.0, geared towards psychometric properties, is presented and described in greater 
detail in an earlier work [91]. The PedsQL has demonstrated satisfactory psychometric 
properties [83, 91]. A Cronbach’s alpha  0.77 was obtained for the Norwegian translation of 
the PedsQL for the age group 13-15, which indicates good internal consistency [91]. 
3.4.3 Children’s mental health and psychosocial functioning 
Two kinds of outcome measure were used to assess mental health and psychosocial 
functioning. The reliability and validity of the measurements presented below have been 
documented to be accurate. 
The mental health of the children was assessed using two outcome measures of behavioural 
and emotional problems based on standardized questionnaires. The Child Behavior Checklist 
(CBCL) [103] was completed by the parents, and the Youth Self-Report (YSR) [104] 
questionnaire was completed by children over 10 years old. The Norwegian version has 112 
problem items, 90 of which are common to both the CBCL and the YSR. For both forms the 
questions are scored 0 (no), 1 (sometimes), and 2 (often). Eight syndrome scales are 
generated, five of which are subdivided into two subscales. The internalizing subscale covers 
issues such as withdrawal, somatic complaints, and anxiety/depression. The externalizing 
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subscale includes delinquent and aggressive behaviour. As population norms for these 
questionnaires have not yet been established in Norway, the present study can only offer raw 
scores. According to the American norm, corrected for gender and age, the 90th percentile (T-
score>63) is used as a cut-off point for total, internalizing, and externalizing scores implying 
psychiatric problems. 
An additional outcome measure was the Strength and Difficulties Questionnaire (SDQ), 
which is designed to assess the mental and psychosocial health of children and adolescents 
[105]. The SDQ is a brief behavioural screening questionnaire consisting of 25 items in 
addition to a supplement on what impact various difficulties might have on the child and 
family. There are 5 subscales: Emotional Symptoms, Conduct Problems, Hyperactivity, Peer 
Problems and Prosocial Behaviour: the first four add up to the Total Difficulties Score. Each 
item uses a 3-point ordinal Likert format and can be answered with: “not true”, “somewhat 
true” or “certainly true”, rated 0-2 for negatively worded items and rated inversely 2-0 for 
positively worded items. In this way, and for all items, higher scores indicated greater levels 
of difficulty. There are similar versions for parents. The SDQ demonstrates satisfactory rates 
of reliability and validity [105, 106].
3.4.4 Intellectual functioning 
The Wechsler Intelligence Scale for Children, Third edition (WISC-III) [107] [108], was used 
to assess cognitive functioning in the children. The Full Scale IQ summarizes overall 
performance on the WISC-R, and provides a broad assessment of general intelligence and the 
ability to do well in school. For the purposes of the present study, we used the Full Scale 
Intelligence Quotient (FSIQ), the Verbal Intelligence Quotient (VIQ), the Performance 
Intelligence Quotient (PIQ), as well as the four indexes: the Verbal Comprehension Index 
(VCI); the Perceptual Organization Index (POI); the Freedom from Distractibility Index 
(FDI); and the Processing Speed Index (PSI). 
3.4.5 Parental interview 
Parents were interviewed separately by a child psychologist using a modified version of the 
standardized, semi structured, investigator-based Parental Account of Children’s Symptoms 
(PACS) [109]. The PACS includes questions that are relevant for a psychiatric assessment of 
the index children, and is also helpful in registering sociodemographic factors. The parental 
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interview also had supplementary questions directed at uncovering the parents experiences 
and concerns with regards to the child and to her or his siblings, as well as: developmental 
aspects from birth to early childhood previous to the diagnosis of ALL; the emotional and 
practical aspects of treatment procedures; the medical follow-up; the family climate; the 
availability of network and social support; and the parents own subjective experience with 
respect to the possibility of late effects after ALL treatment. 
3.4.6 Parents QOL and mental health 
The General Health Questionnaire (GHQ-30) [110] was included to assess parents’ own QOL 
and mental health. The GHQ-30 is the most frequently used screening instrument for distress, 
psychopathology and quality of life in adults, showing acceptable reliability and validity in 
studies of medical and psychiatric populations. The GHQ includes both positive and negative 
questions and its shorter equivalent, the GHQ-30, contains 30 items covering symptoms that 
are thought to reflect distress and psychopathology. GHQ-30 avoids using physical symptoms 
as an indicator of distress.
4. STATISTICS 
The statistical methods used in the present study are described in greater detail in the various 
papers. The study took parametric statistics as its starting point (Paper I and II).
To assess differences between two independent groups, the independent t-test was used.
In the methodological part of the study, internal consistencies (Cronbach’s alpha) and factor 
analyses (Paper III) are recorded. Validity was further examined by exploring the 
intercorrelations between and among the four PedsQL Subscales [111]. In addition, we 
calculated intraclass correlation coefficients (ICC) to assess parent and child convergence on 
the PedsQL subscales. ICC takes into account not only the correlation but also differences in 
intercept and slope between replicant ratings [86]. Paired t-tests were used to assess the extent 
to which adolescents or their proxies scored systematically lower on the subscales of the 
PedsQL. In order to evaluate the minimally important difference in scores, we calculated the 
standardized response mean, a distribution-based approach that compares temporal change by 
the standard deviation of change [112]. Gender differences in the self-report scales were 
analyzed with a two-sample t-test. A multiple hierarchical linear regression analysis was 
conducted to investigate the relationship between depressive symptoms and the HRQOL 
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scores as measured by the PedsQL when the potential effects of gender, age, SLE and SPAI-C 
were statistically controlled for. Additional independent multiple hierarchical linear 
regression analysis was conducted for each of the PedsQLTM summary scales as dependent 
variables (paper IV). Multicollinearity was tested with the measures of Tolerance and VIF. 
 The Statistical Package for Social Sciences (SPSS 12.0 and 14.0) statistics program for 
Windows was used for the analyses (SPSS Inc., Chicago, III, USA), and generally a critical 
value (Į) of 5% or less were considered as statistically significant. In order to reduce the risk 
of making the Type 1 errors associated with multiple comparisons, a Bonferroni corrected 
alpha level of 0.004 was chosen (Paper I and IV). Adjustments for multiple comparisons are 
often performed by the correction of Bonferroni. However, Bonferroni adjustments may cause 
over-correction of type I errors and a disastrous impact upon type II errors [113]. Choosing a 
p-value of p < .01 as implying statistical significance is more cautious than the usual p < .05, 
and therefore reduces the chance of false positive results. It means that on average only 1 in 
100 comparisons would observe such extreme differences purely by chance alone (Paper II).
5. ETHICAL ASPECTS OF THE STUDY 
The study was approved by the Regional Ethics Committee for Medical Research, The 
Central Norway Regional Health Authority. The children and their parents received written 
information about the study by mail. Informed written consent was obtained from 
participating children at the age 12 and from their parents. Non-responses to the letter were 
followed up once by telephone. When we did not manage to reach a family, we sent a written 
reminder. When clinical problems were detected in children, the adolescents and their parents 
were involved in discussions about possible referrals for further treatment.  
6. SUMMARY OF RESULTS 
6.1 Synopsis of papers I-V
Paper I 
HEALTH-RELATED QUALITY OF LIFE AND INTELLECTUAL FUNCTIONING 
IN CHILDREN IN REMISSION FROM ACUTE LYMPHOBLASTIC LEUKAEMIA. 
In this cross-sectional study we evaluated health-related quality of life (HRQOL) and 
intellectual functioning of children in remission from Acute Lymphoblastic Leukaemia 
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(ALL). Children and adolescents treated for ALL (n = 40) (mean age 11.8 years, range 8.5-
15.4) and healthy controls (n = 42) (mean age 11.8, range 8.11-15.0) were assessed through a 
cross-sectional approach using the Pediatric Quality of Life inventory (PedsQLTM) 4.0 and the 
Wechsler Intelligent Scale for children-III (WISC-III).  
Children and adolescents treated for ALL reported on average significantly lower HRQOL 
compared to healthy controls: the mothers proxy-report showed significantly lower HRQOL 
for their children, as did the fathers proxy-report, as measured by the PedsQLTM 4.0 Total 
Scale and Psychosocial Health Scale. Intellectual functioning as measured by the WISC-III 
Full Scale IQ was below that of the control group, but still within the normal range.  
We concluded that significant group differences found between children treated for ALL and 
their control group for the PedsQL Psychosocial Health Scale may indicate that the complex 
illness-treatment experience can make children more vulnerable with regards to psychosocial 
sequels, in spite of otherwise satisfactory physical and intellectual functioning. Follow-up 
programs which target the psychosocial health of children in remission from ALL should be 
implemented. 
Paper II 
CHILDREN IN REMISSION FROM ACUTE LYMPHOBLASTIC LEUKAEMIA: 
MENTAL HEALTH, PSYCHOSOCIAL ADJUSTMENT AND PARENTAL 
FUNCTIONING
By this stage, we assessed mental health, psychosocial adjustment and parental functioning in 
children in remission from Acute Lymphoblastic Leukaemia (ALL) compared to healthy 
controls. In this cross-sectional study 40 children treated for ALL (mean age 11.3 years, range 
8.5-15.4), and 42 healthy controls (mean age 11.3, range 8.9-15.0) were assessed using the 
Youth Self-Report (YSR) and the Strength and Difficulties Questionnaire (SDQ).Their 
parents completed the Child Behavior Checklist (CBCL) and the SDQ parent-report. The 
mental health of the parents themselves were evaluated using the General Health 
Questionnaire (GHQ-30). Children treated for ALL showed on average significantly more 
symptoms as measured by the CBCL compared to healthy children. Fathers reported more 
anxiety and depression, as measured by the GHQ-30, compared to healthy controls.  
We concluded that adequate rehabilitation and follow-up programs should be implemented for 
children and parents after treatment. Table 2 (page 28) summarizes the major findings in 
children in remission from ALL as well as in the control group of healthy children.
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Table 2. Comparison of PedsQLTM scale scores of the 40 children diagnosed with ALL, and 
the 42 healthy children as controls. Further, comparison of the YSR and the CBCL scale 
scores.
    Note. Relevant significant differences between the groups are presented in the papers. 
  ALL (n =40) Healthy (n =42) 
Mean        SD  Mean         SD 
PedsQL Child self-report 
    Total score 81.70      (12.56) 88.98        (7.57) 
    Psychosocial health  79.27      (13.99) 87.22        (9.20) 
    Physical Functioning 86.25      (12.13) 92.26        (6.45) 
    Emotional Functioning 75.13      (18.69) 83.21      (12.68) 
    Social Functioning 86.00      (14.11) 92.50        (7.67) 
    School Functioning 76.63      (16.38) 85.95      (12.98) 
PedsQL Mother Proxy-report     ALL (n=36) Healthy (n=38) 
    Total score 79.42     (12.50) 89.62      (10.26) 
    Psychosocial health  75.86     (14.22) 88.07      (11.28) 
    Physical Functioning 86.14     (13.69) 92.52      (10.47) 
    Emotional Functioning 70.28     (15.63) 85.00      (13.46) 
    Social Functioning 82.81     (15.54) 93.16      (  9.89) 
    School Functioning 74.44     (19.88) 86.05      (14.57) 
PedsQL Father Proxy-report    ALL (n=21) Healthy (n=25) 
    Total score 78.05     (12.50) 90.13      (12.24) 
    Psychosocial health  74.30     (13.95) 88.60      (12.47) 
    Physical Functioning 84.82     (12.86) 93.00      (12.70) 
    Emotional Functioning 71.43     (15.01) 86.40      (13.88) 
    Social Functioning 78.75     (18.98) 91.60      (11.88) 
    School Functioning 73.09     (16.47) 87.80      (15.82) 
YSR raw scores  
(n=32) Controlgr. (n=30) 
      
      Total behavior score 28.72      (17.74) 20.27      (15.46) 
      Internalising score   8.94        (6.99) 5.80        (5.46) 
      Externalising score   8.81        (5.26) 6.00        (5.75) 
Clinical range (Total T>63), No.(%)     1            (3.1)        1           (3.3) 
CBCL raw scores (mothers)      
(n=35) Controlgr. (n=38) 
      Total behavior score 22.19      (20.31) 11.18      (11.78) 
      Internalising score   6.83        (6.71) 3.24        (3.13) 
      Externalising score   6.92        (8.41) 2.92        (4.46) 
Clinical range (Total T>63), No.(%)    6            (17.1)        0           (0) 
CBCL raw scores (fathers)  
(n=21) Controlgr. (n=26)
      Total behavior score 23.43       (17.73) 9.54   (13.66) 
      Internalising score   7.19         (6.49) 2.85   (4.01) 
      Externalising score   6.38         (5.70)             2.11   (4.77) 
Clinical range (Total T>63), No.(%)      5           (23.8)            1     (3.8) 
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Paper III 
MEASURING HEALTH RELATED QUALITY OF LIFE: RELIABILITY AND 
VALIDITY OF THE NORWEGIAN VERSION OF THE PEDIATRIC QUALITY OF 
LIFE INVENTORY (PEDSQLTM 4.0) 
In this first validation study we evaluated the psychometric properties of the Norwegian 
translation of the Pediatric Quality of Life Inventory (PedsQLTM) 4.0 generic core scale in a 
sample of healthy young adolescents. This cross-sectional study included 425 healthy young 
adolescents and 237 of their caregivers participating as a proxy group. Reliability was 
assessed using Cronbach’s alpha. Construct validity was assessed using exploratory factor 
analysis and by exploring the intercorrelations between and among the four PedsQL subscales 
for adolescents and their parents. All the self-report scales and proxy-report scales showed 
satisfactory reliability with the Cronbach’s alpha varying between 0.77 and 0.88. Factor 
analysis showed results that were comparable to the original version, with the exception of the 
Physical Health scale. On average, monotrait-multimethod correlations were higher than 
multitrait-multimethod correlations. Sex differences were noted on the emotional functioning 
subscale, with girls reporting lower HRQOL than boys. We concluded that the Norwegian 
PedsQL is a valid and reliable generic paediatric Health-Related Quality of Life measurement 
tool that can be recommended for self-reports and proxy-reports for children in age groups 
ranging between 13 and 15.
Paper IV 
THE PEDIATRIC QUALITY OF LIFE INVENTORY (PedsQLTM) 4.0 AS AN 
ASSESSMENT MEASURE FOR DEPRESSIVE SYMPTOMS: A CORRELATIONAL 
STUDY WITH YOUNG ADOLESCENTS 
This correlation study explored the associations between depressive symptoms in young 
adolescents and the PedsQL scores when controlling for known risk factors.
An adolescent sample (N=425) filled in a range of different measures, including the 
PedsQLTM Norwegian version, the Short Mood and Feeling Questionnaire (SMFQ), the 
Social Phobia and Anxiety Inventory for Children (SPAI-C), and the Stressful Life Events 
checklist (SLE).
The results indicate a significant moderate correlation between the different measures – 
PedsQL, SMFQ, SPAI-C and SLE. The presence of depressive symptoms significantly 
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predicted the PedsQL scores for the adolescents, and explained 17 % of the variance in 
outcome for the PedsQL Total Scale.  
The findings suggest that the PedsQLTM is an adequate instrument of assessment with regards 
to depressive symptoms in young adolescents, and can be useful in both clinical practice and 
in further research into children’s mental health.   
Paper V 
CHILDREN WITH CANCER: CHILDREN’S ADJUSTMENT TO AND 
UNDERSTANDING OF THEIR CANCER 
In this article we considered both the clinical and theoretical aspects of how children adapt to 
life with a serious illness. The main focus was on the developmental changes, emotional and 
cognitive, undergone by the child during the different age spans. The strategies 
used by children to cope with their situation are discussed.
This article show that a child’s understanding of her or his cancer illness depends a great deal 
on certain developmental aspects, such as their ability to gain knowledge, as well as to 
understand and reflect upon their situation. Both the coping strategies of the families and the 
attitudes professionals have towards informing the child will have a further impact on how 
well the child manages to adapt. Such knowledge has potential implications for how we 
inform children about their illness. The interactive process between the child and her or his 
caregiver is a critical part of this process, and it should be prioritized by health professionals. 
This paper is presented as a theoretical and clinical background for the thesis. 
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7. DISCUSSION 
The present part of the discussion will look at some of the major findings in the research field, 
and at links between them, with particular reference to more recent literature: consideration 
will also be given to methodological limitations and to the implications of both the 
methodological study (paper III and IV) and the clinical study (paper I and II).  
7.1 The methodological study 
7.1.1 HRQOL in children and young adolescents as measured by the 
PedsQLTM4.0
This first validation study of the PedsQL Norwegian version was a pilot study which was 
carried out with young adolescents, and was part of a larger study with a broader focus on 
quality of life and mental health in this age group. This study gave us an opportunity to begin 
the process of validating the PedsQL. We are aware how important it is to include different 
age groups; not least validation may be more challenging when it comes to younger children. 
However, when starting a validation process, it can be scientifically and economically useful 
to first investigate the psychometric properties of one’s instruments in a smaller sample – like 
a pilot – before continuing with a larger sample. 
The third article describes the psychometric properties of the Norwegian translation of the 
PedsQLTM 4.0 generic core scale in a healthy sample of young adolescents and their 
caregivers. The results from the present study resemble the findings of the original PedsQLTM  
[83, 102] and the UK-English version [39] and as such confirm that the measure can be used 
for both self-reports and proxy-reports in school health settings and community populations. 
Table 3 (page 32) gives comparison of PedsQLTM scale scores across different studies in large 
samples of schoolchildren. 
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Table 3.  Comparison of PedsQL™ scale scores across different studies in large samples of 
schoolchildren
Publication      
US version. 
Varni et al., 2006 
[102] 
.
UK-English
version
Upton et al., 2005 
[92] 
Norwegian version
Reinfjell et al., 
2006 [91] 
Region San Diego School 
District, USA 
South Wales, 
Great Britain 
3 urban and 2 rural 
areas in Norway 
Sample characteristics  2,435 children aged 
8-18 years; 48% 
boys, 52% girls; 
47% higher school 
education;
23% middle to high 
socioeconomic 
status
1,033 children 
aged 8-18 years; 
51% boys, 49% 
girls
419 adolescents 
aged 13-15 years; 
44% boys, 56% 
girls; 72% of 
parents had higher 
school education;
95% good to very 
good household 
income/assets 
Mean        SD  Mean         SD     Mean       SD 
PedsQL Child self-report    
    Total score 80.6       (13.3) 83.9      (11.8) 85.3      (11.1)
    Psychosocial health  78.2       (14.9) 81.8      (13.2) 82.2      (12.5)
    Physical Functioning 85.2       (13.7) 88.5      (11.6) 91.1      (10.4)
    Emotional Functioning 74.3       (18.7) 78.5      (17.9) 77.2      (17.3)
    Social Functioning 82.9       (18.5) 87.7      (16.5) 88.1      (13.1)
    School Functioning 77.3       (17.0) 78.9      (15.9) 78.0      (15.5)
    
PedsQL Parent- report          
    Total score 76.9       (16.8)  84.6      (11.2) 86.1     (10.2) 
    Psychosocial health  76.1       (16.3)  82.2      (12.7) 84.7     (10.9) 
    Physical Functioning 78.5       (22.3)  89.1      (12.3) 88.8     (11.8) 
    Emotional Functioning 77.0       (17.5)  78.3      (15.5) 80.0     (14.1) 
    Social Functioning 78.7       (21.1)  86.8      (15.4) 88.1     (13.4) 
    School Functioning 72.5       (20.2)  81.5      (16.1) 89.0     (12.3) 
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It should be pointed that there will be fewer points of correspondence with the factor structure 
obtained in the original PedsQLTM 4.0 publication because the age range in this present study 
is more restricted. Limitations on the age sample, and comparisons with a healthy population, 
may compensate for the apparent variability. The results of the factor analysis for items 5, 6 
and 7 in the Physical Function scale, as well as items 4 and 5 in the School Function scale, 
may be typical for healthy samples, and the factor structure should therefore be reinvestigated 
in clinical samples.  
The adolescent-parent agreement did not exceed the preferred intra-class correlation of 
0.40, except in the case of the scale measuring School function. A lack of agreement between 
parents and children may result from differences in how the same situation is perceived, and 
also differences in how different items are interpreted [114]. As opposed to some previous 
research [115], our findings did not find higher levels of agreement between parents and 
adolescents with regards to physical problems. Parents rated the physical function scale lower 
than the reports of their children. Furthermore, a recent study found that proxy and self-report 
correlation was higher for children with health problems than for healthy children [39]. 
Parents and children may be more likely to share information about an issue if it is perceived 
as a problem [39]. However, the reliability of this agreement has also been challenged in 
research on children with Cystic Fibrosis [71]. Another explanation for the low concordance 
between adolescents and parents with respect to physical functioning can be seen in the factor 
analysis (table 4 and 5) in paper 3: there it emerged that items relating to physical functioning 
(item 5, 6, 7) were rather diffuse components associated with both physical and emotional 
domains, and were therefore difficult to distinguish between – something that could further 
influence both adolescents and parents ratings. Children reported lower HRQOL on the 
emotional scale compared with their parents, and this supports research carried out previously 
by Modi & Quittner [71]. There may be several explanations for this: young children may 
have difficulty expressing their emotions directly to their parents, for example: it is also 
probable that proxy-reports reflect parental anxiety about their child [39].  This factor should 
be investigated further using different patient populations, and it confirms the need to measure 
both child and parent perspectives when evaluating HRQOL. From a clinical perspective, 
those discrepancies potentially allow for more interventions which reflect the children’s 
subjective ratings, as well as that of their parents [71, 114].
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With regards to gender differences, we found that girls reported lower levels of emotional 
functioning than boys. This is consistent with previous research on gender differences in 
emotional health [116-118]. Differences in response that relate to differences in gender would 
seem to reflect a genuine disparity between boys and girls: they provide further evidence for 
the validity of PedsQLTM as a sensitive measure of the emotional functioning of children and 
adolescents [39]. 
7.1.2 PedsQL as a measure for depressive symptoms 
The results of this study clearly show that depressive symptoms and social anxiety symptoms 
predict self-reported HRQOL. These results suggest that the PedsQL may in the near future 
provide an interesting assessment measure for depressive symptoms in young adolescents. 
The main results indicated that individuals who reported higher levels of depressive 
symptoms exhibited significantly lower levels of HRQOL as measured by the PedsQL, even 
when controlling for gender, age, number of stressful life events, and levels of social anxiety 
symptoms. These results are the same for both the PedsQL Total Score and for all of the four 
PedsQL subscales. The inherently high correlation between the SMFQ and the PedsQL Total 
Scale could nevertheless be problematic, since it might possibly indicate that both the SMFQ 
and PedsQL measure the same phenomena. On the other hand it seems positive that the 
percentage is not higher than it is, for it suggests that the measures do in fact cover different 
areas. When looking at the different PedsQL subscales, it is clear that the Emotional Function 
Subscale has a higher correlation with the SMFQ than with the other subscales, and as such it 
influences the PedsQL Total Scale. However, the lower correlations for the other subscales 
(Physical health, Social Functioning and School Functioning) confirm that the PedsQL does 
measure different areas. This shows how important it is to use the subscales as additional 
tools of assessment and along with the PedsQL Total Scale when assessing depressive 
symptoms. 
Generally speaking, one would be interested in increasing the HRQOL of adolescents in a 
clinical setting. The scores on each PedsQL factor may then provide us with valuable 
information. Individual differences in PedsQL scores should be taken into account when 
tailoring prevention interventions for mental problems.  
The Emotional and School Functioning Subscales all remained significantly associated with 
levels of depressive symptoms when controlling for gender, age, the occurrence of stressful 
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life events, and social anxiety. Interestingly, the SMFQ showed significantly stronger rates of 
prediction for the PedsQL School Functioning Subscale than the SPAI-C. This finding seems 
to indicate that the PedsQL School Function Subscale is an interesting means of assessing and 
measuring both depressive and social anxiety symptoms: it also reaffirms the necessity, when 
evaluating daily functioning, of taking into account contexts that are of relevance to children’s 
lives, such as school and community [71].
7.2 The clinical study
7.2.1 HRQOL, intellectual, mental and psychosocial findings for children in 
remission from ALL. 
HRQOL and intellectual outcome in children treated for ALL 
The results showed that children and adolescents treated for ALL report significant lower 
HRQOL scores for both the Total Scale and the Psychosocial Health Scale as measured by the 
PedsQLTM4.0. Most of the intellectual scores as measured by the WISC-III were also 
significant lower for the children treated for ALL compared to controls. For most of the 
PedsQL Scales parental impressions of the HRQOL were significantly different from those of 
the control group, and as such confirm a previous and major study which took for its subject 
the HRQOL of children and adolescents as this was perceived by parents [119]. Interestingly, 
the children in remission from ALL showed lower scores for the Psychosocial Health Scale 
compared to the Physical Functioning Health Scale as reported by both the PedsQL self-report 
and parent proxy-report. This finding confirms the few previous findings which look at 
children in remission from ALL [23, 24,119]. See Table 4 (page 36). Psychosocial support 
therefore remains important several years after treatment has ended, even when the overall 
physical health appears to be good [23].
 Psychosocial problems can be caused by several factors, and among these may be a 
continuing anxiety about possible late-effects or even a recurrence of the cancer. The children 
may often be afraid on an unconscious level that the disease will recur. In addition to stress 
experienced during the treatment, they can also be confronted with new problems that develop 
from the illness and from the long-term side–effects of treatment [24]. Developmental aspects 
should also be considered. The patients are children for whom about 2.5 years of dynamic 
psychological and social development is interrupted by serious life threatening illness, 
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persistent regular hospital visits, compromised immune system, interruption in school 
attendance and social activities, as well as family crisis. All these factors can influence and 
interrupt normal psychological and social development and further academic achievement. 
Table 4. Comparison of PedsQLTM scale scores across different studies in samples of children 
with cancer. 
Studies      
US study. 
 N=73 
Age 2-18 
Different cancers 
>1 year off 
treatment 
Varni et al., 02 
[131] 
UK-English study   
N=45
Age: 8-18 
Diagn. ALL 
 4 years post 
diagnosis 
Eiser et al., 03  
[23]                              [133]
Norwegian study   
N=40
Age: 8-15 
Diagn. ALL 
 4 years post 
diagnosis 
Reinfjell et al.,07
Dutch study 
N= 105 
Age 5-20 
Different cancers 
Average 4 years post 
diagnosis 
Felder-Puig et al., 04 
[132] 
Mean        SD  Mean         SD   Mean           SD     Mean          SD 
PedsQL Child self-
report 
    
    Total score 77.66     (15.25) 80.97        (12.57)   81.70        (12.56) 82.6       (13.5) 
    Psychosocial health  76.51     (16.03) 79.07        (13.14)   79.27        (13.99)                 - 
    Physical Functioning 80.01     (18.66) 86.16        (14.72)   86.25        (12.13) 86.7        (17.1) 
    Emotional Functioning 77.67     (20.19) -   75.13        (18.69) 78.6        (19.8) 
    Social Functioning 79.64     (19.78) -   86.00        (14.11) 85.8        (18.6) 
    School Functioning 71.41     (18.12) -   76.63        (16.38) 79.5        (14.6) 
     
PedsQL Parent- report     
    Total score 73.68    (18.63) 76.50        (16.10)   79.42         (12.50) 80.4        (13.4) 
    Psychosocial health  72.92    (17.98) 73.71        (16.95)   75.86         (14.22)                  - 
    Physical Functioning 74.96    (24.01) 84.73        (19.73)   86.14         (13.69) 85.0        (16.5) 
    Emotional Functioning 72.84    (19.85) -   70.28         (15.63) 73.9        (17.5) 
    Social Functioning 76.11    (21.66) -   82.81         (15.54) 83.9        (18.7) 
    School Functioning 69.06    (23.00) -   74.44         (19.88) 78.7        (15.7) 
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On average, children and adolescents treated for ALL show intellectual functioning in 
the normal range, but below that of the control group. Intellectual functioning in the normal 
range is considered as a protective factor with regards to the mental and psychosocial health 
of children and adolescents. However, this study shows that despite adequate intellectual 
functioning in children in remission from ALL, their levels of Psychosocial Health as 
measured by the PedsQL are significant lower compared to the control group. This tendency 
is similar for both the child self-report as well as for the parent proxy-report.
There were significant differences between children with ALL and their healthy 
controls for three of the WISC-III IQ scales, as well as for two of the different composite 
factors. In the present study, only one child underwent both chemotherapy and radiotherapy, 
and this child functioned adequately, while the remaining children underwent chemotherapy. 
The suggestion that it might be chemotherapy alone which contributes towards cognitive 
deficits is still a controversial one [54, 61, 64]. Studies have indicated that children and 
adolescents experience rather vague problems with attention and concentration after 
treatment, and that these complaints derive from more subtle impairments in processing speed 
[64]. A recent meta-analysis showed that children who were survivors of ALL appeared to 
experience clinically significant declines in neurocognitive functioning [37], in both global 
and specific areas of neurocognitive functioning. The findings were thought to have been a 
consequence of the treatments used to cure their disease. Interestingly, when compared to 
normative data, these declines become less clear [37]. Since cognitive deficits may be subtle, 
continued evaluation of levels of cognitive and learning functioning in children who have 
been treated for moderate-risk acute lymphocytic leukaemia is recommended [65]. The 
significant differences found in the present study between children in remission from ALL 
and their control group should be further assessed with respect to neuropsychological 
functioning.
Mental and psychosocial outcome in children with ALL 
Children treated for ALL showed significantly higher symptom scores on all domains of 
CBCL and YSR than healthy children. According to the reports of their mothers, six children 
had a CBCL score  90 percentile, which is indicative of severe problems, as opposed to none 
in the control group. The CBCL as reported by the fathers showed that five children scored 
90 percentile, as opposed to only 1 child from the control group. One child scored  90 
percentile on the YSR and was therefore in clinical range, while there was one child in the 
control group. Our results confirm that children with chronic health conditions occupy the “at 
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risk” status when it comes to psychiatric difficulties. Although major psychiatric disturbances 
are not common among long-term survivors of ALL [120], studies have shown that this 
population has increased risks of mental health and adjustment problems [45]. Based on the 
meta-analysis, where more than 700 studies were reviewed, it could be concluded that 
children with chronic physical illness were more likely to exhibit internalizing than 
externalizing problems, but not to have lower self-esteem [98]. A Swedish study indicates that 
there is a greater risk of psychosocial problems in the period after treatment than there is 
during it. Children and adolescents who were no longer being treated reported higher levels of 
depression and anxiety: seven (14%) reported a high level of depression; six of the children 
were off treatment [20]. Shelby [101] showed that children treated for ALL were reporting 
significantly more problems in terms of social competence and internalizing behaviour. In the 
same study, adolescents exhibited more difficulties in these areas than younger children, there 
were no differences found between children who had received cranial radiation and those who 
had not, and the age at the time of diagnosis did not have an impact on their current function.
In contrast to the results in this present study, whose significance is measured and confirmed 
by the instrument CBCL, the SDQ self-report for children showed no statistically significant 
differences in psychosocial health between children with ALL and their healthy controls. 
Eiser [38] argues that where there are no differences, a post hoc explanation which needs to 
be thought about is a lack of sensitivity in the measurements. However, for the mothers of 
children treated for ALL, the SDQ Parent self-report showed higher scores for Emotional 
symptoms than did the healthy controls. As such, this finding confirms some of the CBCL 
findings.
To sum up: taken together, the findings show children in remission from ALL have an at risk 
status when it comes to potential mental and psychosocial late-effects. Greater awareness of 
high-risk groups should facilitate more timely identification of problems in the future [53]. 
7.2.2 HRQOL and mental health in parents of children treated for ALL 
Fathers in the present study showed significantly more anxiety and depression as measured by 
the GHQ-30 compared to healthy controls, while no such differences were found for mothers. 
Eiser (2005) points out that fathers often remained more involved in everyday life despite the 
child’s illness. This may influence the father’s own situation and needs, since by staying at 
home or at work more during the child’s treatment phase, the father will not be able to get 
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adequate help for his own emotional needs, and this may affect his later adjustment. That 
fathers in the present study showed more depression and anxiety several years after their 
child’s diagnosis may be an indication of this aspect. Kazak et al. argues that fathers are often 
underrepresented in paediatric research samples, and her previous studies have found that 
fathers of childhood cancer survivors have levels of Posttraumatic stress symptom which are 
nearly as high as those of mothers [121]. Many of the fathers in Kazak’s study reported that 
they were afraid of revealing unpleasant memories, believing that this would be detrimental to 
other family members. Interestingly, the researchers found by studying a group of 150 
families that participants had significantly fewer symptoms of post-traumatic stress after a 
one-day treatment program employing cognitive-behavioural principles, compared to a 
control group who did not receive the treatment [122]. Adverse effects on the long-term 
physical and mental health of parents has also been reported previously [123], with a 
significant number of parents found to be still suffering from clinical distress five years after 
treatment [124].Thus, assessing the overall quality of life in survivors should also include the 
long-term effects for the family as well.  
Adequate rehabilitation and follow-up programs should be implemented for both children and 
parents after treatment. Further research is needed to evaluate the specific areas of parental 
stress, and to look at how parental coping affects mental health and QOL in these areas.  
7.3 Limitations of the study 
The methodological study (Paper 3 and 4) 
With regards to the Norwegian PedsQL TM 4.0 validation study, the present findings have 
several potential limitations. Test-retest reliability and responsiveness are not reported. 
Information on non-participants was not available, something that can limit generalizability.  
In the American validation study, the PedsQL differentiated between HRQOL in healthy 
children and in children with acute or chronic health conditions. This will also be an 
important future investigative goal for the Norwegian PedsQL version, and is something the 
authors are taking into consideration. In addition, this study utilized a relatively restricted age 
range. When in comes to developmental aspects, further research should investigate the 
psychometric properties of the Norwegian PedsQL versions, focusing on the upper-age range
which the adolescent PedsQL was designed for, as well as on younger age-groups.
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Furthermore cross-sectional designs can not determine causal relations, and their absence 
represents an important shortcoming in the present study and implies that the results should be 
treated with some caution. In further studies using the PedsQLTM 4.0, it will be essential to 
explore this measure in a prospective, longitudinal design, in order to be able to search for 
causal factors and to disentangle the true risk and protective factors from mere correlates. In 
addition, although the depressive measure used in this study is reported to have satisfactory 
psychometric properties, and moderate to high correlations with a diagnostic interview [125-
127], it is not based on DSM-IV or ICD-10 diagnostic criteria for depressive disorder. The 
future use of diagnostic interviews based on such diagnostic criteria is recommended. 
However, in epidemiological samples the SMFQ does, distinguish between clinically 
depressed and not depressed as well as the longer version of the MFQ [125]. Moreover, due to 
the limited administration time set aside by participating schools, only a selection of 
acknowledged stressful life events [128-130] were included. The questionnaires used on SLE 
might therefore lead to an underestimation of the strengths of the findings. The inclusion of 
full scales assessing stressful and negative life events is recommended. Finally, a relatively 
high percentage of the parents in the present study have higher education. This might have 
had an influence on our findings, since children from higher social classes may have a better 
quality of life. At the same time it should be pointed that the amount of children whose scores 
were in the clinical range for depressive symptoms is similar to the percentage expected in 
healthy samples, and as such confirms that the sample is representative. 
The clinical study (Paper 1 and 2) 
The strengths of our study include how homogenous the sample of children with ALL is with 
respect to both diagnosis and age-span, and the use of a control group. Drawing control 
groups from the same local population as the ALL survivors is recommended as an 
appropriate means of comparison [37]. However, limitations in our study should be noted: it 
has a cross-sectional design, and we were therefore unable to control for premorbid 
functioning; the small size of our group of children was another drawback. Cross-sectional 
designs cannot determine causal relations, and their absence represents an important 
shortcoming in the present study and implies that the results should be treated with some 
caution. Furthermore, the psychologist who performed the WISC-III test was not blinded to 
the ALL diagnosis, and this should also be taken into consideration when interpreting the 
results. It should also be pointed that the data are less representative for girls compared to 
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boys. 61.76% of the total eligible sample was girls, while 86.36% were boys. This may also 
influence the results regarding gender differences. 
To be able to investigate the systematic effects of chemotherapy on HRQOL outcomes and 
intellectual functioning over a longer period of time, longitudinal designs should be 
implemented for children treated for ALL, and controls involving other types of cancers 
should be carried out to control how cancer is experienced more generally.
The findings based on the 21 fathers of ALL patients who participated in our study should 
also be treated with a degree of caution. But the results may indicate the need to pay attention 
to the mental health and adjustment of fathers during the time of the child’s treatment as well 
as the rehabilitation phase. The fact that only 21 fathers participated may indicate a common 
problem in clinical research, namely that more fathers should be included in future research 
on children with cancer and their parents: ways of making this happen need to be found and 
implemented. 
7.4 Implications of the study  
An important aim in the care for children and adolescents with chronic illnesses is to 
minimize the consequences of the psychosocial difficulties following treatment for ALL. The 
findings revealed by this study have practical, therapeutic and research-related implications.  
The implementation of HRQOL measures in paediatric research 
x In this study we have shown that the PedsQL Norwegian version is generally a valid 
and reliable instrument, and that it reproduces some of the earlier findings for the 
original version. The Norwegian PedsQL TM 4.0 version can therefore be 
recommended as a valuable tool for assessing the HRQOL of young adolescents in 
Norway.
x The imperfect concordance observed between self-and proxy-reports supports the need 
to measure the perspectives of child and parent in evaluating paediatric HRQOL. It is 
important to emphasize the clinical usefulness of looking at child-parent discrepancies, 
which give us the possibility of measuring both child and parent perspectives. To the 
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extent that HRQOL is subjective, there are strong arguments in favour of eliciting data 
directly from children whenever possible. 
x The findings suggest that the Paediatric Quality of Life measure (PedsQLTM) is an 
interesting measure for assessing depressive and social anxiety symptoms in young 
adolescents, and can be useful in both clinical practice and further research as an 
outcome measure in studies on the mental health of children.
x The results indicate that HRQOL instruments such as the PedsQLTM 4.0 can be a 
sensitive outcome measure for how children function after treatment for ALL, and 
such measures of health and functioning should be included in paediatric settings and 
research trials. Normal childhood development can be profoundly affected by the 
toxicity and adverse impact of aggressive medical treatments. Information about the 
HRQOL of children with cancer may provide us with a more comprehensive means of 
evaluating the outcome of treatment than survival rates and relapse-free intervals 
alone. HRQOL measures should be used to predict treatment outcomes, or to evaluate 
the impact of a treatment or intervention.  In a clinical setting one would generally be 
interested in increasing children’s HRQOL. The scores on each PedsQL factor may 
then be highly informative. Individual differences in PedsQL scores should be taken 
into account when tailoring preventive intervention and rehabilitation programs for 
children after treatment.  
Practical and therapeutic implications for children in long-term remission from ALL
x The significant group differences found between children treated for ALL and their 
control group, may indicate that treatment for ALL can make children more vulnerable 
to late-effects that will have an impact on HRQOL and intellectual functioning. The 
results indicating impairments in HRQOL compared to the control group show the 
need for follow-up. Adequate follow-up for children in long-term remission from ALL 
should be implemented. This presents the healthcare community with several 
challenges: how to focus on providing appropriate care for the survivors, as well as the 
need to prevent the long-term psychosocial sequels of cancer and its treatment.   
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x Several issues need to be addressed, such as educating survivors and healthcare 
providers with respect to potential late effects. This study shows that problems can be 
seen several years after diagnosis and treatment, and demonstrates the need for a 
closer awareness of adjustment issues related to mental health and psychosocial 
functioning in children after their treatment for ALL. To be able to detect and address 
actual problems effectively, children should be followed-up from the time they return 
to school and further into their academic careers. In addition to the medical follow-up 
given to patients in clinics, outpatient centres should also be addressing these equally 
vital challenges and needs.
x Psychosocial check-ups should be provided in parallel with the routine and regular 
medical follow-ups. Professional mental health guidance with a developmental and 
family perspective should be implemented. 
x Information about and counselling for potential late-effects and problems with respect 
to HRQOL and mental health should be given to both parents and children. 
Information should be individually adjusted to the child’s developmental and 
cognitive level. 
Parents of children in long term-remission from ALL 
x The result may indicate the need to pay more attention to the mental health and 
adjustment of fathers during the time of the child’s treatment as well as the 
rehabilitation phase. The fact that only 21 fathers participated may indicate a common 
problem in clinical research, namely that fathers should be included in future research 
on children with cancer and their parents: ways of making this happen need to be 
found and implemented.  
x Further research is needed to evaluate the specific areas of parental stress, and how 
parental coping affects mental health and QOL in these areas.  
x Adequate rehabilitation and follow-up programs should be implemented for both 
children and parents after treatment. 
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Implications for further research 
x Developing Norwegian norms for the different age spans the PedsQL is designed for 
should be a priority in future works. 
x The children’s intellectual functioning was in the normal range, but below that of the 
control group, and this needs further investigation, particularly with respect to 
neuropsychological functioning. It is recommended that further research be carried out 
into the HRQOL of children in remission from ALL, and that this should be 
implemented for different age-groups. 
x To be able to investigate the systematic effects of chemotherapy on HRQOL outcomes 
and intellectual functioning over a longer period of time, longitudinal designs should 
be adopted for children treated for ALL, and for controls involving other types of 
cancers should be carried out to get a more comprehensive perspective on the cancer 
experience.
x Generally speaking, the standard deviation for the group of children with ALL is high 
with respect to the subscales for the PedsQL, the CBCL/YSR and the WISC-III, and 
this could indicate differences in adjustment with respect to the HRQOL, mental 
health and intellectual functioning of the group of children in remission from ALL. 
This requires further investigation, with particular attention being paid to the type of 
treatment protocol, time since diagnosis, age at diagnosis, and difficulties related to 
HRQOL, mental health and intellectual functioning. 
x To be able to determine the relative influence of age, illness, and treatment variables 
statistically, the size of a research sample has to be adequate. Although large-scale 
studies may be important in identifying certain risk factors, studies that concentrate on 
homogeneous subgroups of patients will provide more information about the 
significance of risk factors involved for that population. In designing these studies, 
collaboration is needed at the national and international levels. This is further 
dependent on the availability of parallel forms of measures in different languages. 
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x Looking at the developmental aspects of emotional functioning in children in long-
term remission from ALL should be further investigated using a bigger pool of 
children, with different age groups represented at both the times of diagnosis and 
assessment, in order to be able to find subgroups of children who might be especially 
vulnerable when it comes to emotional functioning. How sensitive the different 
instruments which measure this aspect are should be the subject of further 
investigation.
x It would be interesting to obtain information about how the survivors meet 
developmental tasks in growing up. How survivors function later in life should 
therefore be investigated in order to yield new insights.
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Abstract
Aim: To evaluate the health-related quality of life (HRQOL) and intellectual functioning of children in
remission from acute lymphoblastic leukaemia (ALL).
Methods: Children and adolescents treated for ALL (n = 40; mean age 11.8 years, range 8.5–15.4)
and healthy controls (n = 42; mean age 11.8, range 8.11–15.0) were assessed through a
cross-sectional approach using the Pediatric Quality of Life inventory (PedsQLTM) 4.0 and the
Wechsler Intelligent Scale for children-III (WISC-III).
Results: Children and adolescents treated for ALL reported on average significantly lower HRQOL
compared to healthy controls: the mother’s proxy-report showed significantly lower HRQOL for their
children, as did the father’s proxy-report, measured by the PedsQLTM 4.0 Total Scale and Psychosocial
Health Scale. Intellectual functioning as measured by the WISC-III Full Scale IQ was below that of the
control group, but still within the normal range.
Conclusions: Significant differences found between children treated for ALL and their control group for the
PedsQL Psychosocial Health Scale may indicate that the complex illness-treatment experience can make children
more vulnerable with regard to psychosocial sequels, in spite of otherwise satisfactory physical and intellectual
functioning. Follow-up programs that target the psychosocial health of children in remission from ALL should be
implemented.
INTRODUCTION
Acute lymphoblastic leukaemia (ALL) is the most common
form of cancer in children. New treatments involving a com-
bination of chemotherapy and radiotherapy have resulted in
significant improvements to rates of survival in recent years,
with an approximate 80% average in the 5-year survival rate
(1). Late effects from these forms of treatment may include
somatic complications, such as reduced fertility (particularly
in boys), cardiomyopathy (especially in girls), reduced lung
functioning and osteoporosis. Further complications may
involve reduced linear growth and endocrine disturbances
when cranial irradiation is used as part of the therapy, as
well as a second occurrence of the cancer (2–3% of all pa-
tients) (2). A recent meta-analysis showed that children who
survived ALL appeared to experience clinically significant
declines in neurocognitive functioning (3).
Medical and psychological late effects are defined as oc-
curring after the successful completion of medical therapy,
and usually 2 or more years from the time of diagnosis (4).
The literature on childhood cancer and psychosocial ad-
justment has resulted in some controversial findings (5–7),
which can be attributed to methodological restrictions in
the heterogeneity samples of patients (e.g. differences in di-
agnoses and time since diagnosis) (7), as well as differences
in the criteria for selecting the control groups (3,8). The fo-
cus has often been on the degree to which mental health
problems are experienced and on maladjustment, instead of
on coping and functioning in everyday life (8,9). Paying at-
tention to only the former aspects can potentially limit what
we can learn about actual adjustment problems for children
with cancer (10).
As the treatment for childhood cancer can be aggressive
and associatedwith both acute and long-termmorbidity (11),
the research focus has changed in order to emphasize the
health-related quality of life (HRQOL) (12). HRQOL mea-
sures must be multidimensional and consist of the phys-
ical and the psychological (including the emotional and
cognitive) dimension, as well as taking into account the
social health dimensions delineated by the World Health
Organization (WHO) (13). Only recently have there been
studies that have focused on HRQOL (14), but such mea-
sures of health and functioning should be included in pae-
diatric settings and research trials. Normal childhood de-
velopment can be profoundly affected by the toxicity and
adverse impact of aggressive medical treatments (15). Infor-
mation about the HRQOL of children with cancer may pro-
vide us with a more comprehensive means of evaluating the
outcome of treatment than survival rates and relapse-free
intervals alone.
Paediatric patient self-report should be considered the
standard for measuring HRQOL, although there are circum-
stances when children are too young, too cognitive impaired
or fatigued to complete a HRQOL instrument, and parent
proxy-report instruments are needed in such cases (16).
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The few previous studies that measured HRQOL show
that children in remission fromALL experience considerably
compromised psychosocial functioning, even when physi-
cal problems diminish in the course of time and the overall
health appears to be good (17–19). In addition to measuring
HRQOL, in the present study we wanted to assess intellec-
tual functioning, because adequate intellectual functioning
is considered as a protective factor in a child’s state of psy-
chosocial health (20).
The aim of the present studywas (i) to describeHRQOL in
children and adolescents in remission fromALL by assessing
both the PedsQL child self-report and parent proxy-report
in comparison with healthy controls, and (ii) to assess the
intellectual functioning in children in remission from ALL
compared to healthy controls.
PATIENTS AND METHODS
Patients
Children and adolescents in remission from ALL were
recruited from two University Hospitals in Norway:
Rikshospitalet-Radiumhospitalet Medical Centre in Oslo
and St. Olavs Hospital in Trondheim. The children were
born in the period 1989–1995, had a mean age of 11.8 (range
8.5–15.4), took part 4.2–12.5 years after ALL diagnosis and
were treated according to the Nordic protocol, The Nordic
Society of Pediatric Hematology/Oncology (NOPHO-ALL,
1992); their parents were also invited to participate in the
study. Children who suffered relapses, or who had other
kinds of severe medical condition (e.g. Down’s syndrome)
were excluded. Of the 56 children who fulfilled the crite-
ria for participation, a total of 40 (71.4), comprising 21 girls
(52.5%) and 19 boys (47.5%), took part. Parental informa-
tion was supplied by 36 mothers, whose mean age was 40.0
(range 30–55), and 21 fathers, whose mean age was 43.0
(range 32–58): both mothers and fathers were asked to give
their evaluation of the PedsQL proxy-report separately. Data
regarding diagnoses and treatment protocols were collected
from the medical records. The average age at the time ALL
was diagnosed was 4.0 years (range 0–7.6). The average time
since diagnosis was 7.9 years (range 4.2–12.5). The treat-
ment categories were scored according to the Nordic pro-
tocol (NOPHO-ALL, 1992) with the following categories:
(i) standard risk (SR); (ii) intermediate risk (IR); (iii) high
risk (HR); (iv) high risk-1 (HR-1); (v) high risk-2 (HR-2)
and (vi) very high risk-1 (VHR). With regard to the small
sample in the four last categories, we scored these as one
category—high/very high risk. One child had been treated
with chemotherapy combined with radiation therapy (1800
Cgy), and the remaining children with chemotherapy only.
One child was in the infant-risk group, treated according
to the NOPHO-92 protocol HR-1. Sociodemographic char-
acteristics and treatment-related variables are presented in
Table S1.
In the 16 families that did not participate, there were a
higher amount of girls (n = 13) than boys (n = 3). Most of
them answered that they were too busy or distressed or that
they did not wish to be confronted with past experiences
of sickness and hospitalisation. Practical difficulties, such as
geographical distance were also a factor.
The children treated for ALL were compared to a group of
healthy children with a similar age and gender distribution
(n = 42; Table S1), recruited from two elementary schools
and two junior high schools in the middle part of Norway,
and from both urban and rural areas. Children with a psy-
chiatric diagnosis or with other specific and relevant medi-
cal problems, such as cognitive dysfunction were excluded.
Informed consent was obtained from all the children and
adolescents, as well as from their parents. The study was
approved by the Regional Ethics Committee of Medical Re-
search. (Table S1).
Procedure
Leaders of the Paediatric departments of Rikshospitalet-
Radiumshospitalet and St Olavs Hospital were contacted
and gave us their permission to contact the patients whose
names were taken from their patient pool. Written infor-
mation about the project and consensus formulas for the
parents and for the older children were sent to the parents
of 56 survivors by ordinary mail, and they were contacted
by phone for further information. After informed consent
was received from the families, appointments were made by
phone for the interview, which was often planned to coin-
cide with their follow-up appointment at the hospital.
All assessments of both the children and their parents
were carried out at the hospital. The interview session was
conducted by a clinical psychologist (the first author). The
parents of the children treated for ALLwere interviewed sep-
arately. All children were individually assessed by different
standardized instruments in a quiet room. Data regarding
treatment protocols were collected from the patient’s medi-
cal records.
With regard to the control group, the educational sections
of two municipal districts were contacted in order to discuss
the demographics of different schools and for permission to
contact school principals in their county. When informed
consent was given in writing by the sections, four school
headmasters were contacted and their informed consent was
given in turn. Two headmasters in the city of Trondheim
were instructed to make a sample by drawing lots based
on age and gender matches. Another group from the ru-
ral county of Nord-Tr ndelag was matched along the lines
of gender and the nearest age in month. Other lots were
drawn by necessity, as when several children matched the
age group. Written information and consent formula were
sent to the families by the different principals, and they also
contacted the families by phone to inform them about the
project. When informed consent was given by the parents
and adolescents, the assessments with each child were car-
ried out individually in a quiet room at the schools, using
the same procedure as with the children in remission from
ALL.
After the assessments each pupil received an envelope,
which contained information and a questionnaire for their
parents. Parents were asked to fill out the questionnaires
separately before returning them in a pre-stamped envelope.
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When necessary, the participants were further able to
contact the researcher by phone to obtain additional
information.
Measures
HRQOL
The Pediatric Quality of Life Inventory (PedsQLTM4.0; 21)
was used to measure HRQOL in children and adolescents.
The 23-item PedsQL, version 4.0 Generic Core Scales, can
be grouped into four domains of HRQOL: (i) physical func-
tioning (8 items), (ii) emotional functioning (5 items), (iii)
social functioning (5 items) and (iv) school functioning
(5 items). The Generic Core Scales comprised of a child
self-report including ages 5–7, 8–12 and 13–18 years. The
parent proxy-report covers ages 2–4, 5–7, 8–12 and 13–18,
and assesses how parents perceive their child’s HRQOL. The
items for self-report and proxy-report are essentially identi-
cal, differing in the language that they use, which is develop-
mentally appropriate, and in using the first- or third-person
pronoun.
The questions ask how much of a problem each item has
been during the past 1 month: 0 = never a problem; 1 =
almost never a problem; 2 = sometimes a problem; 3 = of-
ten a problem; 4 = almost always a problem. In addition to
the four subscales, a Total Summary Health score (23 items)
can be computed. A Psychosocial Health Summary score
(15 items) can be computed as the sum of the items divided
by the number of items answered in the Emotional, Social
and School Functioning Subscales, and a Physical Health
Summary score (8 items) is the same as the Physical Func-
tioning subscale. The PedsQLTM4.0 provided a very reliable
Total Scale score with a Cronbach’s alpha ≥ 0.89, and it
has been shown to differentiate between healthy children
and children with chronic health conditions (22). A Norwe-
gian version of the PedsQL 4.0, geared towards psychomet-
ric properties, is presented and described in greater detail in
an earlier work (23). The PedsQL has demonstrated satis-
factory psychometric properties (23,24). A Cronbach’s alpha
≥0.77was obtained for theNorwegian translation of the Ped-
sQL for the age group 13–15, which indicates good internal
consistency (23).
Intellectual functioning
The Wechsler Intelligence Scale for Children, Third edi-
tion (WISC-III), complete test (25) was used to evaluate
intellectual functioning in the children. For the purposes of
the present study, we used the Full Scale Intelligence Quo-
tient (FSIQ), the Verbal Intelligence Quotient (VIQ) and
the Performance Intelligence Quotient (PIQ), as well as the
four indexes: the Verbal Comprehension Index (VCI), the
Perceptual Organization Index (POI), the Freedom from
Distractibility Index (FDI) and the Processing Speed Index
(PSI).
Statistical analysis
A t-test for independent samples was used to analyse dif-
ferences in HRQOL and intellectual functioning between
the treatment group and healthy children. Ninety-five per-
cent confidence intervals were calculated for the differences.
In order to reduce the risk of making type 1 errors due to
multiple comparisons, a Bonferroni corrected alpha level of
0.004 was chosen. The Statistical Package for Social Sci-
ences (SPSS 14.0, SPSS Inc., Chicago, IL) was used for all
the analyses.
RESULTS
Health-related quality of life (HRQOL)
The PedsQLTM 4.0 scores for self-reports and for the par-
ent proxy-report for children treated for ALL and for their
healthy controls are presented in Table S2. Children treated
for ALL showed significantly lower scores for both the
PedsQL Total Scale and the Psychosocial Health Scale as
these are reflected in both the PedsQL self-report and the
parent proxy-report and compared to healthy controls. In
addition, the PedsQL parent proxy-report also showed sig-
nificant lower scores for the Emotional Function Subscale.
The PedsQL mother proxy-report was lower for the So-
cial Function Subscale, while the School Function Subscale
was lower for the PedsQL father proxy-report compared to
healthy controls. Generally, children in remission from ALL
showed lower scores for Psychosocial Health Scale overall
compared to the Physical Functioning Scale as this was il-
lustrated by both the self-report and the parent proxy-report
(Table S2).
Intellectual functioning
TheWISC-III scores for childrenwith ALL and their healthy
controls are presented in Table S3. Both groups obtained
an average FSIQ within the normal range, but there were
significant differences between children with ALL and their
healthy controls for both the WISC-III FSIQ, the VIQ and
the PIQ scale, as well as for two of the different composite
factors (Table S3).
DISCUSSION
This study presents descriptive data related to the HRQOL
and intellectual functioning in children and adolescents in
remission from ALL, and in comparison with healthy chil-
dren. The results showed that children and adolescents
treated for ALL report significantly lower HRQOL scores
for both the Total Scale and the Psychosocial Health Scale
as measured by the PedsQLTM4.0. Most of the intellec-
tual scores as measured by the WISC-III were also signif-
icantly lower for the children treated for ALL compared to
controls.
The parental impressions of the HRQOL were for most
of the PedsQL Scales significantly different from those of
the control group, and as such confirm a previous and ma-
jor study that took for its subject the HRQOL of children
and adolescents as it was perceived by parents (18). Inter-
estingly, the children in remission from ALL showed lower
scores for the Psychosocial Health Scale compared to the
Physical Functioning Health Scale as reported by both the
PedsQL self-report and parent proxy-report. This finding
confirms the few previous findingswith respect to children in
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remission from ALL (17–19). Psychosocial support therefore
remains important several years after the treatment, even
when the overall physical health appears to be good (17).
Psychosocial problems can be caused by several factors,
and among these may be a continuing anxiety about possible
late-effects or even a recurrence of the cancer. The children
may often be afraid on an unconscious level that the disease
will recur. In addition to stress experienced during the treat-
ment, they can also be confronted with new problems that
develop from the illness and from the long-term side-effects
of treatment (17). Developmental aspects should also be con-
sidered. The patients are children for whom about 2–5 years
of dynamic psychological and social development is inter-
rupted by serious life-threatening illness, persistent regular
hospital visits, compromised immune system, interruption
in school attendance and social activities, as well as family
crisis. All these factors can influence and interrupt normal
psychological and social development and further academic
achievement.
Looking at developmental aspects with respect to the
HRQOL functioning of children in remission from ALL
should be investigated using a bigger pool of children, with
different age groups represented at both the time of diagno-
sis and assessment, in order to find subgroups of children
who might be especially vulnerable when it comes to the
possibility of a reduction in HRQOL.
On average, children and adolescents treated for ALL
show intellectual functioning in the normal range, but be-
low that of the control group. Intellectual functioning in the
normal range is considered as a protective factor with regard
to the mental and psychosocial health of children and ado-
lescents. However, this study shows that despite adequate
intellectual functioning in children in remission from ALL,
their levels of psychosocial health as measured by the Ped-
sQL are significantly lower compared to the control group.
This tendency is similar for both the child self-report as well
as for the parent proxy-report.
There were significant differences between children with
ALL and their healthy controls for three of the WISC-III IQ
scales, as well as for two of the different composite factors. In
the present study, only one child underwent both chemother-
apy and radiotherapy, and this child functioned adequately,
while the remaining children underwent chemotherapy. The
suggestion that it might be chemotherapy alone that con-
tributes towards cognitive deficits is still a controversial one
(26–28). Studies have indicated that children and adoles-
cents experience rather vague problems with attention and
concentration after treatment, and that these complaints
derive from more subtle impairments in processing speed
(28). A recent meta-analysis showed that children who were
survivors of ALL appeared to experience clinically signif-
icant declines in neurocognitive functioning (3), in both
global and specific areas of neurocognitive functioning. The
findings were thought to have been a consequence of the
treatments used to cure their disease. Interestingly, when
compared to normative data, these declines become less
clear (3). Because cognitive deficits may be subtle, contin-
ued evaluation of levels of cognitive and learning functioning
in children who have been treated for moderate-risk acute
lymphocytic leukaemia is recommended (29). The signifi-
cant differences found in the present study between chil-
dren in remission from ALL and their control group should
be further assessed with respect to neuropsychological
functioning.
The strengths of our study include how homogenous the
sample of children with ALL is with respect to both diag-
nosis and age span, and the use of a control group. Draw-
ing control groups from the same local population as the
ALL survivors is recommended as an appropriate means of
comparison (3). However, limitations in our study should
be noted: it has a cross-sectional design, and we were there-
fore unable to control for premorbid functioning; the small
size of our group of children was another drawback. Cross-
sectional designs cannot determine causal relations, and rep-
resents an important shortcoming in the present study and
implies that the results should be treated with some caution.
Furthermore, the psychologist who performed theWISC-III
test was not blinded to the ALL diagnosis, and this should
also be taken into consideration when interpreting the
results.
To be able to investigate the systematic effects of
chemotherapy on HRQOL outcomes and intellectual func-
tioning over a longer period of time, longitudinal designs
should be implemented for children treated for ALL, and
controls involving other types of cancers should be carried
out to control how cancer is experienced more generally.
CONCLUSIONS
Despite adequate intellectual functioning, the children
treated for ALL on average show a lower HRQOL for
the Psychosocial Health Scale compared to healthy con-
trols. The children’s intellectual functioning was in the nor-
mal range, but below that of the control group, and this
needs further investigation, particularly with respect to neu-
ropsychological functioning. It is recommended that further
research be carried out into the HRQOL of children in re-
mission from ALL. The results indicating impairments in
the HRQOL compared to healthy controls show the need
for such follow-up. This presents the healthcare community
with several challenges: how to focus on providing appro-
priate care for the survivors of cancer, as well as the need
to prevent or eventually treat long-term remission. Several
issues need to be addressed, such as educating survivors
and healthcare providers regarding potential psychosocial
sequels. The kind of psychosocial support offered to the pa-
tient during or after the treatment should also be investigated
in future longitudinal research.
The results indicate that HRQOL instruments, such as
the PedsQLTM 4.0 can be a sensitive outcome measure of
a child’s functioning subsequent to treatment for ALL. In a
clinical setting one would generally be interested in increas-
ing children’s HRQOL. The scores on each PedsQL factor
may then be highly informative. Individual differences in
PedsQL scores should be taken into account when tailor-
ing preventive intervention and rehabilitation programs for
children after treatment.
C©2007 The Author(s)/Journal Compilation C©2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1280–1285 1283
Quality of life in children with ALL Reinfjell et al.
ACKNOWLEDGEMENTS
The authors would like to thank all the participating children
treated for acute lymphoblastic leukaemia and their par-
ents, and also the children and parents in the control group
for their valuable contribution to this study. This research
was supported by the Department of Psychology, Norwegian
University of Science and Technology (NTNU); the Section
of Child and Adolescents Psychiatry, Department of Paedi-
atrics, Rikshospitalet-Radiumhospitalet, Oslo, Norway; the
St. Olavs University Hospital, Trondheim, Norway and the
Norwegian Support Group for Children with Cancer.
References
1. Gatta G, Capocaccia R, De Angelis R, Stiller C, Coebergh JW,
Grp EW, et al. Cancer survival in European adolescents and
young adults. Eur J Cancer 2003; 39: 2600–10.
2. Schmiegelow K, Gustaffson G. Acute lymphoblastic
leukaemia. In: Vouˆte PA, Barrett A, Stevens MCG, Caron HN,
editors. Cancer in children: clinical management. 5th ed,
pp. 138–70. New York: Oxford University Press, 2005.
3. Campbell LK, Scaduto M, Sharp W, Dufton L, Van Slyke D,
Whitlock JA, et al. A meta-analysis of the neurocognitive
sequelae of treatment for childhood acute lymphocytic
leukemia. Pediatr Blood Cancer 2007; 49: 65–73.
4. Mulhern RK. Neuropsychological late effects. In: Bearison A,
Mulhern R, editors. Pediatric psycho-oncology: Psychological
perspectives on children with cancer, pp. 99–121. New York:
Oxford University Press, 1994.
5. Zebrack BJ, Chesler M. Health-related worries, self-image,
and life outlooks of long-term survivors of childhood cancer.
Health Soc Work 2001; 26: 245–56.
6. Mulhern RK, Wasserman AL, Friedman AG, Fairclough D.
Social competence and behavioral-adjustment of children
who are long-term survivors of cancer. Pediatrics 1989; 83:
18–25.
7. Zebrack BJ, Zeltzer LK, Whitton J, Mertens AC, Odom L,
Berkow R, et al. Psychological outcomes in long-term
survivors of childhood leukemia, Hodgkin’s disease, and
non-Hodgkin’s lymphoma: a report from the childhood cancer
survivor study. Pediatrics 2002; 110: 42–52.
8. Eiser C, Hill JJ, Vance YH. Examining the psychological
consequences of surviving childhood cancer: systematic
review as a research method in pediatric psychology. J Pediatr
Psychol 2000; 25: 449–60.
9. Eiser C, Mohay H, Morse R. The measurement of quality of life
in young children. Child Care Health Dev 2000; 26: 401–13.
10. Van Dongen Melman JEWM, Pruyn JFA, De Groot A, Koot
HM, Hahlen K, et al. Late psychosocial consequences for
parents of children who survived cancer. J Pediatr Psychol
1995; 20: 567–86.
11. Eiser C. Cancer. In: Koot HM, Wallander JL, editors. Quality
of life in child and adolescent illness, concepts, methods and
findings, pp. 267–295. East Sussex, UK: Brunner-Routledge,
2001.
12. Upton P, Maddocks A, Eiser C, Barnes PM, Williams J.
Development of a measure of the health-related quality of life
of children in public care. Child Care Health Dev 2005; 31:
409–15.
13. WHO. Constitution of the World Health Organization basic
document. World Health Organization, Geneva, 1948.
14. Last BF, Grootenhuis MA, Eiser C. International comparison
of contributions to psychosocial research on survivors of
childhood cancer: past and future considerations. J Pediatr
Psychol 2005; 30: 99–113.
15. Spieth LE. Generic health-related quality of life measures for
children and adolescents. In: Koot HM, Wallander JL, editors.
Quality of life in child and adolescent illness, concepts,
methods and findings, pp. 49–88. East Sussex, UK:
Brunner-Routledge, 2001.
16. Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of
their children’s health-related quality of life: an analysis of
13878 parents’ reliability and validity across age subgroups
using the PedsQL 4.0 Generic Core Scales. Health Qual Life
Outcomes (serial online) 2007; 5: 2. Available at: http://www.
hqlo.com/content/5/1/2. January 3 (accessed March 15, 2007).
17. Eiser C, Vance YH, Horne B, Glaser A, Galvin H. The value of
the PedsQLTM in assessing quality of life in survivors of
childhood cancer. Child Care Health Dev 2003; 29: 95–102.
18. Speechley KN, Barrera M, Shaw AK, Morrison HI, Maunsell
E. Health-related quality of life among child and adolescent
survivors of childhood cancer. J Clin Oncol 2006; 24:
2536–43.
19. Grant J, Cranston A, Horsman J, Furlong W, Barr N, Findlay
S, et al. Health status and health-related quality of life in
adolescent survivors of cancer in childhood. J Adolesc Health
2006; 38: 504–10.
20. Werner EE, Smith RS. Overcoming the odds: high risk
children from birth to adulthood. Ithaca, New York: Cornell
University Press, 1992.
21. Varni JW, Seid M, Rode CA. The PedsQL (TM): measurement
model for the pediatric quality of life inventory. Med Care
1999; 37: 126–39.
22. Varni JW, Burwinkle TM, Seid M. The PedsQL (TM) 4.0 as a
school population health measure: feasibility, reliability, and
validity. Qual Life Res 2006; 15: 203–15.
23. Reinfjell T, Diseth TH, Veenstra M, Vikan A. Measuring
health-related quality of life in young adolescents: reliability
and validity in the Norwegian version of the Pediatric Quality
of Life inventoryTM 4.0 (PedsQL) generic core scales. Health
Qual Life Outcomes (serial online) 2006; 4(61). Available at:
http://www.hqlo.com/content/4/1/61.September 14 (accessed
March 15, 2007).
24. Varni JW, Seid M, Kurtin PS. PedsQL (TM) 4.0: reliability and
validity of the pediatric quality of life Inventory (TM) Version
4.0 generic core scales in healthy and patient populations.
Med Care 2001; 39: 800–12.
25. Wechsler D.Weschler Intelligence Scale 3rd edition. WISC-III.
Swedish version manual: Psykologiforlaget AB 2003.
26. Brown RT, Madan-Swain A, Pais R, Lambert RG, Sexon S,
Ragab A. Chemotherapy for acute lymphocytic leukemia:
cognitive and academic sequelae. J Pediatr 1992; 121: 885–9.
27. Brown RT, Madan-Swain A, Walco GA, Cherrick I, Ievers CE,
Conte PM, et al. Cognitive and academic late effects among
children previously treated for acute lymphocytic leukemia
receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol
1998; 23: 333–40.
28. Mennes M, Stiers P, Vandenbussche E, Vercruysse G,
Uyttebroeck A, De Meyer G, et al. Attention and information
processing in survivors of childhood acute lymphoblastic
leukemia treated with chemotherapy only. Pediatr Blood
Cancer 2005; 44: 479–86.
29. Brown RT. Cognitive status of children treated with central
nervous system prophylactic chemotherapy for acute
lymphocytic leukemia. Arch Clin Neuropsychol 1992; 7:
481–97.
Supplementary material
The following supplementary material is available for this
article:
1284 C©2007 The Author(s)/Journal Compilation C©2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1280–1285
Reinfjell et al. Quality of life in children with ALL
Table S1 Sociodemographic characteristics of children with
ALL and healthy controls: Treatment variables for children
with ALL
Table S2 HRQOL of 40 children diagnosed with ALL and
42 healthy children as controls
Table S3 Intellectual functioning of 40 children diagnosed
with ALL and healthy children as controls
This material is available as part of the online article from:
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1651-
2227.2007.00383.x
(This link will take you to the article abstract).
Please note: Blackwell Publishing is not responsible for the
content or functionality of any supplementary materials sup-
plied by the authors. Any queries (other than missing mate-
rial) should be directed to the corresponding author for the
article.
C©2007 The Author(s)/Journal Compilation C©2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1280–1285 1285
Table S1.  Sociodemographic characteristics of children with ALL and healthy controls.     
Treatment variables for children with ALL.
    ALL  
  (n = 40) 
Healthy 
(n = 42) 
t score       P  
Gender          -.11    .91  
   Girl: n (%)               21    (52.5)     21 (50.0)   
   Boy: n (%) 19    (47.5) 21 (50.0)   
Age at study          .14 .92 
           Mean (SD)      11.8   (1.9)       11.8 (1.9)   
           Median            11.4     11.6   
           Range              8.5-15.4 8.11-15.0    
Family Composition           -.75 .46 
           Both parents   31     (77.5) 29 (69.0)   
           Single mothers    8     (20.0) 12 (28.6)   
           Single fathers    1       (2.5)        1   (2.4)   
Parental Characteristics     
         Age, median (range)     
               Mother  40.0 (30-55) 40.0 (31-52)         -.25 .81 
               Father  43.0 (32-58) 43.5 (34-72)         -.09 .93 
Education, median(range)     
               Mother  14.0 (10-19) 13.0 (9-19)           .07 .95 
               Father  14.0 (10-20)    13.0 (10-19)           .84 .40 
Community             .69 .49 
           Urban  15     (37.5)     18 (42.9)     
           Rural  25     (62.5) 24 (57.1)   
Home             .72 .48 
           Own house       36     (90.0) 39 (92.9)   
           Own apartment    3       (7.5)        3   (7.1)   
           Renting apartment    1       (2.5)            -   
Economy            -.04 .96 
           Very satisfying  27     (67.5) 21 (50.0)   
           Good                      8     (20.0) 21 (50.0)   
           Poor                       5     (12.5)            -   
Diagnosis and treatment     
       Age at diagnosis     
           Mean (SD)   4.0 (1.9)      -   
           Median 3.1 -   
           Range 0-7.6 -   
Years since diagnosis     
           Mean (SD) 7.9 (2.0) -   
           Median 7.1 -   
           Range 4.2-12.5 -   
Treatment protocols      
           Standard risk 15 (37.5) -   
           Intermediary risk 15 (37.5) -   
          High/very high risk 10 (25.0) -   
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ABSTRACT 
Objective: To assess the mental health and psychosocial adjustment of children in remission 
from Acute Lymphoblastic Leukemia (ALL) and parental functioning compared to healthy 
controls.
Methods: A cross-sectional study of 40 children treated for ALL (mean age 11.8 years, range 
8.5-15.4) and healthy controls (n = 42) (mean age 11.8, range 8.11-15.0) were assessed by the 
Child Behavior Checklist (CBCL), the Youth Self-Report (YSR) and the Strength and 
Difficulties Questionnaire (SDQ). The parent’s own mental health was assessed by the 
General Health Questionnaire (GHQ-30).
Results: Children treated for ALL showed on average significantly more symptoms as 
measured by the CBCL Total Behavior Score for mother’s report (p= .005), and for father’s 
report (p=.004) compared to healthy children. Fathers reported more anxiety (p= .03) and 
depression (p=.02) as measured by the GHQ-30 compared to healthy controls.  
Conclusions: Children in remission from ALL showed on average significantly more 
problems regarding mental health and psychosocial adjustment as reported by their parents 
compared to healthy controls. Adequate rehabilitation and follow-up programs should be 
implemented for children in remission from ALL. The results indicate the need to pay 
attention to the mental health of fathers during the rehabilitation phase. 
Key words: paediatrics; mental health; psychosocial adjustment, children; parents.
INTRODUCTION
Over the last decades survival rates of children treated for Acute Lymphoblastic Leukemia 
(ALL), have increased dramatically. New treatments involving a combination of 
chemotherapy and radiotherapy have resulted in significant survival improvements, with an 
approximate 80 % average in the 5-years survival [1, 2]. This progress in medical treatment 
has changed the focus toward the illnesses impact on the psychosocial situation of the child 
and the family during and after treatment [3].  
Outcome regarding mental health and psychosocial functioning in childhood cancer 
has been the subject of previous research, but generally do not provide consistent results 
regarding adjustment. Studies have shown that many survivors functioning reasonably well, 
with little difference found between results for survivors and those for their peers or siblings 
[4-6].  It is also reported that a considerable proportion of survivors had long-term coping [7, 
8], while poorer coping in cancer patients was associated with longer treatment time [7]. In 
addition, other studies have indicated increased risk for maladaptive psychosocial sequels, 
such as depression, anxiety, problems of self-esteem and fluctuations in mood [9-13], and 
symptoms of posttraumatic stress [14,15]. However, many studies of the psychosocial effects 
of surviving cancer have included children with a wide variety of cancers, and often research 
has failed to separate the results according to type of cancer [13]. Another problem is the use 
of different criteria for the selection of controlgroups, and a lack of a longitudinal approach 
[16, 17]. 
Parental functioning is one of the strongest contributors to adjustment in children with 
chronic health conditions [18]. Emotional distress among parents remains heightened one year 
after diagnosis but appears to decrease over time [19]. However, adverse consequences for 
parents related to long-term physical and mental health has been reported [20], a significant 
number of parents still suffer from clinical distress five years post treatment [21].Thus, quality 
of survival should also include the long-term effects for the parents as well.  
The objective of the present study was to explore aspects of mental health and 
psychosocial adjustment of children in remission from ALL and their parents compared to 
healthy controls. Regarding the length of treatment for ALL that can vary from 2 to 2.5 years, 
as well as the enormous stress associated with a diagnosis of cancer, and that children with 
ALL often are isolated from their peer groups for long periods of time, we hypothesized that 
children in remission from ALL would have more mental and psychosocial symptoms 
compared to healthy children.  
PATIENTS AND METHODS 
Patients
Children and adolescents in remission from ALL were recruited from two University 
Hospitals in Norway: Rikshospitalet-Radiumhospitalet Medical Centre in Oslo and St.Olavs 
Hospital in Trondheim. The children were born in the period 1989-1995, had a mean age of 
11.8 (range 8.5-15.4), took part 4.2-12.5 years after ALL diagnosis, and were treated 
according to the Nordic protocol, The Nordic Society of Pediatric Hematology/Oncology 
(NOPHO-ALL, 1992): their parents were also invited to participate in the study. Children 
who suffered relapses, or who had other kinds of severe medical condition (e.g. Down’s 
syndrome) were excluded. Of the 56 children who fulfilled the criteria for participation, a 
total of 40 (71.4), comprising 21 girls (52.5%) and 19 boys (47.5%), took part. Parental 
information was supplied by 36 mothers, whose mean age was 40.0 (range 30-55), and 21 
fathers, whose mean age was 43.0 (range 32-58): each parent was asked to give their 
evaluation of the PedsQL proxy-report separately. Data regarding diagnoses and treatment 
protocols were collected from the medical records. The average age at the time ALL was 
diagnosed was 4.0 years (range 0-7.6). The average time since diagnosis was 7.9 years (range 
4.2-12.5). The treatment categories were scored according to the Nordic protocol (NOPHO-
ALL, 1992) with the following categories: 1) Standard risk (SR); 2) Intermediate risk (IR); 3) 
High risk (HR); 4) High risk-1 (HR-1); 5) High risk-2 (HR-2); and 6) Very high risk-1 
(VHR). With regards to the small sample in the four last categories, we scored these as one 
category – high/very high risk. One child had been treated with chemotherapy combined with 
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radiation therapy (1800Cgy) , and the remaining children with chemotherapy only. One child 
was in the infant-risk group, treated according to the NOPHO-92 protocol HR-1. 
Sociodemographic characteristics and treatment-related variables are presented in Table 1.
The children treated for ALL were compared to a group of healthy children with a 
similar age and gender distribution (n=42), drawn by lots based on age and gender matches. 
(Table 1), recruited from two elementary schools and two junior high schools in the middle 
part of Norway, and from both urban and rural areas. Children with a psychiatric diagnosis or 
with other specific and relevant medical problems such as cognitive dysfunction were 
excluded. Informed consent was obtained from all of the children and adolescents, as well as 
from their parents. The study was approved by the Regional Ethics Committee of Medical 
Research.
INSERT TABLE 1 ABOUT HERE 
Measures
Children`s mental health and psychosocial functioning 
The parents completed the Child Behavior Checklist CBCL [22], while the children 
completed the standardised questionnaire Youth Self-Report (YSR) [23]. The Norwegian 
version has 112 problem items, 90 of them are common to both CBCL and YSR. For both 
forms the questions are scored 0 (no), 1 (sometimes), and 2 (often). Eight syndrome scales are 
generated; five of them are subdivided into two subscales. The internalising subscale includes 
withdrawal, somatic complaints, and anxiety/depression. The externalising subscale includes 
delinquent and aggressive behaviour. As population norms for these questionnaires have yet 
not been established in Norway, the present study reports raw scores. According to the 
American norm, corrected for sex and age, the 90th percentile (T-score>63) is used as a cut-
off point for total, internalising, and externalising scores implying psychiatric problems..  
The Strength and Difficulties Questionnaire (SDQ) was used to assess the mental and  
psychosocial health in children and adolescents [24]. The SDQ is a brief behavioural 
screening questionnaire consisting of 25 items in addition to a supplement on the impact of 
the difficulties for the child and family. There are 5 subscales: Emotional Symptoms, Conduct 
Problems, Hyperactivity, Peer Problems and Prosocial Behaviour, the first four adding up to 
the Total Difficulties Score. Each item uses a 3-point ordinal Likert format and can be 
answered with: “not true”, “somewhat true” or “certainly true”, rated 0-2 for negatively 
worded items and rated inversely 2-0 for positively worded items. In this way, for all items, 
higher scores indicated more problematic attributes. The SDQ shows satisfactory reliability 
and validity [24, 25]. 
Parental Assessment 
Parents were interviewed separately by a child psychologist using a modified version of the 
standardized, semistructured, investigator-based interview Parental Account of Children`s 
Symptoms (PACS) [26]. The PACS includes questions relevant for psychiatric assessment of 
the index children, as well as registration of sociodemographic factors.  
Parent`s mental health 
The General Health Questionnaire (GHQ-30) [27] were included to assess parents` own 
mental health. The GHQ-30 [27] is the most used  screening instrument for distress, 
psychopathology and quality of life in adults, showing acceptable reliability and validity in 
studies of medical and psychiatric populations. The GHQ includes both positive and negative 
questions and the short version GHQ-30 contains 30 items covering symptoms considered to 
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reflect distress and psychopathology. GHQ-30 avoids using physical symptoms as indicators 
of distress. 
Statistical Analysis
A T-test for independent samples was used to analyse differences in mental health and 
psychosocial functioning between the children treated for ALL and healthy children, as well 
as for their parent’s QOL and mental health compared to healthy controls. 95% confidence 
intervals were calculated for the differences. In order to reduce the risk of making Type 1 
errors due to multiple comparisons, a corrected alpha level of 0.01 was chosen, otherwise the 
significance level was set at p<0.05. The Statistical Package for Social Sciences (SPSS 14.0) 
statistics program for Windows was used for all the analyses.  
RESULTS
Mental health and psychosocial functioning in children 
The CBCL and YSR for children treated for ALL and their healthy controls are presented in 
Table 2. Children treated for ALL showed significantly higher symptom scores for the CBCL 
Total Problem Scale, as well as for the Internalizing and Externalizing Subscales. Six children 
had a CBCL score of  90 percentile indicative of severe problems, as reported by the 
mothers, while none in the controlgroup. The CBCL as reported by the fathers showed that 
five children scored  90 percentile, 1 child from the controlgroup. Children treated for ALL 
showed higher symptom scores for the YSR as well, but these results were not significant 
when the corrected alpha level of 0.01 was chosen. One child scored  90 percentile on the 
YSR, and one child in the controlgroup. 
The SDQ self-report for children indicated no statistically significant differences in 
psychosocial health between children with ALL and their healthy controls. However, the SDQ 
parent self-report for mothers showed significant differences for the Emotional Symptoms 
Summary Scale (t = 2.726, p = .008, CI: 1.41 to 0.22). 
INSERT TABLE 2 ABOUT HERE 
Parent`s mental health
The fathers showed significantly more anxiety (t= 2.195, p= 0.03, 95% CI: 0.02 to 0.46) and 
depression (t = 2.515, p= 0.02, CI: 0.05 to 0.44) as measured by the GHQ-30 compared to 
healthy controls, while no such differences were found for the mothers.  
DISCUSSION 
This study presents descriptive data regarding mental health and psychosocial 
functioning in children and adolescents in remission from ALL and their parents. The results 
as reported by the parents confirmed our hypothesis showing that both children’s mental 
health and psychosocial adjustment was significantly lower compared with healthy controls. 
The fathers’s own mental health showed for some areas lower scores compared to controls.
Children’s mental health 
Children treated for ALL showed significantly higher symptom scores on all domains of the 
CBCL compared to healthy children. Six children had a CBCL score  90 percentile 
indicative of severe problems, as reported by the mothers. The CBCL as reported by the 
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fathers showed that five children scored  90 percentile. Children treated for ALL showed 
higher symptom scores for the YSR as well, but these results remained not significant when 
the alpha level was corrected to 0.01. One child scored  90 percentile on the YSR. The 
severity of a child’s problems may appear quite different, and depend on whether the source 
of information is the parent or child [28]. Mental health professionals regarded mothers as 
more useful informants than children for both internalizing and externalizing problems [29]. 
Discrepancies between child and parent agreement in this present study should be further 
investigated. Although major psychiatric disturbance are not common among survivors of 
ALL [11], the few earlier studies have shown that this population is at increased risk for 
mental health and adjustment problems [13, 30]. A previous study indicates that the period 
after treatment is characterized by a higher risk of psychosocial problems compared to the 
actual treatment period. Children and adolescents off treatment reported higher levels of 
depression and anxiety, seven children (14%) reported a high level of depression, six of the 
children were off treatment [31].  
In contrast to the results in this present study, whose significance is confirmed by the 
instrument CBCL, the SDQ self-report for children showed no statistically significant 
differences in psychosocial health between children with ALL and their healthy controls. The 
same tendency was shown for most of the SDQ parent proxy-report scales. This confirms that 
the choice of adequate instruments when assessing the situation for children treated for cancer 
should be of concern [32], since the measurements might lack sensitivity [33]. However, the 
SDQ Parent proxy-report as reported by mothers of children treated for ALL showed higher 
score for Emotional symptoms than did the healthy controls. As such, this finding confirms 
some of the CBCL findings. 
Parents QOL and mental health 
The fathers showed significantly more anxiety and depression as measured by the 
GHQ-30 compared to healthy controls, while no such differences were found for the mothers. 
Eiser (2005) points out that fathers often remain more involved in everyday life despite the 
child`s illness. This aspect may influence the father’s own situation and needs, since by 
staying at home or at work more during the time the child is being treated, the fathers will not 
be able to get adequate help for his own emotionally needs, and this may affect his later 
adjustment. Even as research participants, fathers are often underrepresented in paediatric 
research samples [15, 20]. Many of the fathers in a previous study reported that they had 
feared that expressing their upsetting memories would be detrimental to other family 
members [15].  
Limitations 
The strength of our study includes how homogenous the sample of children with ALL 
is with respect to both diagnosis and age-span, and the use of a control group. However, 
limitation in our study should be noted. This study has a cross-sectional design, and we were 
therefore unable to control for premorbid functioning, the small size of our group of children 
was another drawback. Cross-sectional designs cannot determine causal relations, and their 
absence represents an important shortcoming in the present study and implies that the results 
should be treated with some caution. For the future, longitudinal designs should be 
emphasised with children treated for ALL, and for controls who have other types of cancers 
and treatments.  
The findings based on the 21 fathers of ALL patients who participated in our study 
should also be treated with a degree of caution. But the result may indicate the need to pay 
attention to the mental health and adjustment of fathers during the time of the child’s 
treatment as well as the rehabilitation phase. The fact that only 21 fathers participated may 
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indicate a common problem in clinical research, namely that more fathers should be included 
in future research on children with cancer and their parents. 
CONCLUSION 
This study shows that problems can be seen several years after diagnosis and 
treatment, and demonstrates the need for close awareness of adjustment related to mental 
health and psychosocial functioning in children in remission from ALL. To be able to detect 
and address actual problems effectively, children should be followed-up from returning to 
school and further into their academic careers.  Parallel to the medical follow-up in clinics, 
outpatient centres should have this aspect of concern as well. Further research should consider 
within group differences in the group of children treated for ALL, with particular attention 
being paid to the type of treatment protocol, time since diagnosis, age at diagnosis, and family 
variables. Indeed, knowing what separates those children with good coping and adjustment 
from the others is critical.  
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9Table 1.  Sociodemographic characteristics  of children with ALL and healthy controls. 
Treatment variables for children with ALL.
    ALL
  (n = 40) 
Healthy
(n = 42) 
t score P
Gender        -.11    .91
   Girl: n (%)               21    (52.5)     21 (50.0) 
   Boy: n (%) 19    (47.5) 21 (50.0) 
Age at study          .14 .92
           Mean (SD) 11.8   (1.9)   11.8 (1.9) 
           Median 11.4     11.6 
           Range 8.5-15.4 8.11-15.0  
Family Composition         -.75 .46
           Both parents 31     (77.5) 29 (69.0) 
           Single mothers    8     (20.0) 12 (28.6) 
           Single fathers   1       (2.5)        1   (2.4) 
Parental Characteristics 
         Age, median (range) 
               Mother 40.0 (30-55) 40.0 (31-52)         -.25 .81
               Father 43.0 (32-58) 43.5 (34-72)         -.09 .93
Education, median(range) 
               Mother 14.0 (10-19) 13.0 (9-19)           .07 .95
               Father 14.0 (10-20)    13.0 (10-19)           .84 .40
Community           .69 .49
           Urban 15     (37.5)     18 (42.9)
           Rural 25     (62.5) 24 (57.1) 
Home           .72 .48
           Own house 36     (90.0) 39 (92.9) 
           Own apartment    3       (7.5)        3   (7.1) 
           Renting apartment    1       (2.5)            - 
Economy          -.04 .96
           Very satisfying 27     (67.5) 21 (50.0) 
           Good   8     (20.0) 21 (50.0) 
           Poor   5     (12.5)            - 
Diagnosis and treatment 
       Age at diagnosis 
           Mean (SD) 4.0 (1.9)      - 
           Median 3.1 -
           Range 0-7.6 -
Years since diagnosis 
           Mean (SD) 7.9 (2.0) -
           Median 7.1 -
           Range 4.2-12.5 -
Treatment protocols  
           Standard risk 15 (37.5) -
           Intermediary risk 15 (37.5) -
          High/very high risk 10 (25.0) -
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Abstract
Background: Health-Related Quality of Life (HRQOL) studies concerning children and
adolescents are a growing field of research. The Pediatric Quality of Life Inventory (PedsQL™) is
considered as a promising HRQOL instrument with the availability of age appropriate versions and
parallel forms for both child and parents. The purpose of the current study was to evaluate the
psychometric properties of the Norwegian translation of the Pediatric Quality of Life Inventory
(PedsQL™) 4.0 generic core scale in a sample of healthy young adolescents.
Methods: A cross-sectional study of 425 healthy young adolescents and 237 of their caregivers
participating as a proxy. Reliability was assessed by Cronbach's alpha. Construct validity was
assessed using exploratory factor analysis and by exploring the intercorrelations between and
among the four PedsQL subscales for adolescents and their parents.
Results: All the self-report scales and proxy-report scales showed satisfactory reliability with
Cronbach's alpha varying between 0.77 and 0.88. Factor analysis showed results comparable with
the original version, except for the Physical Health scale. On average, monotrait-multimethod
correlations were higher than multitrait-multimethod correlations. Sex differences were noted on
the emotional functioning subscale, girls reported lower HRQOL than boys.
Conclusion: The Norwegian PedsQL is a valid and reliable generic pediatric health-related Quality
of Life measurement that can be recommended for self-reports and proxy-reports for children in
the age groups ranging from 13–15 years.
Background
Mirroring a modern bio-psycho-social orientation toward
the concept of health, the development of a multidimen-
sional Health-Related Quality of Life (HRQOL) measure-
ment has been an important concern of research in recent
years. It is realized that an instrument measuring HRQOL
must consist of the physical, mental, and social health
dimensions delineated by the World Health Organization
(WHO) [1]. HRQOL studies related to children are a rela-
tively new field of research [2], still there are only a few
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measures that assess Quality of life outcomes for children
and adolescents [3]. Such studies can have considerable
significance for understanding children's psychosocial
functioning and development like their perception of ill-
ness and its effect on their daily life [4,5]. However, the
lack of valid and reliable measures for children and ado-
lescents is one significant limitation of current HRQOL
research [6].
Issues related to young persons continuous and often
rapid developmental change were initially not sufficiently
realized [4,7]. A pediatric health-related quality of life
(HRQOL) instrument which includes a developmental
perspective must for instance show sensitivity to both cog-
nitive and emotional changes throughout the age span.
Daily functioning in contexts relevant for children, such
as school and community, should also be assessed [8].
Furthermore, a problem of these scales has been low con-
cordances between proxy-and self-reports on HRQOL
instruments. This has been observed in studies of children
in both pediatric and psychiatric population [9,10]. Con-
cordances tend to be lower for internalizing problems (eg.
depression) than for externalizing problems (eg. hyperac-
tivity) [11]. The presence of low concordance between
proxy-and self-reports suggests a critical need in pediatric
HRQOL measurement for reliable and valid child self-
report instruments for the broadest age range possible [9].
The Pediatric Quality of Life Inventory (PedsQL) [9] is
considered one of the most promising HRQOL instru-
ments for children and adolescents, integrating generic
core scales and disease-specific modules into one meas-
urement system [12].
The instrument includes a broad age range with develop-
mental sensitivity as well as categories for both parents
and the young persons themselves. The PedsQL version
4.0 builds on programmatic instrument development
research during the past 15 years, beginning with the
measurement of pain and functional status [13]. The 4.0
version was designed to measure the core health dimen-
sions delineated by WHO [1], including role (school)
functioning [9], and were developed through focus
groups and cognitive interviews [6]. The PedsQL 4.0 has
been proposed as a valid and reliable generic pediatric
HRQOL measurement that can be used for self-reports
and proxy-reports in age groups ranging from 2 to 18
years [9], and can also be used in clinical practice, clinical
trials, and research, as well as school health settings, and
community populations [7,9].
The PedsQL is translated into many European and other
international languages, and widely used in research. Ped-
sQL was translated into Norwegian during 2002/2003, at
that time no other HRQOL measurements for children
were available in Norway. When selecting a HRQOL
measure it will be important to examine its psychometric
adequacy as well as its ability to tap outcomes of primary
interest to a particular investigation [14]. The importance
of validating new translations should be emphasized to
investigate the acceptability of the psychometric proper-
ties for further use in both clinical practice and research.
This first validation study of the PedsQL Norwegian ver-
sion is a pilot study with young adolescents, and is part of
a larger study with a broader focus on young adolescent's
quality of life and mental health.
The objective of the current paper was to evaluate reliabil-
ity and validity of the Norwegian translation of the Ped-
sQL™ (version 4.0 generic core scale) in a sample of
healthy young adolescents. The focus in the present paper
is therefore on the scales that are relevant for adolescents.
Methods
Participants
A sample of 440 young adolescents and their parents were
recruited through five junior high schools in Norway,
three from urban and two from rural areas. A total of 440
questionnaires were distributed and 425 were returned,
which gives a response rate of 96.6%.
Self-report forms were completed by 425 adolescents, 235
girls (56%) and 184 boys (44%), six did not report gen-
der. In junior high schools in Norway adolescents
between 13 to 15 years of age are separated in three differ-
ent grades and participants were distributed as follows for
8th, 9th and 10th grade; 33%, 33%, 34%, respectively.
Proxy-reports were completed by 237 (56%) caregivers.
The proxy-reports were completed by 139 (59%) mothers,
by both parents in 69 (29%) of the cases, by 27 (11%)
fathers, or by other caregivers such as grandparents 2
(0.8%). For 229 adolescents both adolescent self-report
and parent proxy-report on the PedsQL were available.
Information about non-response in the sample of adoles-
cents as well as the sample of parents was not available,
because of the anonymity required. Sociodemographic
characteristics of the sample are given in Table 1. The Data
Inspectorate and the Regional Committee for Medical
Research Ethics approved the study. Written parental
informed consent and child assent were obtained.
Measures
The 23-item PedsQL, version 4.0 Generic Core Scales, can
be grouped into 4 domains of HRQOL: 1) Physical Func-
tioning (8 items), 2) Emotional Functioning (5 items), 3)
Social Functioning (5 items) and 4) School Functioning
(5 items). These scales are feasible for child self-report
including ages 5 to 7, 8 to 12 and 13 to 18 years. Parent
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proxy-report includes ages 2 to 4, 5 to 7, 8 to 12 and 13 to
18, and assesses parent's perceptions of their child's
HRQOL.
The items for self-report and proxy-report are essentially
identical, differing in developmentally appropriate lan-
guage, and first or third person tense. The instructions ask
how much of a problem each item has been during the
past 1 month. A 5-point response scale is utilized across
child self-report for ages 8 – 18 and parent proxy-report (0
= never a problem; 1= almost never a problem; 2 = some-
times a problem; 3 = often a problem; 4 = almost always
a problem). Subjects are requested to rate how much
problems they experienced during the past month with
health (eg. "I hurt or ache"), activities (eg. "It's hard for
me to run"), or feelings (eg. "I feel afraid or scared").
Items are reverse-scored and linearly transformed to a 0 to
100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), so that
higher scores indicate better HRQOL. Scale scores are
computed as the sum of the items divided by the number
of items answered (this accounts for missing data). In
addition to the four subscales, two summary scores can be
computed. Physical Health Summary score (8 items) is
the same as the Physical Functioning subscale, and Psy-
chosocial Health Summary score (15 items) is computed
as the sum of the items divided by the number of items
answered in the Emotional, Social, and School Function-
ing subscales.
The translation and linguistic validation of the PedsQL
questionnaire followed recommended guidelines [15,16].
Two independent forward translations were conducted by
a psychiatrist and a clinical psychologist, the translators
discussed semantic and conceptual discrepancies and
finally developed a consensus forward translation. The
translation of the first reconciled forward version of the
PedsQL questionnaire back into the source language was
done by a skilled english speaking person with experience
from living in English speaking countries.
In a following pilot-project, the questionnaire was admin-
istrated to 10 children, 12 adolescents and 23 parents to
test the interpretation and understanding of items and
response ratings. Cognitive interview techniques [15]
were used to obtain feedback about the interpretation and
understanding of items and respons ratings. The question-
naires were then revised in response to feedback from
children and parents. A written report was sent to Varni
for further review. The relevant changes in the translation
process were reviewed and authorised by Varni. In addi-
tion to the PedsQL 4.0, the questionnaires included infor-
mation about children's socio-demographic
characteristics.
Procedure
Local junior high schools were contacted and teachers dis-
tributed written consent forms that the adolescents pre-
sented to their parents. Each pupil received an envelope,
which contained information and a questionnaire for
their parents. Parents were asked to return the completed
questionnaire in a pre-stamped envelope. The participants
could further contact the researchers to obtain additional
information. Approvals signed by the parents and
returned to the teacher, confirmed that the adolescent had
permission to participate.
The self-report instruments were administrated and com-
pleted in the classrooms. Children were given verbal and
written information before completing questionnaires in
class, under the supervision of a research assistant.
Statistical analysis
Scale internal consistency reliability was determined by
calculating Cronbach's alpha coefficient [17]. Scales with
reliabilities equal to or greater than 0.70 were considered
satisfactory and are also recommended for comparing
patient groups [18,19].
We used exploratory factor analysis to examine the struc-
ture of relationships between the items of the PedsQL™
Table 1: Sociodemographic characteristics of 419 adolescents 
and their parents
Adolescents N %
Total sample 419
Girls 235 56.1
Boys 184 43.9
School grade:
8th grade 140 32.9
9th grade 142 33.4
10th grade 143 33.7
Parental education and economy
Mothers 216
Mothers education:
Elementary school 10 4.7
Highschool graduate 51 23.6
Post high school 155 71.7
Fathers 110
Fathers education:
Elementary school 5 4.4
Highschool graduate 25 22.8
Post high school 80 72.8
Economy 235
Very satisfying 26 11.1
Good 198 84.2
Poor 11 4.7
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4.0 and to compare the factor structure in the present
study with the structure reported for the original PedsQL™
[9]. Regarding Varni's results where the school function-
ing items loaded on two separate factors, we expected to
find a five factor structure. To extract the factors we
applied Principal Component Analysis, with oblique rota-
tion (Direct Oblimin). Factors with an eigenvalue less
than 1 were disregarded.
Validity was further examined by exploring the intercorre-
lations between and among the four PedsQL Subscales
[20]. To strengthen faith in the validity of the PedsQL ver-
sion 4.0, multitrait-monomethod correlations (eg. corre-
lations among subscales within self-report and proxy-
report) should be lower than monotrait-multimethod
correlations (eg. concordance between self-report and
proxy-report for the same subscale). Correlations are des-
ignated as small (0.10–0.29), medium (0.30–0.49), and
large (=0.50) [21]. Given shared method variance [18]
and that the PedsQL items were developed to measure an
integrated multidimensional construct (pediatric
HRQOL), it was expected that heterotrait-monomethod
correlations among the Subscales would be medium to
large (0.30–0.50). Proxy/child concordance for the same
subscale was furthermore expected to demonstrate
medium to large effect sizes.
Based on previous literature [9] it was anticipated that the
Physical Functioning Subscale would demonstrate the
largest concordance, and heterotrait-heteromethod con-
cordance was expected to be small. In addition, we calcu-
lated intraclass correlation coefficients (ICC) to assess
parent and child convergence on the PedsQL subscales.
ICC takes into account not only the correlation but also
differences in intercept and slope between replicant rat-
ings [22]. Paired t-test were used to assess the extend to
which adolescents or proxies systematically scored lower
on the subscales of the PedsQL. As a measure of the min-
imally important difference in scores, we calculated the
standardized response mean, a distribution-based
approach that compares temporal change by the standard
deviation of change [21]. Standardized response mean of
0.2–0.5, 0.5–0.8, and >0.8 are regarded as small, moder-
ate, and large, respectively. Gender differences in the self-
report scales were analysed with two-sample t-test. For all
analyses, we used SPSS statistical software version 12.0
(SPSS Inc., Chicago, III, USA) and a critical value (α) of
5%.
Results
Scale-level analysis
Mean scale scores, percentage of scores at the floor and
ceiling and Cronbach's alpha are shown in Table 2. All the
self-report scales and proxy-report scales exceeded the
minimum reliability standard of 0.70. No floor effects
were found on self or proxy-report for this healthy sample
of adolescence. Ceiling effects existed and ranged from
minimal (eg. 2.6% and 3.4% for self and proxy-report,
respectively for Total score) to moderate (eg. 26.5% and
24.2% for self and proxy-report for Physical Functioning).
The largest effect was found for Social Functioning (43%
and 46% for self and proxy-report). Table 2 gives informa-
tion about scale descriptives and internal consistency reli-
ability for the PedsQL 4.0.
Further, for all 23 items, item means for self-report ranged
from 67.9 to 99.9 with 12 of 23 items falling within a 10-
point range. Item means for proxy report ranged from
67.8 to 98.9, with 13 items falling within a 10-point
range. Two items from the Physical health scale have a rel-
atively small standard deviation namely: 1.2 (item 5) and
9.6 (item 1) for the self-report, 8.2 (item 5) and 8.8 (item
1) for the proxy report. The remaining standard deviations
ranged from 13.3 to 25.8 for self-report items and 14.8 to
23.7 for proxy-report items.
Construct validity
Adolescent-parent report
Monotrait-multimethod correlations are all statistically
significant but generally modest. Table 3 shows the inter-
correlations between and among the four subscales of the
PedsQL.
For the subscale School Functioning we found moderate
(>0.40) intercorrelations between adolescents and par-
ents. All multitrait-multimethod correlations were lower
than the monotrait-multimethod correlations. However,
some of the multitrait-multimethod correlations are
higher than the convergent correlations of the other three
subscales, in particular for Emotional functioning and
Social functioning. The average convergent correlation is
0.31 and the average off-diagonal correlation is 0.22. This
indicates that on average the monotrait-multimethod cor-
relations are higher than the multitrait-multimethod cor-
relations. The intraclass-correlation (ICC) was relatively
low for all scales, indicating poor to fair (<0.40) child-
proxy agreement for all scales but one. Moderate agree-
ment (ICC = 0.41) was found for the sub scale measuring
School functioning. Lowest agreement was found for the
emotional functioning scale (ICC = 0.21). The results of
the paired t-tests suggested that parents scores were sys-
tematically higher than that of adolescents for Emotional
functioning (t = 2.32; df = 228; p = 0.02) and School func-
tioning (t = -5.28; df = 228; p < 0.001). Conversely, par-
ents reported lower on the subscales for Physical
functioning (t = 2.9; df = 233; p = 0.004) and Psychosocial
health scale (t = -2.7; df = 231; p = 0.007). The scores on
the Social Functioning scale did not yield statistically sig-
nificant differences between parents and adolescents (t =
1; df = 228; p = 0.268). Only the difference found for
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School Functioning corresponded to a small effect size
(0.35), the other differences between parents and adoles-
cents all have effect sizes below 0.20.
Gender differences
A statistically significant gender differences was found on
the emotional subscale, with girls on average scoring
lower than boys (t = 4,79; df = 416, p < 0.001). However,
the mean score for girls (73.92 and sd = 17.53) as well as
for boys (81.85 and sd = 15.83) were at the high end of
the scale. No statistically significant gender differences
were found for the remaining scales.
Factor analysis
The results of the factor analysis for self-report and proxy-
report are shown in table 4 and 5.
An eigenvalue cutoff of 1.0 resulted in a five factor solu-
tion for self-report and proxy-report, accounting for 56 %
and 61 % of the variance. The school functioning items
split into two different factors, like the originally version.
For physical functioning, item 5 ("hard to take bath or
shower"), item 6 ("hard to do chores around the house")
and item 7 ("hurth or arche") split into different factors.
The items related to emotional and social functioning are
consistent with the original PedsQL™ version [23].
Discussion
This article describes the psychometric properties of the
Norwegian translation of the PedsQL™ 4.0 generic core
scale in a healthy sample of young adolescents and their
caregivers. The results from the present study resemble the
findings of the original PedsQL™ [9] and the UK-English
version [24] and as such confirm that the instrument can
be used for self-reports and proxy-reports in school health
settings and community populations.
Reliability
Internal consistency was satisfactory with Cronbach's alph
coefficient >0.70 for all four subscales. No floor effects
were found for any of the scales. The presence of ceiling
effects in the present study may be expected in generic
HRQOL instruments, because they are made to be appli-
cable to a wide range of populations [24]. This could be a
Table 3: Intercorrelations between and among PedsQL subscales
Adolescent self-report Parent proxy-report
Adolescent self-report 1 2 3 4 5 6 7
1 Physical functioning
2 Emotional functioning 0,65
3 Social functioning 0,66 0,61
4 School functioning 0,56 0,54 0,46
Parent proxy-report
5 Physical functioning 0,35 0,12ns 0,21 0,35
6 Emotional functioning 0,25 0,22 0,29 0,30 0,52
7 Social functioning 0,20 0,12ns 0,28 0,25 0,51 0,50
8 School functioning 0,17 0,15 0,19 0,42 0,53 0,54 0,49
Notes: N = 229; NS = Not significant at 5% level; Multitrait-monomethod correlations are in bold; monotrait-multimethod correlations are 
underlined; multitrait-multimethod correlations are italicised.
Table 2: Scale Descriptives and Internal Consistency Reliability for PedsQL 4.0
Scale Items N Mean SD Percentage floor Percentage ceiling Cronbach's alpha
Adolescent self-report
Total score 23 414 85.29 11.11 0 2.6 .84
Physical health 8 422 91.12 10.35 0 26.5 .78
Psychosocial health 15 416 82.16 12.50 0 3.1 .82
Emotional functioning 5 424 77.15 17.32 0 10.4 .79
Social functioning 5 424 88.12 13.11 0 43.6 .80
School functioning 5 424 78.02 15.47 0 8.3 .73
Parent proxy-report
Total score 23 232 86.10 10.20 0 3.4 .77
Physical health 8 236 88.83 11.76 0 24.2 .80
Psychosocial health 15 234 84.66 10.92 0 4.3 .88
Emotional functioning 5 238 79.98 14.13 0 12.7 .78
Social functioning 5 238 88.05 13.37 0 46.0 .82
School functioning 5 238 88.97 12.37 0 13.5 .75
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sample specific phenomenon, and should be further
explored through the administration of PedsQL™ to chil-
dren with different health issues including those children
and adolescents experiencing acute health problems.
Regarding single item descriptives, it is interesting to note
the low standard deviation for two items from the Physi-
cal health scale. These results are challenging the require-
ments of equivalent item means and variance. However,
this finding may be typical for the way PedsQL behaves in
a healthy sample.
Validity
Our results showed that on average the monotrait-multi-
method correlations are higher than the multitrait-multi-
method correlations. This high multitrait-multimethod
correlations indicate that the different traits measured in
the four subscales show considerable overlap. For exam-
ple, three items in the physical functioning scale ("hard to
take bath or shower", "hard to do chores around the
house", and "hurt or ache") are loading on another factor
than the other physical functioning items. This could be
more related to a fatigue component, which seems more
relevant for a chronically ill patient population than
healthy adolescents. A confirmatory factor analysis could
provide further insight in the degree of overlap between
items hypothesized to measure different constructs, and
also in the equivalence of factor loadings on the items
within a single factor.
The adolescent-parent agreement did not exceed the pre-
ferred intra-class correlation of 0.40, except for the scale
measuring School function. Lack of agreement between
parents and children may result from differences in per-
ception of the same situation, and also differences in
interpretation of different items [11], or may be due to the
young adolescents becoming more independent from the
parents. As opposed to some previous research [25], our
findings did not find higher agreement between parents
and adolescents regarding physical problems. Parents
rated the physical function scale lower than their chil-
dren's reports. Further, a recent study found that proxy
and self-report correlation was higher for children with
health problems than for healthy children [24]. Parents
and children may be more likely to share information
about an issue if it is perceived as a problem [24]. How-
ever, the strength of this agreement has also been chal-
lenged in research on children with Cystic Fibrosis [8].
Table 4: PedsQL 4.0 Norwegian version Factor Loadings for Adolescents Self-Report
Scale/Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
Physical Functioning
1. Hard to walk more than one block ,079 ,702 -,356 ,086 ,299
2. Hard to run ,327 ,887 -,359 ,145 ,270
3. Hard to do sports or exercises ,375 ,851 -,322 ,142 ,240
4. Hard to lift something heavy ,251 ,568 -,484 ,052 ,363
5. Hard to take bath or shower -,036 ,039 ,041 ,509 -,195
6. Hard to do chores around house ,497 ,255 -,363 -,008 ,421
7. Hurth or arche ,562 ,460 -,441 ,229 ,436
8. Low energy ,531 ,595 -,474 ,131 ,371
Emotional Functioning
1. Feel afraid or scared ,723 ,344 -,479 ,183 ,323
2. Feel sad or blue ,799 ,419 -,385 ,092 ,387
3. Feel angry ,742 ,210 -,363 ,027 ,418
4. Trouble sleeping ,553 ,301 -,249 ,182 ,305
5. Worry about what will happen ,641 ,387 -,492 ,035 ,489
Social Functioning
1. Trouble getting along w/peers ,500 ,349 -,730 ,032 ,219
2. Other kids not wanting to be friend ,481 ,369 -,770 ,164 ,213
3. Teased ,450 ,299 -,583 ,163 ,161
4. Doing things other peers do ,201 ,401 -,772 ,061 ,341
5. Hard to keep up when play with others ,247 ,400 -,799 ,019 ,412
School Functioning
1. Hard to concentrate ,377 ,326 -,341 ,129 ,825
2. Forget things ,435 ,335 -,330 ,024 ,799
3. Trouble keeping up with schoolwork ,418 ,387 -,317 ,100 ,825
4. Miss school – not well ,462 ,287 -,161 ,571 ,286
5. Miss school – doctor appointment ,109 ,105 -,163 ,791 ,251
Eigenvalue cutoff: 1.0; Total Variance Explained for Adolescents Self-Report: 57%; Bold = highest factor loading for each item.
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Another explanation for the low concordance between
adolescents and parents regarding physical functioning
can be seen in the factor analysis (table 4 and 5) which
indicated that items concerning physical functioning (5,
6, 7) were rather diffuse components related to physical as
well as emotional domains, and therefore difficult to dis-
tinguish, something that could further influence both
adolescents and parents ratings. Children reported lower
HRQOL on the emotional scale compared with their par-
ents, and corresponds to the previous research of Modi &
Quittner [8]. Young children may have difficulty express-
ing their emotions directly to their parents, another factor
could be the likeliness that proxy-report reflect parental
anxiety about their child [24]. This aspect should be fur-
ther investigated in different patient populations, and
confirms the need to measure both child and parent per-
spectives when evaluating HRQOL. Clinically, those dis-
crepancies give a potential for interventions emphasizing
the children's subjective ratings, as well as their parents
[8,11].
Regarding gender differences, we found that girls reported
lower levels of emotional functioning than boys. This is
consistent with previous research regarding gender differ-
ences in emotional health [26-28]. The gender differences
would seem to reflect a genuine disparity between boys
and girls and therefore gives further evidence for the valid-
ity of PedsQL™ as a sensitive measure of the emotional
functioning of children and adolescents [24].
The result of the factor analysis resembles Varni's five-fac-
tor structure in the original PedsQL™ version, except for
some items. Like the results of Varni et al. [9] two of the
five items (4 and 5) related to school functioning were
loading to another factor. A natural explanation for this
could be that the three first items related to school func-
tioning (eg. "hard to concentrate", "forget things", "trou-
ble keeping up with schoolwork") are more likely to have
a cognitive component, while the others are more related
to physical aspects (eg. "miss school because not feeling
well", "miss school because of doctor appointment").
All items related to social functioning had a clear factor
loading, as well as the items related to emotional func-
tioning. The physical items seem to split into three factor
loadings (see Table 4). Item 1 ("hard to walk more than a
block"), item 2 ("hard to run"), item 3 ("hard to do sports
or exercises"), item 4 ("hard to lift something heavy") and
item 8 ("low energy") are all loading on factor 2. Further,
item 6 ("hard to do chores around the house", item 7
Table 5: PedsQL 4.0 Norwegian version Factor Loadings for Parent Proxy-Report
Scale/Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
Physical Functioning
1. Hard to walk more than one block ,151 ,808 -,143 ,190 -,263
2. Hard to run ,322 ,816 -,364 ,305 -,149
3. Hard to do sports or exercises ,302 ,812 -,392 ,326 -,196
4. Hard to lift something heavy ,230 ,774 -,260 ,225 -,253
5. Hard to take bath or shower ,003 ,687 -,152 ,196 -,210
6. Hard to do chores around house ,052 ,309 -,272 ,291 -,738
7. Hurth or arche ,491 ,339 -,202 ,279 -,664
8. Low energy ,428 ,421 -,426 ,384 -,692
Emotional Functioning
1. Feel afraid or scared ,775 ,187 -,281 ,294 -,263
2. Feel sad or blue ,716 ,338 -,471 ,367 -,411
3. Feel angry ,597 ,166 -,293 ,420 -,387
4. Trouble sleeping ,680 ,158 -,159 ,180 -,112
5. Worry about what will happen ,715 ,344 -,432 ,391 -,141
Social Functioning
1. Trouble getting along w/peers ,327 ,316 -,833 ,279 -,259
2. Other kids not wanting to be friend ,337 ,231 -,905 ,358 -,118
3. Teased ,237 ,277 -,776 ,359 -,169
4. Doing things other peers do ,241 ,530 -,618 ,462 -,013
5. Hard to keep up when play with others ,170 ,359 -,545 ,618 ,026
School Functioning
1. Hard to concentrate ,321 ,278 -,296 ,852 -,222
2. Forget things ,222 ,267 -,222 ,761 -,370
3. Trouble keeping up with schoolwork ,363 ,207 -,369 ,841 -,214
4. Miss school – not well ,408 ,250 -,108 ,352 -,661
5. Miss school – doctor appointment ,386 ,147 -,135 ,348 -,263
Eigenvalue cutoff: 1.0; Total Variance Explained for Proxy-Report: 60%; Bold = highest factor loading for each item.
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("hurth or arche") on factor 1. Item 5 ("hard to take bath
or shower") on factor 4. In the results of Varni et al. [9] the
loading for the four first items for the physical functioning
scale is similar to our results. The factor loadings for the
proxy-report also indicate that the physical factor loadings
seem to have the same pattern, most of the factor loadings
are similar to the child self-report. It should be pointed
that comparisons to the factor structure obtained in the
original PedsQL™ publication may be restricted and less
comparable due to the restricted age range in this present
study. The restricted age range, with a healthy population,
may attenuate the variability achieved. The results from
the factor analysis regarding item 5, 6 and 7 in the Physi-
cal Functioning scale, as well as items 4 and 5 in the
School Function scale may be typically for healthy sam-
ples, the factor structure should therefore be reinvesti-
gated in clinical samples.
Limitations
Concerning the Norwegian PedsQL™ 4.0 validation study,
the present findings have several potential limitations.
Test-retest reliability and responsiveness are not reported.
Information on non-participants was not available, some-
thing that can limit generalizability. In the American vali-
dation study, the PedsQL differentiated HRQOL between
healthy children and children with acute or chronic health
conditions. This will also be an important future goal to
investigate for the Norwegian PedsQL version, and is
something the authors are taking into consideration. In
this study the age range utilized was quite restricted.
Regarding developmental aspects, further research should
investigate the Norwegian PedsQL versions' psychometric
properties concerning the upper-age range which the ado-
lescent PedsQL was made for, as well as younger age-
groups.
Conclusion
The PedsQL Norwegian version is generally a valid and
reliable instrument, replicating some of the earlier find-
ings for the originally version. The Norwegian PedsQL™
4.0 version will be a valuable tool for assessing the
HRQOL of young adolescents in Norway.
The imperfect concordance observed between self-and
proxy-reports supports the need to measure the perspec-
tives of child and parent in evaluating pediatric HRQOL
[9,29]. It would be important emphasizing the clinically
usefulness regarding child-parent discrepancies still when
challenging the validity of measures.
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ABSTRACT 
Background: Health-related quality of life (HRQOL) is today considered as an important 
assessment measurement, but still only a few measures assess HRQOL outcomes for children 
and adolescents. One of them is the Pediatric Quality of Life Inventory (PedsQLTM). This 
correlation study explored the associations between depressive symptoms in young 
adolescents and the PedsQL scores when controlling for known risk factors.
Methods: An adolescent sample (N=425) completed a battery of measures including the 
PedsQLTM Norwegian version, the Short Mood and Feeling Questionnaire (SMFQ), the 
Social Phobia and Anxiety Inventory for children (SPAI-C), and the occurrence of Stressful 
Life Events (SLE).
Results: The results showed a mild to moderate correlation between the measures PedsQL, 
SMFQ, SPAI-C and SLE. The presence of depressive symptoms significantly predicted the 
PedsQL scores for the adolescence, and explained 17 % of the variance in outcome for the 
PedsQL Total Scale. 
Conclusion: The findings suggest that the PedsQLTM is an adequate assessment instrument 
regarding depressive symptoms in young adolescents, and can be useful in both clinical 
practise and further research as an assessment measure regarding children’s mental health.   
Key words: Health-related quality of life; depression; young adolescents.
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BACKGROUND
Depression, both symptoms and disorders, increases throughout adolescence with a 
marked of increase in early and middle adolescence [1, 2]. Studies have shown that 8 % of 
Scandinavian adolescents aged 13-18 years were having a moderate, and 2% a severe 
depressive symptom level [3]. This is consistence with other international studies [4], and 
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further a lifetime prevalence estimated to range from 15% to 20% among adolescents [5]. A 
relatively high correlation is found between depressive and anxiety symptoms. Studies of 
social anxiety in childhood show that anxiety symptoms predict later depression [6, 7]. 
Developing measures that can reliably identify protective factors for psychiatric 
disorders with high prevalence such as depression is of general interest [8], especially since an 
early onset of depression has been shown to predict poor prognosis [9-11]. However, little 
attention has been paid to the health-related quality of life (HRQOL) in children and 
adolescents with psychiatric disorders [12, 13]. Despite the growing interest in HRQOL 
outcomes, there are still only a few measures assessing HRQOL in children and adolescents 
[12]. Among 20.000 publications on HRQOL , approximately 13 % were related to children 
(N= 3050). More recent research has emphasised the assessment of HRQOL in psychiatry as 
an important part of the diagnostic process because it can give insight into the areas of 
functioning in which a child is suffering the most. [14]. Finding [13] show that having a 
psychiatric problem is at least as large on HRQOL as the impact of having a chronically 
physical disorder. Improvement in the quality of everyday life should therefore be an 
important treatment goal [14], and can further give information regarding HRQOL areas that 
can be of a protective value. The concept of HRQOL could also be used to define outcome 
variables in treatment outcome research.  
The term HRQOL is frequently used interchangeably with quality of life (QOL) [15]. 
However, QOL is considered as a broader general conceptual term related to non health-
related aspects of life (e.g., the evaluation of the impact of architectural surroundings on 
general well-being) [16], further QOL is often used synonymous with happiness or material 
wealth. The concept of HRQOL refers specifically to the impact health and illnesses may 
have for the individual well-being and functionality in daily life, with respect to the physical 
and the psychological (including the emotional and cognitive), as well as the social health 
dimensions delineated by the World Health Organization  [17].  
The Pediatric Quality of Life Inventory (PedsQLTM) [18-21] is presenting one of the 
most promising HRQOL instruments for children. This is because it integrates generic core 
scales and disease-specific modules into one measurement system [22]. The PedsQL 4.0 has 
been proposed as a valid and reliable generic pediatric HRQOL measurement instrument that 
can be used for self-reports and proxy-reports in age groups ranging from 2 to 18 years [21], 
and can also be used in clinical trials, research, clinical practice, as well as school health 
settings, and community populations [21, 23]. A Norwegian version of the PedsQL 4.0, 
showed adequate psychometric properties in earlier work [24]. 
Several important risk factors that influence levels of depressive symptoms have been 
identified, such as adverse life events in adolescents  [10], and that also seems to play a vital 
role in later episodes of depression independent of previous symptoms [25, 26]. Previous 
studies have indicated that the occurrence of a serious life event or an accumulation of 
damaging experiences (e.g., loss of social support systems, loss of a parent, a childhood 
history of physical or sexual abuse), are important risk factors for depression in adolescence 
[10, 11].  When exploring the associations between depressive symptoms and HRQOL scores, 
it is thus important to control for known risk factors such as adverse life events and social 
anxiety.
In this first phase to examine the value of the PedsQL as an assessment measure 
regarding young adolescent’s mental health, the association between depressive symptoms 
and HRQOL will be investigated. The purpose of this study was to examine the value of the 
PedsQL as an assessment instrument regarding depressive symptoms in a sample of young 
adolescents when controlling for known risk factors such as adverse stressful life events and 
social anxiety. 
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METHODS
Procedure
Six randomly selected schools were invited to participate, one school declined. Three of the 
schools were localized in Trondheim, and two in the surrounding villages in the countryside 
of Norway. Local junior high schools were contacted and teachers distributed written consent 
forms that the adolescents presented to their parents. Each pupil received an envelope, which 
contained information and a questionnaire for their parents. Parents were asked to return the 
completed questionnaire in a pre-stamped envelope. The participants could further contact the 
researchers to obtain additional information. Approvals signed by the parents and returned to 
the teacher, confirmed that the adolescent had permission to participate. The self-report 
instruments were administrated and completed in the classrooms.  
Children were given verbal and written information before completing questionnaires 
in class, and a research assistant was available to answer potential questions regarding the 
scales. Written parental informed consent and child assent were obtained. The Data 
Inspectorate and the Regional Committee for Medical Research Ethics approved the study. 
Participants 
A total of 440 questionnaires were distributed and 425 were returned, which gives a response 
rate of 96.6%. 
Self-report forms were completed by 425 adolescents, 235 girls (56%) and 184 boys 
(44%), six did not report gender. In junior high schools in Norway adolescents between 13 to 
15 years of age are separated in three different grades and participants were distributed as 
follows for 8th, 9th  and 10th grade; 33%, 33%, 34%, respectively.
Information about non-response in the sample of adolescents as well as the sample of 
parents was not available, because of the anonymity required. Sociodemographic 
characteristics of the sample and information about the young adolescent’s experience of 
stressful life events (SLE) are given in Table 1.  
INSERT TABLE 1 ABOUT HERE 
Measures
Pediatric Quality of Life inventory TM (PedsQLTM) 4.0 Norwegian version 
The 23-item PedsQL, version 4.0 Generic Core Scales, can be grouped into 4 domains 
of HRQOL: 1) Physical Functioning (8 items), 2) Emotional Functioning (5 items), 3) Social 
Functioning (5 items) and 4) School Functioning (5 items). The Generic Core Scales are 
comprised of child self-report included ages 5 to 7, 8 to 12 and 13 to 18 years. Parent proxy-
report includes ages 2 to 4, 5 to 7, 8 to 12 and 13 to 18, and assesses parent`s perceptions of 
their child`s HRQOL.
The items for self-report and proxy-report are essentially identical, differencing in 
developmentally appropriate language, and first or third person tense. The instructions ask 
how much of a problem each item has been during the past 1 month. A 5-point response scale 
is utilized across child self-report for ages 8 – 18 and parent proxy-report (0 = never a 
problem; 1= almost never a problem; 2 = sometimes a problem; 3 = often a problem; 4 = 
almost always a problem). Subjects are requested to rate how much problems they 
experienced during the past month with health (eg. “I hurt or ache”), activities (eg. “It’s hard 
for me to run”), or feelings (eg. “I feel afraid or scared”).  
All items are reverse-scored and linearly transformed to a 0 to 100 scale (0 = 100, 1 = 
75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate better HRQOL. Scale scores are 
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computed as the sum of the items divided by the number of items answered. The PedsQL has 
shown adequate psychometric properties [21, 24].  A Cronbach’s alpha  0.77 was obtained 
for the Norwegian translation of the PedsQL, which indicates good internal consistency [24]. 
Stressful life events (SLE) 
 Adolescents were asked for the lifetime occurrence of the following stressful life 
events: death in family, illness in family or self, divorce in family, open category of negative 
life event and bullying. Prior to the item tapping the occurrence of bullying, there was a short 
ingress that defined and differentiated bullying from teasing in accordance with the definition 
given by Solberg and Olweus [27]. All items had a dichotomous response format. The SLE 
score is simply the sum of the total number of stressful life events reported for each 
adolescent. The selected life events are all in the Life Event Scale of Holmes and Rahe [28] 
and in the Life Events Checklist [29-32], and they are frequently selected as severe adverse 
life events reported by adolescents [33, 34]. 
Social Phobia and Anxiety Inventory for Children (SPAI-C) 
The SPAI-C is a 26-item self-report instrument designed to assess social anxiety and 
social anxiety disorder among children and young adolescents [35, 36]. High scores reflect 
higher severity of social anxiety. Items assess a range of potentially anxiety-producing 
situations (i.e. reading aloud, performing in play, eating in the school cafeteria) including 
physical and cognitive symptoms as well as avoidant behaviours. Each item is rated on a 3-
point Likert scale (“never or hardly never”, “sometimes”, “most of the time or always”). The 
SPAI-C has been found to possess adequate psychometric properties and acceptable 
convergent and discriminant validity [36]. A Cronbach’s alpha of 0.91 was obtained for the 
Norwegian translation of the SPAI-C, which indicates good internal consistency [37].
Short Mood and Feeling Questionnaire (SMFQ) 
 The brief 13 item screening version of the Mood and Feeling Questionnaire (MFQ) 
was used. All items are negatively phrased on a three-point Likert scale. High scores reflect 
higher severity of depressive symptoms [38-40]. The SMFQ is an unifactorial scale with 
adequate reliability (Cronback’s alpha = .90) [41]. It correlates highly with more extensive 
evaluations like the Childrens’ Depression Inventory (CDI) [42] with a correlation of r = .67, 
and the Diagnostic Interview Schedule of Children (DISC) [43] with a correlation of r = .51 
[39]. The SMFQ differentiates between referred child psychiatric subjects and unselected 
paediatric controls, and between depressed subjects and non-depressed subjects in a general 
population sample [39].  
Statistical analysis 
The study used a cross-sectional design. Correlations between the included variables were 
calculated. A multiple hierarchical linear regression analysis was conducted to investigate the 
relationship between depressive symptoms and the HRQOL scores as measured by the 
PedsQL when the potential effects of gender, age, SLE and SPAI-C were statistically 
controlled for. The following independent variables were entered in separate steps as 
predictors: 1) gender, 2) age 3) stressful life-events (SLE), 4) depressive symptoms (SMFQ), 
5) social anxiety (SPAI-C), 6) SMFQ and SLE. 
Additional independent multiple hierarchical linear regression analysis was conducted for 
each of the PedsQLTM summary scales as dependent variables: a) physical health, b) 
emotional function, c) social functioning and d) school functioning.  Multicollinearity was 
tested with the measures of Tolerance and VIF. 
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RESULTS
Descriptive findings and correlations 
The means, standard deviations, and correlations between the PedsQLTM scores, SMFQ, 
SPAI-C and SLE are presented in table 2.  Using cut-off criteria of 12, 43 participants 
(10.1%) demonstrated possible clinically relevant levels of depressive symptoms.  
Table 2 displays that the correlations between the young adolescents self-report on the 
instruments PedsQL, SMFQ, SPAI-C and SLE, was mild to moderate. The percentage of 
missing values for the PedsQL was calculated. For the adolescents self-report, the percentage 
of missing responses was 0.2% respectively. 
INSERT TABLE TWO ABOUT HERE 
Multiple regression 
The multicolleniarity tests were acceptable for the further regression analyses (Tolerance 
=1.0052 and VIF factor=0.995). 
Separate hierarchical multiple regression analyses were conducted to examine the 
contribution of each of the independent variables (see Table 3). HRQOL as measured by the 
PedsQL was used as the dependent variable. Gender was entered in the first step, age in the 
second step, SLE-scores in the third step, SPAI-C-scores score in the fourth step, and SMFQ 
in the fifth step. The interaction between the SMFQ score and the SLE was entered on the 
sixth step.
INSERT TABLE THREE ABOUT HERE 
The results indicated that gender was significantly associated with level of the PedsQL 
Total Scale, as well as for the subscales Physical Functioning and Emotional Functioning. 
(see Table 3). Girls were on average scoring lower than boys on the Emotional Function 
Subscale (t =4,79, p<0.001), as well as for the Total Scale (t =2.65, p<0.01) and Physical 
Functioning (t =1.95, p=0.05). Age was not significantly associated with level of PedsQL 
Total Score outcome for any of the subscales. No statistically significant gender differences 
were found for the remaining subscales. 
 The SPAI-C was found to significant predict strongest for the PedsQL Total 
Scale, as well as for three of the PedsQL Subscales (see Table 3), while the SMFQ predicted 
strongest for the PedsQL School Functioning Subscale.
   The SMFQ was significantly predicting levels of the PedsQL Total Score, as well as 
the other PedsQL-Total Scores for Physical Health, Emotional Function, Social Function and 
School Functioning (see Table 3). The interaction between the SMFQ score and the SLE were 
significantly predicting for the PedsQL Social Functioning Subscale.
DISCUSSION 
The results from this study show that depressive symptoms and social anxiety symptoms 
predict self-reported HRQOL. This may indicate that the PedsQL can be an interesting 
assessment measure for depressive symptoms in young adolescents. The main results 
indicated that individuals who reported higher levels of depressive symptoms exhibited 
significantly lower levels of HRQOL as measured by the PedsQL, even when controlling for 
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gender, age, number of stressful life events, and levels of social anxiety symptoms. These 
results apply to both the PedsQL Total Score and all of the four PedsQL subscales. 
The inherently high correlation between the SMFQ and the PedsQL Total Scale may be 
problematic because this could indicate that both the SMFQ and PedsQL possibly measure the 
same phenomena. On the other hand it might be positive that the percentage is not higher than 
it is, accounting for the measures covering different areas. When looking at the different 
PedsQL subscales it is clear that the Emotional Function Subscale have a higher correlation 
with the SMFQ compared to the other subscales, and as such influence the PedsQL Total 
Scale. However, the lower correlations for the other subscales: Physical health, Social 
Functioning and School Functioning confirms that the PedsQL are covering different areas. 
This show the importunateness of using the subscales as assessment issues in addition to the 
PedsQL Total Scale when assessing depressive symptoms. 
 Generally, in a clinical setting one would be interested in increasing adolescents’ 
HRQOL. The scores on each PedsQL factor may then be highly informative. Individual 
differences in PedsQL scores should be taken into account when tailoring preventive 
intervention for mental problems.  
The interaction term between stressful life events and depressive symptoms             
were significant for the PedsQL Social Functioning Subscale with an explained variance of 
2%. This result indicates that individuals reporting higher levels of depressive symptoms 
along with higher number of stressful life events are more likely to report lower levels of 
social functioning as measured by the PedsQL. This finding confirm the strong connection 
between depressive symptoms and stressful life events, and may together operate as 
potentially risk factors for young adolescents reporting lower HRQOL regarding social 
functioning.
The Emotional and School Functioning Subscales remained all significantly associated 
with levels of depressive symptoms when controlling for gender, age, the occurrence of life 
events, and social anxiety. Interestingly, the SMFQ showed a stronger significant prediction 
for the PedsQL School Functioning Subscale as compared to the SPAI-C (see Table 3). This 
finding may indicate that the PedsQL School Function Subscale is an interesting assessment 
measure regarding both depressive and social anxiety symptoms, and also highlights the 
importance of assessing the daily functioning in contexts relevant for children, such as school 
and community [44]. 
The results showing that girls reported more depressive symptoms than boys, is 
consistent with other studies concerning gender differences in emotional health [22].  Further, 
studies have also proposed that this gender differences is rooted in adolescence [45, 46]. 
Previously studies have found a significant increase in depressive symptoms between the ages 
14 to 15 [5, 47]. However, no such increase with age was found in our study, and is therefore 
identical with a previous study from the middle part of Norway regarding youth and mental 
health [1]. However, the lack of significant age effects may be due to the limited age range, 
and further studies including a broader age range are therefore needed. Another explanation 
could be that the increase in depressive symptoms may already have occurred. An earlier 
study [48] found a gender specific increase for girls in depressive symptoms between the 13 
and 14 years of age, in a nationwide sample of 12 000 Norwegian adolescents. One 
explanation for this increase in depressive symptoms was the fact that girls were more 
developmentally challenged with the onset of pubertal development. In our study such 
differences were already seen in the age-group 13, and may therefore indicate a decreasing 
age onset of depressive symptoms for girls. 
 The study contains some limitations that should be mentioned. First, cross-sectional 
designs can not determine causal relations, which are an important limitation with the present 
study and implies that the results should be treated with some caution. In the further studies of 
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the PedsQLTM 4.0 it is essential to explore this measure in a prospective, longitudinal design 
to be able to search for causal factors and to entangle the true risk and protective factors from 
mere correlates. Second, although satisfactory psychometric properties and moderate to high 
correlations with a diagnostic interview have been reported for the depressive measure used in 
this study [38, 39, 41], it is not based on DSM-IV or ICD-10 diagnostic criteria for depressive 
disorder. Use of diagnostic interviews based on such diagnostic criteria is recommended. 
However, the SMFQ does in epidemiological samples, distinguish between clinical depressed 
and not depressed as good as the longer version of the MFQ [39]. Third, due to limited 
administration time set by participating schools, only a selection of acknowledged stressful 
life events [29, 31, 33] were included. The questionnaires used regarding SLE might therefore 
lead to an underestimation of the strengths of the findings. The inclusion of full scales 
assessing stressful and negative life events is recommended. Further, a relatively high 
percentage of the parents in the present study have a higher education. This aspect might 
affect the results, since children from higher social classes may have a better quality of life. 
At the same time it should be pointed that the amount of children scoring in clinical range for 
depressive symptoms are the similar percentage that is expected to be found in healthy 
samples. 
CONCLUSION 
The findings suggest that the Pediatric Quality of life measure (PedsQLTM) is an interesting 
assessment measure regarding depressive and social anxiety symptoms in young adolescents. 
Using the PedsQL as an assessment instrument can be useful in clinical practise when 
tailoring an intervention for the individual, as well as for further research  measuring 
children’s mental health. 
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Table 1. Sociodemographic characteristics of 425 adolescents and 237 caregivers
Adolescents N % 
Total sample  425      (100) 
                                                                    Female  235     (56.1) 
                                                                       Male  184     (43.9) 
School grade: 
   8th grade  140     (32.9) 
   9th grade  142     (33.4) 
   10th grade  143     (33.7) 
Stressful Life Events (SLE):   
   Death in family  161     (37.9) 
   Divorce  83     (19.5) 
   Child seriously illness  15     (3.5) 
                                          Family seriously Illness   74     (17.4) 
   Other difficulties  55     (12.9) 
                                                                   Missing        37     (8.8) 
Parents/primary care giver
Total sample:  237      (55.8) 
Mothers      216     (50.8) 
Mothers education:        
   Elementary school  10     (4.7) 
   Highschool graduate  51     (23.6) 
   Post high school  155     (71.7) 
Fathers      110     (25.9) 
Fathers education:   
   Elementary school  4     (4.4) 
   Highschool graduate  25     (22.8) 
   Post high school  80     (72.8) 
Economy:   
   Very satisfying  26     (11.1) 
   Good  198     (84.2) 
   Poor  11     (4.7) 
Table 2. The Means, Standard Deviations, Reliability and Pearson Product Moment 
Correlation between All instruments.
PedsQL
Total
PedsQL
Physical 
PedsQL
Emotion
PedsQL
Social 
PedsQL
School
SMFQ SLE SPAI-C
PedsQL Total score   - 
PedsQL Physical score -.87**     - 
PedsQL Emotional score -.87** -.65**     - 
PedsQL Social score -.77** -.63** -.59**     - 
PedsQL School score -.81** -.56** -.60** -.46**     - 
SMFQ -.70**  -.56** -.69** -.53** -.55**     - 
SLE -.21**  -.20** -.22** -.13** -.13** .21**     - 
SPAI-C total -.62**  -.52** -.56** -.65** -.38** 53** 15** -
No. of items 23 8 5 5 5 13 5 26
N 424 424 424 424 424 412 424 415
M 85.23 91.12 77.15 88.12 78.02 4.95 .91 6.4
SD 11.11 10.35 17.32 13.11 15.47 4.96 .82 7.6
** Correlation is significant at the 0.01 level (2-tailed) 
Abbreviations: PedsQL= Pediatric Quality of Life inventory - Children, SMFQ= Short Mood 
and Feeling questionnaire, SPAI-C=Social Phobia and Anxiety Inventory for Children, 
SLE=Stressful Life Events 
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Table 3 
Summary of the Separate Hierarchical Multiple Regression Analyses using PedsQL 
Total Scale, Physical, Emotional, Social and School Function Scale as the dependent 
variables, and Gender, Age, SLE, SPAI-C, SMFQ and SMFQ-SLE interactionscore as 
Predictor Variables. 
PedsQL total scale PedsQL physical scale 
Adolescent (N = 424) Adolescents (N = 424) 
Step F cha R2 cha Ǻ F cha R2 cha B
1 Gender   8.68† .02    -.15   4.35‡ .01   -.10 
2 Age .08 .00    -.01   .01 .00  .01 
3 SLE   15,84* .04    -.19     14.37* .03 -.19
4 SPAI-C 241.95* .36    -.61   136.68* .25 -.51
5 SMFQ 162.31* .17    -.50     51.86* .08 -.35
6 SMFQ – SLE interactionscore     3.08 .00    -,06 3.22 .00 -.08
PedsQL emotional scale PedsQL social scale 
Adolescent (N = 424) Adolescents (N = 424) 
Step F cha R2 cha Ǻ F cha R2 cha B
1 Gender 25.85* .06   -.25 1.80 .00    -.07 
2 Age      .60 .00   -.04 2.35 .01    .08 
3 Stressful life events (SLE)  17.54* .04   -.20   8.41† .02  -.14 
4 SPAI-C 176.21* .28   -.54   271.68* .40  -.64 
5 SMFQ 163.59* .18   -.52     36.83* .05  -.27 
6 SMFQ-SLE interactionscore     1.59 .00   -.05     14.90* .02  -.15 
PedsQL school functioning 
Adolescent (N = 424) 
Step F cha R2 cha Ǻ
1 Gender .70 .00  -.04 
2 Age     1.82 .00  -.07 
3 Stressful life events (SLE)     4.87‡ .01  -.11 
4 SPAI-C   64.24* .14  -.38 
5 SMFQ   94.27* .16  -.49 
6 SMFQ-SLE interactionscore     1.10 .00    .05 
Note:  * p < .001,  † p < .005,  ‡ p <   .05
Abbreviations are the same as for Table 2
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Innledning
I Norge er det nå årlig om lag 130 nye til-
feller kreft hos barn under 15 år. Kreft i
barneårene er fortsatt den hyppigste
dødsårsak av sykdom hos barn mellom 1
og 15 år i den vestlige del av verden, og
ca. 40 barn dør hvert år. Insidensen har
vært stabil (Kreftregisteret, 2002). Leu-
kemi (blodkreft) utgjør vel en tredel av
alle tilfellene med barnekreft, og hjerne-
svulst utgjør knapt en firedel. Resten er
forskjellige solide svulster. Dette er kreft-
typer som rammer individer i en fysisk og
psykisk meget sårbar alder. I en slik fase
kan en kreftbehandling påføre barna ska-
der med helsemessige og psykososiale
implikasjoner for årtier framover (Ny-
gaard, 1999). Nye behandlingsformer kom-
binerer kjemoterapi (cellegift), stråling
og kirurgi, og fra ca. 20% overlevelse i
1960-årene er den gjennomsnittlige fem
års overlevelse i dag steget til 80% for
barn med blodkreft (leukemi) (Gatta,
Capocaccia, De Angelis, Stiller, Coe-
bergh & the EUROCARE Working
Group, 2003). På verdensbasis har Skan-
dinavia den høyeste overlevelsesraten. Va-
righeten av kreftbehandling vil variere
med type diagnose, for den vanligste
kreftformen akutt lymfatisk leukemi va-
rer behandlingen opp til 2– 2.5 år (Mathi-
sen, 2000).
Somatiske komplikasjoner er i dag
grundig dokumentert, og omfatter nevro-
logiske fortstyrelser, sanseskader, vekst-
hemning, sterilitet, hormonelle forstyr-
relser og mer isolerte organskader av hjer-
te, kar, lever og urinveier (Hawkins &
Stevens, 1996; Nygaard, 1991; Wallace &
Green, 2004). Fysiske senskader kan
grupperes i fire store problemkomplekser
knyttet til hjernens funksjoner, vekst, sek-
sualutvikling og kjønnsfunksjoner, inklu-
dert evnen til å få barn (fertilitet), og ny
kreftsykdom (Nygaard, 1999).
Barn som får diagnosen kreft, gjen-
nomgår ofte langvarig behandling preget
av mye smerte, ubehag og uvisshet. Fami-
liens totale livssituasjon vil i stor grad på-
virkes. Den enkelte i familien vil måtte
gjennomgå mange og nye utfordringer for
å tilpasse seg de praktiske forandringer i
hverdagen, den medisinske situasjonen og
ikke minst de emosjonelle påkjenningene.
Studier viser at kronisk sykdom hos
barn gir 2–3 ganger høyere risiko for psy-
kososiale vansker (Gortmaker, Walker,
Weitzman & Sobol, 1990; Wallander &
Thompson, 1995). Psykososiale vansker
omfatter emosjonelle problemer og at-
ferdsforstyrrelser, redusert funksjon på
skole og arbeid, negativt kroppsbilde,
vanskeligheter i interpersonlige relasjo-
ner, omfattende bruk av benektning som
forsvarsmekanisme og overdreven av-
hengighet av foreldrene (Koocher &
O’Malley, 1981; Mackie, Hill, Kondryn
& McNally, 2000; Zeltzer et al., 1997).
Men mange av studiene er vanskelige å
generalisere på grunn av små og hetero-
gene utvalg og mangel på kontrollgrup-
per (Dyregrov, 1996; Zebrack, 2002).
Det antas også at kreft hos barn kan
predisponere enkelte individer til lettere
å få noen av symptomene som er karak-
teristiske for posttraumatisk stressfor-
styrrelse (PTSD). Kreft blir assosiert med
en trussel til livet og mange angripende
og smertefulle prosedyrer (Stuber, Chris-
takis, Houskamp & Kazak, 1996). Kupst
og medarbeidere (1995) påpeker viktig-
heten av å finne barna og familiene som
befinner seg i en risikogruppe for å utvik-
le tilpasningsproblemer.
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Kognitiv og nevropsykologisk funk-
sjonssvekkelse omfatter konsentrasjons-
vansker og distraksjon, nedsatt hukom-
melse, mental treghet og svekket IQ. Bar-
na kan ha både generelle og spesifikke
lærevansker (Anderson, Godber, Smi-
bert, Weiskop & Ekert, 2000; Mennes et
al., 2005; Nygaard, 1999).
Graden av aktuelle senfølger vil være
avhengig av både grunnsykdom og type
behandling barna har gjennomgått. Sen-
skader som fører til læreproblemer, har i
stor grad vært observert hos barn som har
vært behandlet for hjernesvulst, og strå-
lebehandling av hjernen blir sett på som
en viktig årsak til slike problemer (Ny-
gaard, 1999). Strålebehandling i tidlig al-
der kan gi alvorlige kognitive og nevro-
psykologiske senskader. Kognitive vans-
ker forbundet med kjemoterapi har fått
økt oppmerksomhet, men antas å gi mer
diffuse senfølger enn de som er forbun-
det med stråling (Mennes et al., 2005).
Eiser (1998) påpeker at det foreligger
flere grunner til å forvente redusert kog-
nitiv fungering hos barn med kreft, ut fra
at barn med kreft opplever hyppig og ut-
strakt skolefravær. Stråling eller kjemote-
rapi kan også ha en direkte effekt på læ-
ring.
Med utviklingsperspektivet som teo-
retisk utgangspunkt vil en sykdom kunne
ha ulik påvirkning på barnet avhengig av
barnets alder og modenhet. En stor be-
grensning i forskningslitteraturen er at
barn og ungdommer har vært behandlet
som en homogen gruppe (Eiser, 1995).
Dette gjør det vanskelig å spesifisere
hvordan barns forståelse av sin sykdom
varierer som en funksjon av barnets alder.
Tidligere forskning har også i stor grad
vært begrenset på grunn av mangel på re-
levante måleinstrumenter som tar hen-
syn til barnets utviklingsmessige status,
og av bruken av foreldre og ikke barna
selv som informanter. Oppmerksomhe-
ten har oftest vært rettet mot den kogni-
tive forståelsen, og i mindre grad mot de
emosjonelle og sosiale konsekvensene av
sykdommen (Eiser, 1998).
Denne artikkelen vil belyse kognitive
og emosjonelle forandringer i barns for-
ståelse av sykdom. Vi vil påpeke hvilke
kliniske implikasjoner et slikt utviklings-
psykologisk perspektiv kan ha for å frem-
me forståelse og innsikt hos barn som
gjennomgår alvorlig sykdom. Faktorer
som påvirker barns tilpasning til alvorlig
sykdom, og mestringsstrategier barn be-
nytter for å unngå de mest alvorlige kon-
sekvensene av en truende livssituasjon,
blir belyst. Sentrale problemstillinger er:
Hvilke faktorer er spesielt betydningsful-
le for å fremme barns forståelse og tilpas-
ning til alvorlig sykdom? Hvordan kan
dette vektlegges i klinisk praksis? Hvilke
metodiske tilnærminger kan anvendes
for å ivareta barnets ståsted?
Et historisk tilbakeblikk vil belyse
hvordan våre antagelser om barns behov
er knyttet til den kunnskap vi til enhver
tid har. Vi vil presentere relevante utvik-
lingspsykologiske teorier, og et teoretisk
begrepsapparat for mestring av stress
knyttet til kreft.
De kliniske illustrasjonene er hentet
fra førsteforfatterens kliniske arbeid ved
en barneavdeling på et somatisk sykehus.
Historisk tilbakeblikk
Tre tidsepoker innenfor forskning vedrø-
rende barn med kreft reflekterer forand-
ringer i det gjeldende teoretiske perspek-
tivet (Eiser, 1994). Dette har påvirket
hvilke spørsmål som har blitt stilt, og
måten de profesjonelle og familier har
forholdt seg til sykdommen på. De teore-
tiske perspektivene har preget ivaretagel-
sen av barnets situasjon og behov både i
en klinisk og en forskningsmessig sam-
menheng.
1950- og 1960-årene
I løpet av 1950- og 1960-årene var man
først og fremst opptatt av omsorg for det
døende barnet. I denne tidsperioden lev-
de bare én prosent av barna med leukemi
fem år etter at de fikk diagnosen. Fami-
liene hadde derfor et helt annet utgangs-
punkt enn dagens familier. Den psykolo-
giske hjelpen var rettet mot å beskytte
barnet fra viten om at sykdommen nes-
ten alltid var dødelig, og å forberede
familien på barnets død.
Det teoretiske utgangspunktet var til-
knytningsteori (Bowlby, 1969), med
oppmerksomhet på den tidlige relasjo-
nen mellom mor og barn. Bowlbys til-
knytningsteori bidro til økt forståelse for
tilknytning og separasjon i forhold til
barn på sykehus. Teorien fikk stor innfly-
telse, og i kjølvannet av dette ble praksi-
sen ved norske sykehus endret (Killing-
mo, Auestad & Nyhus, 1975). Barn ble
ikke lenger utsatt for det traumet det er å
skilles fra foreldrene i lange perioder på
grunn av sykehusinnleggelse.
Innflytelse av sykdom på andre fami-
liemedlemmer, inkludert søsken, ble ikke
viet oppmerksomhet. Tidlige studier do-
kumenterte vanskene familiene opplev-
de, som angst og depresjon blant for-
eldre, spesielt mødre (Koocher & O’Mal-
ley, 1981). En frarådet informasjon til
barnet om sykdommen og prognosen,
fordi en antok at det ville være for truen-
de og forårsake unødvendig stress og
angst og begrense barnets evne til mest-
ring (Share, 1972 og Plank, 1964 i Eiser
& Havermans, 1994). Det ble på den ti-
den rapportert at noen foreldre, spesielt
de med små barn, mente at det var umu-
lig for barn å forstå informasjon om syk-
dommen og dens prognose, og at de der-
for må spares for dette (Chesler, Paris &
Barbarin, 1986).
1970- og 1980-årene
I de to neste tiårene skjedde det et skifte
fra et ensidig fokus på døden som eneste
utfall til hvordan en kunne leve med en
livstruende tilstand. Prognosen ble for-
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their cancer
During cancer treatment, most children ex-
perience unpleasant physical side-effects,
behavioural and emotional problems have
also been identified. Children’s understan-
ding of their cancer illness depends on
developmental aspects, such as their ability
to gain knowledge, as well as to understand
and reflect upon their situation. Both the
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nals’ attitudes towards informing the child,
will further influence the children’s adapta-
tion. This article focuses on children’s adap-
tation regarding living with a serious illness.
The main focus is on the developmental
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emotionally and cognitively. Such knowledge
has implications for how to inform children
about their illness. The interactive process
between the child and their caregiver is a cri-
tical aspect, which should be emphasised by
health professionals.
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bedret gjennom medisinske framskritt i
form av kjemoterapi (cellegift), stråling
og kirurgi. Varigheten av kjemoterapi ble
spesialisert i forhold til krefttype. Foreld-
rene måtte lære om sykdommen og be-
handlingen av den, og i større grad ta del
i de praktiske prosedyrene. Det ble mer
åpenhet rundt sykdommen i samfunnet,
og informasjon ble gitt til både familie,
venner og lærere. Barnet levde med sin
kreftsykdom og trengte tilrettelegging i
skolen.
Igjen fikk et perspektivskifte betyd-
ning for forskningen på feltet. Studier ble
rettet mot tilpasning og mestring hos fa-
miliene til barn med kreft, og det ble ut-
ført sammenligninger med relevante
kontrollgrupper (Goggin, Lansky & Has-
sanein, 1976; Kellerman, Zeltzer, Ellen-
berg, Dash & Rigler, 1980).
I denne perioden fikk kognitive teo-
rier økt oppmerksomhet, og man antok
at den påvirkning sykdommen har, er av-
hengig av barns kognitive utviklingsstadi-
er (Cerreto, 1986; Perrin & Gerrity, 1984).
Disse antagelsene var basert på oppfat-
ningen om at visse utviklingsmessige ut-
fordringer må være løst innenfor et gitt
aldersområde (Erikson, 1964), og løsnin-
gen av disse oppgavene ble betraktet som
essensielle for den normale friske utvik-
ling. Dette ble sett på som en interaksjon
mellom modning og erfaringer som gjor-
de barnet i stand til å gjennomføre be-
stemte oppgaver og dermed gå videre til
neste stadium. Fysiske, psykologiske og
miljømessige prosesser ble antatt å van-
skeliggjøre det normale forløpet, og kro-
nisk sykdom ble sett på som en slik ut-
fordring.
Dette skiftet i teoretisk perspektiv ga
også nye oppfatninger i forhold til betyd-
ningen av å informere barna. Kliniske ob-
servasjoner ga et bilde på at barna forsto
og fanget opp forhold fra samtaler mel-
lom de voksne eller diskuterte med andre
barn (Binger et al., 1969). Spinetta og
Deasey-Spinetta (1981) viste gjennom
sin forskning i forhold til døende barn at
mange følte seg isolert fra familien sin på
grunn av all hemmeligholdelse. Barna
med kreft var fullstendig klar over sin
situasjon, men ikke i stand til å stille
spørsmål vedrørende sine bekymringer,
eller dele informasjon med andre.
Kognitive teorier hadde stor innflytel-
se når det gjaldt å bestemme hvor langt
man skulle informere barna om alvorlig-
hetsgraden av sykdommen deres. Det var
antatt at barn mellom 7 og 11 år bare var
i stand til å forstå informasjon i en veldig
«konkret» form. Denne vektleggingen bi-
dro derfor til en bedring av informasjon
vedrørende rent konkrete fakta. De emo-
sjonelle konsekvensene av det å bli infor-
mert om en mulig dødelig sykdom ble i
mindre grad vektlagt.
Bruner (1986) påpeker at utviklings-
teorier generelt har operert med en split-
ting av kognitive og affektive prosesser,
og at dette i stor grad har ført til teoretisk
stagnasjon i forståelsen av utvikling. Men
spedbarnsforskning har vist betydningen
av å betrakte utvikling som en kontinuer-
lig konstruksjonsprosess (Hansen, 1991).
Denne utviklingsprosessen, med vekt på
sentrale begreper som affektiv inntoning
og intersubjektivitet, innebærer at på-
virkning av sykdom avhenger av mer enn
barnets alder og modenhet. Dagens ut-
viklingspsykologi fremstiller barnets selv-
opplevelse og selvforståelse som forank-
ret i en dialogisk matrise, basert på aktiv
interaksjon med andre mennesker (Bru-
ner, 1975; Hansen, 1991a, 1991b; Stern,
1985; Trevarten, 1980; Zeanah et al.,
1989). Samhandlingen mellom barnet
og omsorgspersonen betraktes som grunn-
leggende for barnets utvikling og tilpas-
ning. Når et barn rammes av alvorlig syk-
dom, kan dette samspillet forstyrres,
blant annet på grunn av foreldrenes angst
og bekymring, og derfor være en risiko-
faktor for barnets videre utvikling. Dette
gir oss et annet perspektiv når det gjelder
barnets utvikling, enn de tradisjonelle ut-
viklingsmodellene, som har hatt et mer
egosentrisk perspektiv hvor barnet ser
omgivelsene ensidig fra seg selv og ikke er
i stand til å ta andres perspektiv (Bruner,
1986). Vi får et mer nyansert bilde av
foreldrenes behov når et barn får kreft,
og et grunnleggende spørsmål er derfor:
Hva trenger foreldrene selv for å kunne
være til stede for barnet og gi det en trygg
relasjon?
1990- og 2000-årene
Den senere tiden har vært preget av mer
intensiv behandling av kreft og økt over-
levelse. Men intensiveringen av behand-
lingen har bidratt til en større økning av
sykelighet og morbiditet som følge av be-
handlingen (Nygaard, 1999). Den gene-
relle oppfatningen er nå at ærlig og åpen
kommunikasjon er avgjørende for å
fremme psykisk helse hos barn og bringe
fortrolighet med behandlingen.
I motsetning til tidligere modeller vi-
ser dagens teorier et større mangfold. De
tar hensyn til en rekke sosiale, kulturelle,
familie- og sykdomsvariabler som natur-
lig kan influere på barns tilpasning til syk-
dommen (Eiser & Havermans, 1994).
Det utviklingspsykologiske perspektivet
har fått større innflytelse når det gjelder
forståelse og ivaretagelse av barnets situa-
sjon og behov. Målet er ikke bare å infor-
mere barna, men også å involvere dem i
bestemmelser om behandlingen og gjøre
dem mer delaktige i behandlingsprose-
dyrer. Betydningen av interaksjon står
derfor mer sentralt innenfor moderne
tenkning om barns behov for ivaretagelse
når de rammes av sykdom. Det har
skjedd store endringer i form av å inklu-
dere hele familien. Det er i dag økt opp-
merksomhet på den påvirkning og be-
lastning alvorlig sykdom har på foreldre
og søsken når et barn rammes. Det er
også økt oppmerksomhet på betydnin-
gen av å involvere barnets naturlige nett-
verk som skole, barnehage, venner og fri-
tidsaktiviteter. Dette har igjen fått betyd-
ning for utvikling av helhetlige modeller i
omsorgen for familier til barn med kreft
sammenlignet med tidligere (Eilertsen,
Reinfjell & Vik, 2004). Studier viser at
barn ønsker mye informasjon om alle as-
pekter ved sykdommen (Ellis & Levent-
Oppfatningen nå er at ærlig og åpen kommunikasjon er avgjørende 
for å fremme psykisk helse hos barn og bringe fortrolighet med 
behandlingen
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hal, 1993). Men åpenhet er fremdeles in-
gen selvfølge når et barn dør etter langva-
rig sykdom. En svensk studie viser at
mange foreldre angret på at de ikke had-
de snakket med barnet om døden (Kreic-
berg, Valdimarsdottir, Oneløv, Henter &
Steineck, 2004).
Barns tilpasning til kreftsykdom
Forskning viser at barns tilpasning til kro-
nisk sykdom påvirkes av: 
1) karakteristika ved sykdommen (i
hvilken grad den er livstruende, og
begrenser bevegelse og sosiale aktivi-
teter eller opplevelser).
2) situasjonelle faktorer som stressorer i
barnets behandlingshverdag (behand-
lingsprosedyrer, bivirkninger og kom-
plikasjoner).
3) karakteristika ved barnet (alder, kjønn,
personlighet eller mestringsstil, og tid-
ligere erfaringer).
4) karakteristika ved familien (problem-
løsningsevne eller kommunikasjonsfer-
digheter, og grad av åpenhet i fami-
lien), og sosial støtte fra venner og
familie (Kupst & Schulman, 1988; Van
Dongen-Melman, Pruyn, Van Zanen &
Sanders Woudstra 1886; Varni, Katz,
Colegrove & Dolgin, 1993).
Van Dongen-Melman et al. (1986) pre-
senterer et teoretisk begrepsapparat for
mestring av stress, knyttet til kreft. Mo-
dellen kan hjelpe oss til å forstå hvordan
kreftsykdom påvirker et barns liv. Den er
basert på to psykososiale teorier om men-
neskers atferd: attribusjonsteori (Kelley,
1967, 1971 i Van Dongen-Melman et al.,
1986) og sosial sammenligningsteori (Fest-
inger, 1954; Schachter, 1959, i Van Don-
gen-Melman et al., 1986). Modellen be-
skriver strategier mennesker benytter for
å unngå de mest alvorlige konsekvensene
av en truende livssituasjon.
Begrepet stressor beskriver stimuli
som virker truende på personer. Karakte-
ristika ved personen og den aktuelle
situasjonen avgjør opplevelsen av fare
(Lazarus, 1966).
Viktige personlige variabler er barnets
alder, kognitivt og psykososialt nivå, samt
barnets diagnose. Viktige situasjonska-
rakteristika er graden av støtte fra hjelpe-
apparatet, familie og venner. Ut fra mo-
dellen til Van Dongen-Melmann et al.
(1986) blir stimuli opplevd som en stres-
sor når den er årsak til usikkerhet, gir bar-
net en følelse av mangel på kontroll og
negative følelser, og truer selvaktelsen.
Usikkerhet defineres som mangel på
informasjon om et viktig verdisystem for
personen. Mangel på informasjon redu-
serer personens muligheter til å oppleve
forutsigbarhet. Barn med kreft vil opple-
ve mye uvisshet forbundet med sin syk-
dom og behandling: om de kommer til å
overleve, engstelse for behandlingen, om
medisinene kommer til å virke, om de
må være lenge på sykehuset, og om de
kommer til å miste håret. Angst, sinne og
ubalanse i humøret er vanlige reaksjoner.
Barna kan bli usikre på seg selv og egne
følelser. De kan oppleve uvisshet i for-
hold til hvordan venner vil reagere på
dem og sykdommen deres, om vennene
vil trekke seg tilbake, og hvordan det skal
gå på skolen.
Tap av kontroll defineres som mang-
lende evne til å påvirke det som skjer. Be-
handlingen kan bidra til at barn får opp-
levelsen av å miste kontroll over sitt eget
liv. Sykdommen krever kontinuerlig me-
disinsk tilsyn, og pasientene blir ofte kon-
frontert med at de er avhengige av andre.
De må innordne seg sykehusreglene og
mister sitt privatliv i form av at intimi-
tetsgrenser overskrides. Mange barn kan
oppleve at naturlig og aldersadekvat blu-
ferdighet krenkes av undersøkelser og be-
handling. Videre blir de pålagt restriksjo-
ner som begrenser aktivitetene, og er ofte
overbeskyttet av foreldrene. Pasienten
må akseptere intensive behandlingspro-
sedyrer og bivirkninger som følger disse.
En persons selvaktelse knyttes til opp-
fatningen av egen kropp, emosjonelle til-
stand og evne til å fungere sosialt. Van
Dongen-Melman et al. (1986) påpeker
at områder av betydning for utviklingen
av en positiv selvoppfatning kan bli nega-
tivt påvirket hos barn med kreftsykdom.
Barnet kommer inn i en ny rolle som syk
eller annerledes. Kreftsykdom og be-
handling forandrer barnets utseende, og
fører til kvalme, smerte, tretthet og svak-
het. Barnets kroppsbilde kan derfor kom-
me til å bli kontinuerlig endret. Slike
endringer minner barnet på at det er an-
nerledes enn andre barn. Ungdommer
bekymrer seg for utseendet og sammen-
ligner seg negativt med jevnaldrende.
Barn som mangler selvtillit på grunn av
endret utseende, kan trekke seg tilbake
fra jevnaldrende og skolen og kan få pro-
blemer med emosjonell og sosial tilpas-
ning.
Negative følelser, som sinne, skyld,
skam, ensomhet, apati, bitterhet og for-
virring, observeres ofte hos barn med
kreft. Dette kan bidra til isolasjon. En fin-
ner ofte symptomer på depresjon hos
barn med kreft. Mange er redde for at syk-
dommen kan slå til igjen, og for døden.
Mestringsstrategier. Mestringsstrategier
benyttes for å minske eller eliminere pro-
blemene som er nevnt ovenfor: å søke in-
formasjon, støtte og trøst, lete etter år-
saker til hendelser, forandre situasjonen,
benekte og unngå, og å akseptere situa-
sjonen. Strategiene benyttes for å reduse-
re følelsen av usikkerhet, for å oppnå og
beholde en form for kontroll over situa-
sjonen, for å opprettholde og beskytte
selvaktelsen og for å redusere negative
følelser.
Å søke informasjon. Informasjonsinnhen-
ting benyttes for å redusere usikkerhet og
negative følelser. Dette kan være kunn-
skap som barnet henter fra de ansatte på
sykehuset, primærlegen eller andre fag-
personer, og bøker og TV-programmer.
Hvis denne framgangsmåten ikke når
fram, tyr personen til uformelle kilder. Å
sammenligne sin egen situasjon med
andre som har opplevd noe tilsvarende,
er en vanlig måte å skaffe seg kunnskap
på. Barn legger ofte merke til endringer i
nære personers følelser, eller forandrin-
ger i sykehusrutiner og behandlingsfor-
løp. Van Dongen-Melman et al. (1986)
viser til studier som har dokumentert at
innhenting av nøyaktig informasjon kan
redusere usikkerhetsfølelse og tendenser
til depresjon.
Negative følelser, som sinne, 
skyld, skam, ensomhet, apati, 
bitterhet og forvirring, 
observeres ofte hos barn 
med kreft
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Å søke støtte og trøst. Barn har ofte ut-
bytte av å søke støtte hos jevnaldrende
med samme sykdom, og trøste hverandre
ved å dele erfaringer og opplevelser. Men
slik sammenligning kan også forverre de
negative følelsene, særlig hvis barnet
sammenligner seg med en som er dårlige-
re, eller hvis kameraten dør. Trøst og støt-
te hentes også fra sykepleiere, venner og
sosialarbeidere. Følelsen av støtte er av-
hengig av at venner og hjelpearbeidere
forstår barnerts situasjon. Foreldre blir en
god støtte ved å snakke om følelser, angst
og håp, og ved å dele barnets bekymrin-
ger med sykdommen. Det å motta støtte
og trøst vil styrke pasientens følelse av
kontroll, og virke positivt inn på selvak-
telsen.
Å lete etter årsak til hendelser. Ved å lete
etter og finne forklaringer på det som
skjer, blir det mulig å skape en logisk, for-
ståelig og til en viss grad forutsigbar ver-
den. Når barn får en kreftdiagnose, kan de
begynne å lete etter en grunn til at de har
fått sykdommen. I sin søken etter forkla-
ringer og årsaker kan barnet finne dette i
seg selv (intern attribusjon) eller utenfor
seg selv (ekstern attribusjon). Et eksem-
pel på intern attribusjon er at barnet tror
at det har fått sykdommen som straff for
dårlig oppførsel. Det er oftest mer posi-
tivt for en person å finne eksterne forkla-
ringsmåter, fordi disse tillater at en opp-
rettholder sin selvaktelse. Et eksempel er
at radioaktivt nedfall i naturen antas å
være årsak til kreftsykdommen.
Å forandre situasjonen. Forsøk på å for-
andre situasjonen er den mest aktive
mestringsstrategien, og inkluderer alle
aktiviteter som har til hensikt å fjerne
forventede trusler (Lazarus, 1966). I sam-
menheng med sykdom kan det å forand-
re situasjonen bety å ta medisin, å dra til
sykehuset og å etterkomme det terapeu-
tiske opplegget. Forsøk på å fjerne nega-
tive konsekvenser av sykdommen for-
sterker følelsen av mestring og bygger
opp igjen selvaktelsen.
Å benekte og å unngå. Benektelse av syk-
dommen forutsetter en mangel på opp-
merksomhet i forhold til den. Unngåelse
innebærer at en er oppmerksom på syk-
dommen, men forsøker å undertrykke el-
ler unngå å bli konfrontert med konse-
kvensene av den. Dette er atskilte strate-
gier, men ligner hverandre i måten de
opptrer og fungerer på. Begge kan være
passende måter å takle uunngåelige stres-
sorer på, som i denne sammenhengen,
der hovedstressoren er en livstruende
sykdom. Begge strategiene beskytter mot
angst, slik at barnet kan fungere så nor-
malt som mulig, samt opprettholde sin
selvaktelse. Strategiene blir ofte obser-
vert like etter at barnet har fått kreftdia-
gnosen, og fortsetter å fungere helt til
barnet makter å takle stressoren på en
bedre måte.
Å akseptere situasjonen. Fordi de har
begrenset innflytelse på livstruende syk-
dom, kan barn med kreft avfinne seg
med situasjonen ved å akseptere den.
Dette er en strategi som ofte blir brukt
etter en periode med benektelse og følel-
sesmessig utilpasshet. Akseptering kan
gjøre det lettere for barna å tilpasse seg
en ny virkelighet som krever at en tar en
dag om gangen.
Avslutningsvis bringer Van Dongen-
Melman et al. (1986) inn to mestrings-
strategier til, impulsiv handling og kogni-
tiv restrukturering. Impulsive handlinger
karakteriseres ved plutselige følelsesut-
brudd, som gråt eller sinne. Dette kan
være en metode for å redusere negative
følelser og følelsen av tap av kontroll.
Kognitiv restrukturering kan være en
hjelp til å redusere negative stressorer
som følger kreftsykdommen. Et barn kan
for eksempel benytte seg av selvinstruk-
sjoner for å redusere angst når det gjen-
nomgår intensive medisinske prosedyrer.
Compas, Banez, Malcarne og Wors-
ham (1991) oppsummerer i tråd med
Lazarus (1966) sin gjennomgang av and-
res forskning på dette feltet, med at rela-
sjonen mellom stressorer og mestrings-
strategier må sees på som en prosess. Valg
av mestringsstrategier avhenger av per-
son og situasjon. Barns mestring av syk-
dom vil dessuten være påvirket av dia-
gnose, medisinske prosedyrer og hvordan
sykdomsforløpet utvikler seg. I tillegg må
det tas hensyn til utviklingsperspektivet
når en skal studere barn og mestring. Bar-
nas alder og deres kognitive kapasitet vil
påvirke hvordan de forholder seg til og
takler stressfylte situasjoner. I tillegg vil
valg og utføring av mestringsstrategier
være avhengig av hvor mye støtte de har
i familie og nettverk.
Barns forståelse av alvorlig sykdom
Litteraturen viser som nevnt at det er
store forskjeller på hvordan man har be-
traktet barnets utviklingsmessige forut-
setninger. Dette kan ha sammenheng
med at oppmerksomheten oftest har
vært på den kognitive forståelsen, på be-
kostning av de emosjonelle konsekvense-
ne (Eiser, 1998).
Emosjonsregulering er evnen til å
overvåke og kontrollere emosjonell erfa-
ring og emosjonelle uttrykk hos seg selv
og tilpasse uttrykkene i henhold til sos-
iale og kulturelle forhold (Campos, Cam-
pos & Barrett, 1989). Denne evnen øker
som et resultat av kognitiv utvikling og er-
faring med varierte sosiale og fysiske mil-
jøer (Saarni, 1997). Reguleringen omfat-
ter intensiteten i emosjonene, typen av
emosjonell atferd eller uttrykk, og situa-
sjonen følelsene forekommer i. Forsknin-
gen på dette feltet har vært opptatt av de
spesifikke følelsene hos mennesker som
rammes av alvorlig sykdom. I den tidlige
utviklingen er foreldre og andre nære
omsorgspersoner viktige støttespillere
som kan gi barnet kunnskap om en situa-
sjons emosjonelle betydning og hand-
lingsmuligheter, og hjelpe barnet til å for-
stå egne og andres reaksjoner. I ungdoms-
tiden blir venner sentrale støttespillere
(Tetzchner, 2001).
Førskolebarn
Førskolebarn regulerer stort sett emosjo-
ner gjennom handling eller ved å søke
hjelp av andre, trekke seg vekk fra en
stressende situasjon eller be en voksen
om trøst. Barn kan oppleve mye smerte
og ubehag i forbindelse med en kreftbe-
handling, og for de yngste barna vil det å
ikke forstå årsaken til smerten være for-
virrende. Når det gjelder barn og smerte-
opplevelse, har oppmerksomheten først
og fremst vært rettet mot de større barna
(Eiser, 1995). Innenfor den kognitive til-
nærmingen har spesielt to antagelser
vært vektlagt – hvordan forklare årsaken
til sykdommen og rasjonalet for behand-
lingen for barnet, og hvordan involvere
barnet i en tilpasset selvpleie. Tankegan-
gen er fremkommet på bakgrunn av en
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generell modell basert på synspunkter
vedrørende kognitiv utvikling, først frem-
met av Piaget (1929) og videre anvendt
spesielt i forhold til sykdom av Bibace og
Walsh (1980) og Perrin og Geritty (1981),
hvor grunnantagelsen er at forståelse av
sykdom blant barn mellom to og syv år er
overinfluert av deres umiddelbare per-
sepsjon. Årsaken til sykdom blir sett på
som et eksternt og konkret fenomen av
barnet. Det er ingen forståelse av årsak og
virkning. Eiser (1995) understreker til-
nærmingens begrensninger med hensyn
til vurdering av små barns forståelse.
Dette kan forklare hvorfor oppmerk-
somheten og ivaretagelsen spesielt har
vært rettet mot de større barna, mens
små barns behov kan ha blitt undervur-
dert.
Småbarn er avhengige av hjelp fra
voksne når de opplever stress og emosjo-
nell belastning. Tetzchner (2001) påpe-
ker at det ikke er noe klart skille mellom
emosjonell utvikling og kognitiv utvik-
ling. Følelsesmessige reaksjoner forutset-
ter alltid en vurdering av situasjonen, om
den er trygg eller farlig, gir grunn til sorg
eller glede. McGrath og McAlpine
(1993) konkluderte med at 18 måneder
gamle barn er i stand til å uttrykke at
smerte gjør vondt, lokalisere smerten,
legge merke til smerte hos andre og gjøre
forsøk på å unngå det som gjør vondt.
Barn er oppmerksomme på hvordan de
kan lindre smerten gjennom klemmer,
kyss og å spørre om medisin. Ved 3–4-
årsalderen kan barn spontant bruke av-
ledning og rapportere at å leke kan hjelpe
dem å føle seg bedre.
Skolebarn
Barn i 7–11-årsalderen er i stand til å ten-
ke om årsak til sykdommen, selv om de-
res forklaringer er begrensede. Sykdom
blir forstått å være oppstått gjennom at
kroppen er i fysisk kontakt med noe, og
internalisering. Ved det sistnevnte aksep-
terer barn at sykdommen er lokalisert
inni kroppen selv om de tror at årsaken er
ekstern. På den måten kan de ikke helt
forstå at sykdommen er et resultat av en
feil i en kroppsfunksjon.
Li og Stone rapporterte (1976 i Eiser,
1995) at bare 4 av 142 som hadde over-
levd sin kreftsykdom, hadde blitt fortalt
at de hadde kreft. Koocher og O’Malley
(1981) rapporterte at 42% av utvalget
hadde blitt informert innen ett år etter
diagnostiseringen, og 38% senere. I alt
20% hadde aldri blitt gitt noen formell
forklaring på sin sykdom av legene eller
foreldrene. I dag er man som nevnt mer
oppmerksom på at barn har behov for
detaljert informasjon om sykdommen og
behandlingen.
I den senere førskolealderen har barn
fått et større ordforråd når det gjelder
emosjonsord, og språket får stor betyd-
ning for emosjonshåndteringen. Det gjør
det lettere for barn å formidle sin egen
emosjonelle tilstand til andre, og å forstå
og regulere sine egne følelser.
Skolebarn bruker i økende grad kogni-
tive strategier som å si til seg selv at de
klarer det, eller å prøve å tenke på noe
annet. Tiåringer tar spontant i bruk kog-
nitive strategier, mens femåringer må ha
hjelp til det (Brenner & Salovey, 1997).
Barn i den tidlige skolealderen henviser
mest til foreldre som kilde til emosjonell
støtte, mens eldre barn oftere sier at de
vil søke hjelp hos venner.
Ungdom
Gjennom ungdomstiden har ungdomme-
ne fått økt forståelse for forholdet mellom
sykdom, behandling og helseforebygging.
Fra 14-årsalderen utvikles en gradvis for-
ståelse for den gjensidige avhengigheten
mellom fysisk og psykisk helse, med en
forståelse for hvordan sykdom kan være
påvirket av psykologiske faktorer.
Deling av følelser og emosjonell støtte
er sentrale elementer i ungdommers be-
skrivelser av vennskap, og de vender seg
til venner i større grad etter støtte til å
håndtere emosjonelt vanskelige situasjo-
ner. Dette er også en alder preget av stør-
re svingninger i emosjonalitet. En kreft-
diagnose kan derfor være spesielt trau-
matisk når den framtrer i løpet av ung-
domstiden (Eiser, 1995). De fleste ung-
dommer har noe viten om kreft, og vil
lett innse at de er alvorlig syke. Samtidig
er de ofte mindre i stand til å dele denne
viten enn unge voksne. Informasjonen er
kompleks og vanskelig å forstå. I tillegg
kan mange ha liten sosial støtte. De kan
ha blitt uavhengige av familien, men har
ikke selv etablert nære mellommennes-
kelige relasjoner. Kreft kan da oppleves å
bli en krise som de må håndtere alene.
Rosenberg (1979) fant at den utvik-
lingsmessig viktigste endringen i denne
aldersperioden var at ungdommene be-
gynte å oppfatte seg selv som objekt for
andres oppfatninger. Denne egosentriske
forvirringen bidrar til at ungdommer tror
at alle andre ser på dem, og derfor blir
overbekymret om sin egen framtreden.
Erikson (1959 i Eiser, 1995) hevdet at
selvsentrering eller selvopptatthet er et
kjennetegn for personer i ungdomsalde-
ren. Betydningen av venner er stor, og
kontakt med jevnaldrende kan være van-
skelig å opprettholde i faser av sykdom-
men. I forbindelse med sykdom kan ung-
dommens eventuelle negative tanker og
følelser om seg selv bidra til å vanskelig-
gjøre relasjonen med andre ungdommer,
og skape isolasjon, noe som videre kan
bidra til depresjon. Ungdommer har også
et perspektiv på fremtiden når det gjel-
der utdanning, reiser, familie. En kreft-
sykdom kan oppleves som en trussel mot
planer og drømmer i ungdommenes liv,
og derfor bidra til å forsterke sorg og
frustrasjon over å ha blitt rammet.
Selv om mange ungdommer er mod-
ne nok til å beskrive tanker og følelser når
de har kreft, har hjelpeapparatet fremde-
les en tendens til å bruke foreldre som in-
formanter. Samtidig er det klart at for-
eldre ikke er reliable informanter for sine
egne barn i alle omstendigheter, blant an-
net vil foreldrene ha begrenset kunnskap
om ungdommenes forhold til venner og
skole (Eiser, 1995). For å betrakte hvor-
dan ungdommene selv tenker om sin
kreftsykdom og andre forhold, er det vik-
tig å spørre dem direkte.
Kliniske implikasjoner
Barn må få nødvendige informasjoner og
fakta omkring sykdommen for å fremme
en mest mulig konkret forståelse, gjerne
Magisk og egosentrisk tenkning kan lede barn til å tro at det som skjedde, 
oppstod på grunn av deres tanker eller handlinger
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med bruk av relevante bøker, bildemate-
riell og hånddukker. Eiser (1998) under-
streker betydningen av å oppdatere in-
formasjonen når det skjer endringer i be-
handlingen, som ved tilbakefall, og
påpeker at dette ofte blir oversett. Det
samme gjelder spørsmål i forhold til bi-
virkninger av behandlingen. Barn med
kreft gjennomgår intensive behandlings-
prosedyrer og bivirkninger som følger
disse Barn kan i slike sammenhenger lett
miste kontroll over sine egne følelser.
Emosjonell ubalanse kan være en psykisk
konsekvens av sykdom og tøff behand-
ling, men kan også være forårsaket av
medisiner som benyttes i behandlingen.
Det er viktig ikke å frata barn ansvar i en
behandlingsmessig sammenheng og å
forklare rasjonalen for behandlingen og
diskutere effekter og eventuelt bivirknin-
ger. De voksne rundt barna må forsikre
seg om at informasjonen blir tolket og
riktig forstått (Dyregrov & Raundalen,
1996). I tillegg er det viktig at barnet blir
gitt alternative valg; det kan gi barnet en
følelse av at det selv kan påvirke og ha
innflytelse over sitt eget liv og sin egen
helse.
Barn forstår stadig mer etter hvert
som de utvikler seg, derfor er det viktig å
ta temaer opp igjen med jevne mellom-
rom. Et barn som var fem år da det fikk
sin diagnose og ble forklart om kreften og
behandlingen, vil som niåring ha behov
for ny informasjon. Det å i ettertid bli
klar over hvilken alvorlig sykdom man
har vært igjennom, kan skape usikkerhet
og bekymringer for om sykdommen kan
komme tilbake. Mange barn har med seg
en sorg og et savn etter små medpasien-
ter som døde av sykdommen. Noen barn
bærer på skyldfølelse for at de selv over-
levde sykdommen, mens kameraten ikke
gjorde det. Dyregrov og Raundalen (1996)
understreker at skyldfølelse kan oppstå
hos førskolebarn som følge av barnas
kognitive umodenhet. Magisk og egosen-
trisk tenkning kan lede dem til å tro at
det som skjedde, oppstod på grunn av
deres tanker eller handlinger. Hvis ikke
dette blir korrigert med forklaringer som
kan forhindre unødvendig skyldfølelse,
kan barnet fortsette å bære på følelsen av
at det burde eller skulle ha gjort noe.
Barn på sykehus vil bli kjent med og gjøre
erfaringer i kontakt med andre barn som
har samme sykdom eller ligger på samme
avdeling. I slike sammenhenger har barna
behov for informasjon om de andre bar-
nas sykdomssituasjon, og dette er et vok-
sent ansvar.
Informasjon til barn må betraktes som
en prosess over tid, også i et kortere per-
spektiv. Det er fordi barn tar inn kompli-
sert informasjon gradvis, og gjør konkrete
erfaringer som gjør dem i stand til å inte-
grere mer avansert informasjon i et kor-
tere perspektiv. Første behandlingsfase
preges av krise, hvor kaos, forvirring og
overveldende inntrykk tar stor plass i
barnets opplevelse. Dette medfører at in-
formasjon må gjentas. Informasjon må
være svært enkel og konkret i starten,
men kan etter hvert utvikles og utvides
også i et kortere perspektiv.
Eiser (1995) påpeker at det er utført
lite arbeid med å beskrive hvordan barn
lærer om diagnosen, og viser til studier
som har funnet at barn plukker opp in-
formasjon underveis, mer enn å lære om
sykdommen i formelle situasjoner. Barn
legger merke til endringer i nære perso-
ners følelser, eller forandringer i sykehus-
rutiner og behandlingsforløp. Van Don-
gen-Melman et al. (1995) viser til en rek-
ke studier som har dokumentert at
innhenting av nøyaktig informasjon er av
stor betydning for å redusere usikker-
hetsfølelse og tendenser til depresjon.
Barn registrerer atmosfæren og foreldre-
nes bekymringer, men unngår å spørre
fordi de vil beskytte foreldrene sine. En
syv år gammel jente fortalte om første
gangen hun kom til sykehuset, og be-
skrev følgende:
«Jeg husker veldig godt at foreldrene
mine var så triste og lei seg, mamma gråt.
Jeg skjønte at noe var galt, men jeg var så
redd og torde ikke å spørre.»
Spinetta og Spinetta (1981) viste at
barn som ikke hadde muligheten til å dis-
kutere sine bekymringer, ble tilbaketruk-
ne og bekymrede. Claflin og Barbarin
(1991) konkluderte med at effekten av å
holde tilbake informasjon var å få barna
til å føle seg ensomme og isolerte. En stu-
die av Ellis og Leventhal (1993) viser at
barna ønsket informasjon om alle aspek-
ter ved sykdommen. Selv om 78% av
barna ønsket informasjon om prognosen,
følte bare 38% av foreldrene at dette var
nødvendig. Slavin, O’Malley, Koocher og
Foster (1982) rapporterte at barn som
ble fortalt om sin diagnose innen ett år,
viste en bedre tilpasning til sykdommen
enn de som hadde blitt informert først
etter en lengre tidsperiode. Holen (1999)
påpeker at mangel på informasjon redu-
serer barnets muligheter til å forberede
seg på fremtidige hendelser, og dette ska-
per mye usikkerhet hos barnet.
Den emosjonelle ivaretagelsen
Dyregrov og Raundalen (1996) påpeker
at barn ofte føler seg ensomme med sine
følelser, og at dette kan ha en sammen-
heng med at voksne generelt undervur-
derer barnas reaksjoner, samtidig som
den voksne kan ha vanskeligheter med å
gå inn i barnas følelsesmessige verden på
grunn av sin egen sterke sorg og sitt ønske
om å beskytte barnet. Barn trenger å få
både konkret og detaljert informasjon for
å kunne forstå, og samtidig bli møtt på
sine følelser.
Det vil være en stor utfordring å ivare-
ta barnets emosjonelle behov når en som
forelder selv overveldes av bekymring og
angst. Når foreldre selv er i stand til å er-
kjenne at situasjonen er vond og vanske-
lig, kan dette åpne opp for lignende følel-
ser hos barnet (Dyregrov, 1996). En vik-
tig psykologisk intervensjon vil derfor
være å hjelpe foreldrene til å tørre å kjen-
ne etter på egne følelser, og å finne en ba-
lanse med hensyn til å åpne opp for noen
av disse overfor barnet.
I barnets hverdag på sykehuset vil det
være betydningsfullt å sette av tid til å få
tak i hvordan barnet har det følelsesmes-
sig. Både foreldre og pedagoger som om-
gås barna mellom de intensive behand-
lingsperiodene, er betydningsfulle når det
gjelder å observere barnas allmenntil-
stand og følelsesmessige reaksjoner. Sy-
kehusbarnehagen er et mer ufarlig sted
hvor barnet i større grad får bruke det
friske i seg selv, leke og utfolde seg. Den
er et viktig fristed som kan gi barn trygg-
het til å leve ut følelsesmessige aspekter.
Barnehagen og skolen er bemannet med
personell som har kunnskap om barns
situasjon og behov, voksne som barna
kjenner og har et tillitsforhold til.
Et nært tverrfaglig samarbeid mellom
yrkesgruppene, blant annet sykepleiere,
leger, pedagoger, psykologer og sosiono-
mer, er vesentlig for å kunne gi helhetlig
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og adekvat hjelp til barn med kreft og de-
res pårørende. Man må kjenne til barnets
medisinske situasjon, hvilken type infor-
masjon barnet har fått, hvordan barnet
synes å tolke og forstå informasjonen, og
hvordan barnet reagerte følelsesmessig.
Det vil være betydningsfullt å kjenne til
barnets familiesituasjon og tidligere erfa-
ringer, for eksempel om barnet har opp-
levd dødsfall og ulykker i familien. Dette
kan medføre at barnet vil ha behov for
enda grundigere informasjon og ivareta-
gelse. Den aktuelle krisen som barnet
opplever, kan aktivere tidligere kriser
som barnet og familien har opplevd.
Som hjelpere må vi tørre å spørre bar-
na om de gruer seg, gi bekreftelse på at vi
skjønner at dette er vanskelig, og norma-
lisere de naturlige følelsene i slike sam-
menhenger. Vi må vise at vi ser at barnet
for eksempel er sint, og bekrefte at det er
lov. Det handler også her om å skape et
felles fokus, en god samhandling mellom
barnet og den voksne, hvor barnet blir
bekreftet og gyldiggjort i sin situasjon.
Avhengig av alder kan det være van-
skelig for barnet å forstå sine følelser og
reaksjoner. For ungdom kan det oppleves
flaut å ha oppført seg «barnslig» i en spe-
siell situasjon, noe som kan være en helt
normal reaksjon når de er redde og følel-
sene tar helt overhånd. Forholdet mel-
lom egen framtreden og forestillingen
om hva andre tenker om dem, kan kom-
me i konflikt. Åpenhet kan bidra til å få
normalisert slike forhold, ungdommene
trenger bekreftelse på at deres atferd ikke
er unormal, og få hjelp til å mestre sin re-
aksjon.
Når åpenhet blir en utfordring
Når barn får tilbakefall av sykdommen,
er prognosen dårligere, og det er særlig
utfordrende å kunne være åpen overfor
barnet selv og deres søsken og venner. I
denne sammenhengen blir barnets utvik-
lingsstadier og modenhet viktig å ta i be-
traktning: Hva trenger barnet å vite for å
kunne forstå den endringen som har inn-
truffet? Hvor mye informasjon har bar-
net mental kapasitet til å ta innover seg?
Følgende utsagn fra en jente i tenårene
hvor det nettopp var startet opp strålebe-
handling etter tilbakefall viser utfordrin-
gene i dette: «Hva kommer til å skje hvis
ikke strålingen virker?»
Det kan være at denne jenta har mot-
tatt konkret informasjon om hva som skal
skje videre behandlingsmessig, men hen-
nes direkte spørsmål viser at hun opple-
ver uforutsigbarhet. Dyregrov og Raun-
dalen (1996) påpeker viktigheten av å få
tak i det som kan ligge bak barnets spørs-
mål, den skjulte meningen. Kanskje er det
redselen for å dø som ligger bak jentas
spørsmål. Det er vanlig å ha tanker om at
man kan dø av kreft, og spesielt ved tilba-
kefall av sykdommen kommer slike tan-
ker tilbake. Det er av stor betydning å for-
midle til barnet at man som fagperson tar
imot dette spørsmålet, og ikke snakker
det bort grunnet egen redsel og usikker-
het. I forhold til jentas spørsmål blir det
betydningsfullt å skape en meningsfull
dialog ut fra hennes oppmerksomhetsfo-
kus. Svendsen (i trykk) påpeker at barnet
vil oppleve det meningsfullt å fortsette
med å formidle seg når den voksne retter
sin oppmerksomhet mot det barnet for-
midler, er en god lytter og blir med på å
utforske nærmere hva barnet formidler.
Deling av referansepunkt er som nevnt en
forutsetning for et intersubjektivt felles-
skap og selve utgangspunktet for en me-
ningsskapende dialog (Hansen, 1991a;
Stern, 1985; Trevarthen, 1980).
Affektinntoning er en ikke-verbal em-
patisk formidling som innebærer å tone
seg inn på den andres opplevelsestilstand
(Stern, 1985). Dette forutsetter en gjen-
sidig bekreftelse gjennom deling av den
affektive tilstanden som jenta i eksemp-
let opplever. Denne inntoningsprosessen
spiller en avgjørende rolle for barns opp-
levelse av gjensidighet og mulighet for å
dele følelser. En viktig tilnærmingsmåte
overfor jenta blir i første omgang å vise at
man som hjelper ser henne og hennes
situasjon, stoppe opp og formidle forstå-
else for hennes spørsmål, få frem at man
forstår at dette er vanskelig for henne, og
forhøre seg om hun tenker mye på det,
og om hun er redd.
Å snakke åpent om døden er for man-
ge vanskelig og tabubelagt; det ligger ofte
en stor gjensidig beskyttertrang mellom
barn og voksne, spesielt i den nærmeste
familie. Dette gir utfordringer til helse-
personell i forhold til å bringe døden inn
som et naturlig tema, normalisere og
ufarliggjøre det å ha tanker om døden.
Selv svært unge barn kan ha en forståelse
av døden og hva den innebærer, og barns
holdning til døden gjennomgår ofte en
endring gjennom sykdomsforløpet. En
jente formidlet følgende: «Jeg kommer til
å dø, men mamma og pappa vet ikke at
jeg vet.»
Studier indikerer at det å samtale om
døden med sitt døende barn kan hjelpe
barnet i den vanskelige sluttfasen av livet
og foreldrene i sin sorgbearbeidelse etter-
på. Kreicberg et al. (2004) viser at ingen
av de 147 foreldrene som oppga at de
hadde snakket med barnet om døden,
angret på dette. Derimot angret 27% av
de 258 foreldrene som ikke hadde snak-
ket med barnet om døden. En god åpen-
het bidrar til at barn blir møtt på sine be-
kymringer, ikke bare i forhold til døden,
men også bekymringer for hvordan det
skal gå videre med foreldre og søsken.
Hjelperens rolle og behov
Sykepleiere og leger er nære hjelpere
som kan bidra til å gi god og aldersade-
kvat informasjon rundt den medisinske
situasjonen. De bør også være nære støt-
tespillere overfor foreldre når det gjelder
å fremme åpenhet og ivaretagelse av barn
som kommer til å dø. I tillegg vil pedago-
gisk og psykologisk kompetanse være ve-
sentlig. Fagpersoner må tørre å være til
stede i siste fase når et barn skal dø. Det
innebærer å være emosjonelt til stede for
barnet og familien. En viktig forutsetning
er at helsepersonell våger å gå inn i seg
selv, kjenne på og reflektere over egne
holdninger til døden. Fagpersoner kan
bære med seg ubearbeidede opplevelser
fra sin egen barndom. Alle som arbeider
med alvorlige syke barn, bør få faglig vei-
ledning.
Kjønnsforskjeller
Forskning tyder på at jenter snakker mer
Ingen av de 147 foreldrene som oppga at de hadde snakket med 
barnet om døden, angret på dette
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om følelser enn gutter (Dyregrov, 1994).
Jenter i førskolealderen får flere spørsmål
og kommentarer om sine emosjonelle
forhold fra foreldre og eldre søsken enn
jevnaldrende gutter gjør. Slike kjønnsfor-
skjeller viser seg også i den senere barne-
og ungdomsalderen. Jenter formidler i
større grad enn guttene at de ville snakke
med søsken eller andre om følelser hvis
de var lei seg. Jenter fokuserer mer på sel-
ve følelsen enn gutter gjør, men vil også i
større grad enn gutter bruke kognitive
strategier for å prøve å undertrykke følel-
sen. Gutter sier oftere at de bruker an-
strengende fysisk utfoldelse til å regulere
seg, for eksempel i situasjoner der de fø-
ler seg dårlige, nervøse eller bekymrede
(Brenner & Salovey, 1997). Dyregrov og
Raundalen (1996) påpeker at spesielt for
eldre gutter kan guttekulturen forsterke
bortskyving og underrapportering av fø-
lelser, men selv gutter i førskolealderen
kan ha vanskelig med å uttrykke følelser.
Gutters vanlige mestringsstrategier og
emosjonsregulering vil i en behandlings-
messig hverdag være vanskelig å gjen-
nomføre. Dette er forhold som det er
viktig å være oppmerksom på når barn
rammes av kreft. Fysisk utfoldelse vil i
stor grad begrenses som følge av aktuelle
bivirkninger fra blant annet cellegiftbe-
handlingen.
Metodiske tilnærminger
Hvordan kan man åpne opp for barns
emosjonelle opplevelser og hjelpe barnet
med å gjenkjenne følelser i bestemte si-
tuasjoner? Barnegrupper kan være en
god innfallsvinkel. Barnet får møte andre
i en lignende situasjon og får normalisert
og bekreftet egne følelser. Det er lov å
føle forskjellig, følelser er viktige og sier
noe om hvordan vi har det. Noen barn
forteller at de holder sinnefølelsen inni
seg, mens andre forteller at de bare vil
sparke og slå. Barna får også delt tanker
om hva som kan hjelpe dem.
Hvordan ivareta barns utviklingsfaser
og behov? Her er det mange innfallsvink-
ler å benytte, som leketerapi for de min-
ste, historiefortellinger, samtaler og andre
uttrykksmåter som tegning, bilder, bøker
og kunst. Fagpersonen og barnet kan lage
en fortelling sammen om en jente eller
gutt som opplever noe lignende som bar-
net selv. Dette kan oppleves ufarlig for
barnet ettersom det har en mer indirekte
innfallsvinkel, men samtidig gir barnet
mulighet til å identifisere seg med karak-
terene i historien (Dyregrov & Raunda-
len, 1996). Rollespill er en spennende
innfallsvinkel til å ta opp erfaringer fra li-
vet med behandling på sykehus. Barn kan
i rollen som lege, sykepleier eller pasient
få levd ut egne opplevelser. De rollespil-
ler kjente situasjoner, men har samtidig
nok avstand til at ikke dette blir så farlig.
Rollespill er en unik metode for å invol-
vere de helt minste barna i en gruppe-
sammenheng. Gjennom at fagpersonene
også deltar i rollespillet, gir det barna en
fin mulighet til å spørre om ting de lurer
på. Alle de nevnte tilnærmingsmåtene
bidrar til å skape et felles fokus, en inter-
aktiv prosess hvor barn og voksne, barn
seg imellom som gruppene gir mulighet
til, deler et felles referansepunkt.
Vi har sett at alvorlig sykdom hos barn
kan forstyrre samspillet og den affektive
dialogen mellom barnet og den voksne,
og dermed være en risikofaktor for bar-
nets utvikling. Et viktig spørsmål er hva
foreldrene selv trenger for å gi barnet en
slik relasjon. Individuelle samtaletilbud til
foreldrene, så vel som familieterapi, kan
være en viktig støtte. Foreldrene kan ha
opplevd tidligere kriser som reaktiveres
når barnet får kreft. Det kan være tilleggs-
vansker i familier utover barnets kreftsyk-
dom, for eksempel psykiske lidelser, og
enkelte vil i større grad trenge oppfølging.
Men kreftsykdom hos et barn er i seg selv
en risikofaktor, og kan true samspillet.
Enkelte studier indikerer også PTSD hos
foreldre til barn med kreft etter at barna
er ferdigbehandlet (Stuber, 1996).
Måleinstrumenter
Måleinstrumenter som ivaretar barnets
perspektiv, har vært mangelfulle. I begre-
pet «helserelatert livskvalitet» ligger indi-
videts subjektive opplevelse av sin helse,
sitt velvære og sin livssituasjon. Det er
gjort få systematiske forsøk på å utvikle
instrumenter til å måle livskvalitet hos
barn ved å bruke barns selvrapportering.
Faktorer som modenhet, hukommelse
og språkutvikling, skrive- og leseferdig-
heter blir vesentlig å ta hensyn til i denne
sammenhengen. Livskvalitetsintrumenter
for barn bør utvikles separat for forskjel-
lige aldersgrupper (Ringdal, 1999).
En rekke mål vedrørende helserelatert
livskvalitet for barn under åtte år er ut-
viklet, selv om de fleste omfatter for-
eldreinformasjon (Goodwin, Boggs &
Graham-Pole, 1994). Et relevant instru-
ment er Pediatric Quality of Life Inven-
tory (PedsQLTM) 4.0, utviklet av Varni
et al. (1999) og oversatt og validert for
norske forhold (Reinfjell, Diseth, Veen-
stra & Vikan, 2006). PedsQL er et kort-
fattet og alderstilpasset livskvalitetsskje-
ma, med egne selvrapporteringsskjemaer
for aldersgruppene 5–7, 8–12 og 13–18.
Foreldreversjonene går fra 2–4, 5–7, 8–
12 og 13–18, og omhandler foreldrenes
oppfatning av barnets livskvalitet. Dette
er et klinisk og forskningsmessig relevant
skjema for å kartlegge barns fysiske, emo-
sjonelle, sosiale og skolemessige funge-
ring, alle sentrale faktorer i livskvalitets-
begrepet. I tillegg gir PedsQL mulighet
til å fange opp ulike oppfatninger hos
foreldre og barn, noe som kan være et
nyttig utgangspunkt for intervensjon.
Konklusjon
For å ivareta barns behov for tilretteleg-
ging for å forstå og mestre tilværelsen
som syk vil det være avgjørende at ivare-
tagelse av informasjonsbehov og strategi-
er for å håndtere sykdommen går hånd i
hånd med ivaretagelsen av den emosjo-
nelle opplevelsen. Ivaretagelse og norma-
lisering av følelsene i gitte situasjoner vil
være av stor betydning. Åpenhet overfor
barn er spesielt vanskelig og utfordrende
når barn skal dø, til tross for at vi i dag er
mer bevisste på betydningen av åpenhet
når det gjelder barns tilpasning og mest-
ring av en vanskelig livssituasjon. Dette
bør for fremtiden vies større oppmerk-
somhet både klinisk og forskningsmessig,
og helsepersonells rolle og ansvar i denne
sammenhengen må diskuteres.
Trude Reinfjell
Psykologisk institutt, NTNU
7491 Trondheim
E-post trude.reinfjell@svt.ntnu.no 
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